{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"AC: (доксорубицин 60 + циклофосфамид 600, цикл 21 день)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":279,"table_field_ID_FFOMS":"sh0058","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CAF","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":280,"table_field_ID_FFOMS":"sh0220","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":2,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CMF","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":952,"table_field_ID_FFOMS":"sh0222","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":3,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"D: (доцетаксел 60-100)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":953,"table_field_ID_FFOMS":"sh0705","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":4,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9; C53.0; C53.1; C53.8; C53.9; C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9; C61; C15.0; C15.1; C15.2; C15.3; C15.4; C15.5; C15.8; C15.9; C16.0; C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9; C32.0; C32.1; C32.2; C32.3; C32.8; C32.9; C02.0; C02.1; C02.2; C02.3; C02.8; C02.9; C03.0; C03.1; C03.9; C04.0; C04.1; C04.8; C04.9; C05.0; C06.0; C06.1; C06.2; C06.8; C06.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4; Рак шейки матки, 2020, КР537/1; Рак яичников / рак маточной трубы / первичный рак брюшины, 2020, КР547/2; Рак предстательной железы, 2021, КР12/3; Рак пищевода и кардии, 2021, КР237/5; Рак желудка, 2020, КР574/1; Рак гортани, 2020, КР475/1; Злокачественные новообразования полости рта, 2020, КР164/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CarD (D + карбо)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":802,"table_field_ID_FFOMS":"sh0643","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":5,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9; C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9; C76.0; C76.1; C76.2; C76.3; C76.4; C76.5; C76.7; C76.8; C77.0; C77.1; C77.2; C77.3; C77.4; C77.5; C77.8; C77.9; C78.0; C78.1; C78.2; C78.3; C78.4; C78.5; C78.6; C78.7; C78.8; C79.0; C79.1; C79.2; C79.3; C79.4; C79.5; C79.6; C79.7; C79.8; C79.9; C80.0; C80.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественное новообразование бронхов и легкого, 2021, КР30/3; Рак яичников / рак маточной трубы / первичный рак брюшины, 2020, КР547/2; Опухоли невыявленной первичной локализации, 2021, КР504/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"D + трастузумаб: (доцетаксел 75 + трастузумаб 6)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":281,"table_field_ID_FFOMS":"sh0069","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":6,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"D + трастузумаб + пертузумаб: (доцетаксел 75 + пертузумаб 420 + трастузумаб 6)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":282,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":7,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"D + трастузумаб + пертузумаб: (доцетаксел 75 + пертузумаб 420 + трастузумаб п/к)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":283,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":8,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"D + трастузумаб: (доцетаксел 75 + трастузумаб п/к)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":284,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":9,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"DC: (доцетаксел 75 + циклофосфамид 600)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":803,"table_field_ID_FFOMS":"sh0072","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":10,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"DC + трастузумаб","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":285,"table_field_ID_FFOMS":"sh0996","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":11,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"DCH: (доцетаксел 75 + карбоплатин 6 + трастузумаб 6)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":286,"table_field_ID_FFOMS":"sh0066","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":12,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"DCH: (доцетаксел 75 + карбоплатин 6 + трастузумаб п/к)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":287,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":13,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"DCH + пертузумаб: (доцетаксел 75 + карбоплатин 6 + пертузумаб 420 + трастузумаб 6)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":288,"table_field_ID_FFOMS":"sh0067","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":14,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"DCH + пертузумаб: (доцетаксел 75 + карбоплатин 6 + пертузумаб 420 + трастузумаб п/к)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":289,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":15,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"EC: (циклофосфамид 600 + эпирубицин 75-120)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":290,"table_field_ID_FFOMS":"sh0680","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":16,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; C34.0; C34.1; C34.2; C34.3; C34.8; C34.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"FAC","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":804,"table_field_ID_FFOMS":"sh0189","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":17,"subscribed":null,"table_field_MKB_CODE":"C16.3; C25.0; C41.2; C50.1; C50.2; C50.3; C50.4; C50.5; C50.8; C50.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"FEC","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":291,"table_field_ID_FFOMS":"sh0213","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":18,"subscribed":null,"table_field_MKB_CODE":"C50.2; C50.4 ;C50.8; C50.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CarPac (PaC, P + карбо): (паклитаксел 175-225 + карбоплатин 5-7)","table_field_COMMENTS":"В связи с тем, что меланома может развиваться в различных органах (не только в коже), по Международной статистической классификации болезней и проблем, связанных со здоровьем (МКБ-10), такие опухоли классифицируются в соответствии с органом первичного происхождения","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":954,"table_field_ID_FFOMS":"sh0672","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":19,"subscribed":null,"table_field_MKB_CODE":"C53.0; C53.1; C53.8; C53.9; C34.0; C34.1; C34.2; C34.3; C34.8; C34.9; C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9; C54.0; C54.1; C54.2; C54.3; C54.8; C54.9; C43.0; C43.1; C43.2; C43.3; C43.4; C43.5; C43.6; C43.7; C43.8; C43.9; C51.0; C51.1; C51.2; C51.8; C51.9; C60.9; C63.2; C69.0; D03.0; D03.1; D03.2; D03.3; D03.4; D03.5; D03.6; D03.7; D03.8; D03.9; C15.0; C15.1; C15.2; C15.3; C15.4; C15.5; C15.8; C15.9; C16.0; C32.0; C32.1; C32.2; C32.3; C32.8; C32.9; C76.0; C76.1; C76.2; C76.3; C76.4; C76.5; C76.7; C76.8; C77.0; C77.1; C77.2; C77.3; C77.4; C77.5; C77.8; C77.9; C78.0; C78.1; C78.2; C78.3; C78.4; C78.5; C78.6; C78.7; C78.8; C79.0; C79.1; C79.2; C79.3; C79.4; C79.5; C79.6; C79.7; C79.8; C79.9; C80.0; C80.9; C02.0; C02.1; C02.2; C02.3; C02.8; C02.9; C03.0; C03.1; C03.9; C04.0; C04.1; C04.8; C04.9; C05.0; C06.0; C06.1; C06.2; C06.8; C06.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак пищевода и кардии, 2021, КР237/5; Меланома кожи и слизистых оболочек, 2020, КР546/1; Рак тела матки и саркомы матки, 2021, КР460/3; Опухоли невыявленной первичной локализации, 2021, КР504/2; Злокачественные новообразования полости рта, 2020, КР164/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CarPac (PaC, P + карбо): (паклитаксел 60 + карбоплатин 2)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":955,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":20,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CarPac (PaC, P + карбо): (паклитаксел 60-100 + карбоплатин 2)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":805,"table_field_ID_FFOMS":"sh0144","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":21,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; C53.0; C53.1; C53.8; C53.9; C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4; Рак яичников / рак маточной трубы / первичный рак брюшины, 2020, КР547/2; Плоскоклеточный рак кожи, 2020, КР476/2; Рак шейки матки, 2020, КР537/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"P + трастузумаб: (паклитаксел 175 + трастузумаб 6, цикл 21 день)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":292,"table_field_ID_FFOMS":"sh0150","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":22,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"P + трастузумаб: (паклитаксел 175 + трастузумаб п/к 120, цикл 21 день)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":293,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":23,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"P + трастузумаб: (паклитаксел 80 + трастузумаб 2, цикл 7 дней)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":294,"table_field_ID_FFOMS":"sh0149","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":24,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"P + трастузумаб: (паклитаксел 80 + трастузумаб п/к 120, цикл 7 дней)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":295,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":25,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"P: (паклитаксел 135-200)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":296,"table_field_ID_FFOMS":"sh0671","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":26,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9; C53.1; C53.8; C53.9; C34.0; C34.1; C34.2; C34.3; C34.8; C34.9; C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9; C54.0; C54.1; C54.2; C54.3; C54.8; C54.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак тела матки и саркомы матки, 2021, КР460/3; Рак молочной железы, 2021, КР379/4; Злокачественное новообразование бронхов и легкого, 2021, КР30/3; Рак желудка, 2020, КР574/1; Рак шейки матки, 2020, КР537/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"P: (паклитаксел 30-80)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":956,"table_field_ID_FFOMS":"sh0700","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":27,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9; C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9; C32.0; C32.1; C32.2; C32.3; C32.8; C32.9; C73; C54.0; C54.1; C54.2; C54.3; C54.8; C54.9; C02.0; C02.1; C02.2; C02.3; C02.8; C02.9; C03.0; C03.1; C03.9; C04.0; C04.1; C04.8; C04.9; C05.0; C06.0; C06.1; C06.2; C06.8; C06.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4; Рак яичников / рак маточной трубы / первичный рак брюшины, 2020, КР547/2; Дифференцированный рак щитовидной железы, 2020, КР329/1; Рак тела матки и саркомы матки, 2021, КР460/3; Рак гортани, 2020, КР475/1; Злокачественные новообразования полости рта, 2020, КР164/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Анастрозол","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":730,"table_field_ID_FFOMS":"sh0008","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":28,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9; C54.0; C54.1; C54.2; C54.3; C54.8; C54.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак тела матки и саркомы матки, 2021, КР460/3; Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Бусерелин","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":297,"table_field_ID_FFOMS":"sh0019","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":29,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9; C54.0; C54.1; C54.2; C54.3; C54.8; C54.9; C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3; Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Винорелбин: (винорелбин 25-30, цикл 21 день)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":298,"table_field_ID_FFOMS":"sh0024; sh0024.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":30,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Винорелбин: (винорелбин 60→ 80)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":299,"table_field_ID_FFOMS":"sh0304; sh0304.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":31,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Гемцитабин: (гемцитабин 800-1200, цикл 21 день)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":300,"table_field_ID_FFOMS":"sh0035; sh0035.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":32,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"GemCarbo, CarboGem: (гемцитабин 750-1000 + карбоплатин 3-6)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":957,"table_field_ID_FFOMS":"sh0634; sh0634.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":33,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; C34.0; C34.1; C34.2; C34.3; C34.8; C34.9; C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9; C67.0; C67.1; C67.2; C67.3; C67.4; C67.5; C67.6; C67.7; C67.8; C67.9; C68.0","table_field_CLINICAL_RECOMMENDATIONS":"Рак уретры, 2020, КР450/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"GC, GP: (гемцитабин 750-1250 + цисплатин 25-100)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":806,"table_field_ID_FFOMS":"sh0704; sh0704.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":34,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; C34.0; C34.1; C34.2; C34.3; C34.8; C34.9; C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9; C25.0; C25.1; C25.2; C25.3; C25.4; C25.7; C25.8; C25.9; C76.0; C76.1; C76.2; C76.3; C76.4; C76.5; C76.7; C76.8; C77.0; C77.1; C77.2; C77.3; C77.4; C77.5; C77.8; C77.9; C78.0; C78.1; C78.2; C78.3; C78.4; C78.5; C78.6; C78.7; C78.8; C79.0; C79.1; C79.2; C79.3; C79.4; C79.5; C79.6; C79.7; C79.8; C79.9; C80.0; C80.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак поджелудочной железы, 2021, КР335/4; Опухоли невыявленной первичной локализации, 2021, КР504/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Гозерелин: (гозерелин 3,6)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":301,"table_field_ID_FFOMS":"sh0047","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":35,"subscribed":null,"table_field_MKB_CODE":"С50.0; С50.1; С50.2; С50.3; С50.4; С50.5; С50.6; С50.8; С50.9; С54.0; С54.1; С54.2; С54.3; С54.8; С54.9; С61; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3; Рак молочной железы, 2021, КР379/4; Рак тела матки и саркомы матки, 2021, КР460/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Доксорубицин: (доксорубицин 20)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":302,"table_field_ID_FFOMS":"sh0927","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":36,"subscribed":null,"table_field_MKB_CODE":"C73","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Доксорубицин: (доксорубицин 40-50)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":731,"table_field_ID_FFOMS":"sh0330","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":37,"subscribed":null,"table_field_MKB_CODE":"C44.0; C44.1; C44.2; C44.3; C44.4; C44.5; C44.6; C44.7; C44.8; C44.9; D04.0; D04.1; D04.2; D04.3; D04.4; D04.5; D04.6; D04.7; D04.8; D04.9; C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак тела матки и саркомы матки, 2021, КР460/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Доксорубицин: (доксорубицин 50-75)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":807,"table_field_ID_FFOMS":"sh0639","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":38,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9; C54.0; C54.1; C54.2; C54.3; C54.8; C54.9; C44.0; C44.1; C44.2; C44.3; C44.4; C44.5; C44.6; C44.7; C44.8; C44.9; D04.0; D04.1; D04.2; D04.3; D04.4; D04.5; D04.6; D04.7; D04.8; D04.9; C73; C48.0","table_field_CLINICAL_RECOMMENDATIONS":"Рак тела матки и саркомы матки, 2021, КР460/3; Забрюшинные неорганные саркомы, 2020, КР618/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Иксабепилон","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":303,"table_field_ID_FFOMS":"sh0076","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":39,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Капецитабин: (капецитабин 1750-2500)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":808,"table_field_ID_FFOMS":"sh0650","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":40,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; C53.0; C53.1; C53.8; C53.9; C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9; C44.0; C44.1; C44.2; C44.3; C44.4; C44.5; C44.6; C44.7; C44.8; C44.9; D04.0; D04.1; D04.2; D04.3; D04.4; D04.5; D04.6; D04.7; D04.8; D04.9; C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19; C20; C25.0; C25.1; C25.2; C25.3; C25.4; C25.7; C25.8; C25.9; C32.0; C32.1; C32.2; C32.3; C32.8; C32.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак желудка, 2020, КР574/1; Рак поджелудочной железы, 2021, КР335/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Лапатиниб + капецитабин","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":304,"table_field_ID_FFOMS":"sh0110","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":41,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Лапатиниб + летрозол","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":305,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":42,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Лапатиниб + трастузумаб: (лапатиниб 1000 + трастузумаб 2)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":306,"table_field_ID_FFOMS":"sh0112","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":43,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Лапатиниб + трастузумаб: (лапатиниб 1000 + трастузумаб 6)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":307,"table_field_ID_FFOMS":"sh0112","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":44,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Лейпрорелин: (лейпрорелин 3,75)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":732,"table_field_ID_FFOMS":"sh0113","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":45,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; C54.0; C54.1; C54.2; C54.3; C54.8; C54.9; C61; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак тела матки и саркомы матки, 2021, КР460/3; Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Летрозол","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":308,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":46,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9; C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9; C54.0; C54.1; C54.2; C54.3; C54.8; C54.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4; Рак яичников / рак маточной трубы / первичный рак брюшины, 2020, КР547/2; Рак тела матки и саркомы матки, 2021, КР460/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Летрозол + палбоциклиб","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":309,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":47,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Летрозол + рибоциклиб","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":310,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":48,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Мегэстрол: (мегэстрол 160)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":809,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":49,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9; C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4; Рак яичников / рак маточной трубы / первичный рак брюшины, 2020, КР547/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Медроксипрогестерон: (медроксипрогестерон 200-500)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":311,"table_field_ID_FFOMS":"sh0660","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":50,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; C54.0; C54.1; C54.2; C54.3; C54.8; C54.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Nab-паклитаксел: (nab-паклитаксел 100-150)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":312,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":51,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Nab-паклитаксел: (nab-паклитаксел 260)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":313,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":52,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Тамоксифен: (тамоксифен 20, приём 1 раз в день)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":810,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":53,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Торемифен","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":314,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":54,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Трастузумаб эмтанзин","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":315,"table_field_ID_FFOMS":"sh0181","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":55,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Трастузумаб: (трастузумаб 2, нагрузочная доза 4)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":316,"table_field_ID_FFOMS":"sh0385","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":56,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Трастузумаб: (трастузумаб 6, нагрузочная доза 8)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":317,"table_field_ID_FFOMS":"sh0179","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":57,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Трастузумаб: (трастузумаб п/к)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":318,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":58,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Трипторелин: (трипторелин 3,75)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":733,"table_field_ID_FFOMS":"sh0182","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":59,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9; C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3; Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Фулвестрант","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":319,"table_field_ID_FFOMS":"sh0214","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":60,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Фулвестрант + палбоциклиб","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":320,"table_field_ID_FFOMS":"sh0155","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":61,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Циклофосфамид + метотрексат","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":321,"table_field_ID_FFOMS":"sh0221","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":62,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Эксеместан","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":322,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":63,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9; C54.0; C54.1; C54.2; C54.3; C54.8; C54.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4; Рак тела матки и саркомы матки, 2021, КР460/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Эксеместан + эверолимус","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":323,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":64,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Эпирубицин: (эпирубицин 60-90)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":324,"table_field_ID_FFOMS":"sh0253","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":65,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; C54.0; C54.1; C54.2; C54.3; C54.8; C54.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Эрибулин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":811,"table_field_ID_FFOMS":"sh0255; sh0255.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":66,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9; C54.0; C54.1; C54.2; C54.3; C54.8; C54.9; C48.0","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4; Рак тела матки и саркомы матки, 2021, КР460/3; Забрюшинные неорганные саркомы, 2020, КР618/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Этопозид: (этопозид 100, цикл 21 день)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":325,"table_field_ID_FFOMS":"sh0264","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":67,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Паклитаксел + трастузумаб + пертузумаб: (паклитаксел 80 + трастузумаб 6 + пертузумаб 420)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":326,"table_field_ID_FFOMS":"sh0576; sh0576.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":68,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CF, PF: (фторурацил 500 + цисплатин 50) ","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":812,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":69,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"PC, P + цисплатин: (паклитаксел 175-200 + цисплатин 60-80)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":813,"table_field_ID_FFOMS":"sh0675","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":70,"subscribed":null,"table_field_MKB_CODE":"C53.0; C53.1; C53.8; C53.9; C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9; C54.0; C54.1; C54.2; C54.3; C54.8; C54.9; C76.0; C76.1; C76.2; C76.3; C76.4; C76.5; C76.7; C76.8; C77.0; C77.1; C77.2; C77.3; C77.4; C77.5; C77.8; C77.9; C78.0; C78.1; C78.2; C78.3; C78.4; C78.5; C78.6; C78.7; C78.8; C79.0; C79.1; C79.2; C79.3; C79.4; C79.5; C79.6; C79.7; C79.8; C79.9; C80.0; C80.9","table_field_CLINICAL_RECOMMENDATIONS":"Опухоли невыявленной первичной локализации, 2021, КР504/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Цисплатин + топотекан","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":327,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":71,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак яичников / рак маточной трубы / первичный рак брюшины, 2020, КР547/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб: (бевацизумаб 7,5-15)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":814,"table_field_ID_FFOMS":"sh0011","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":72,"subscribed":null,"table_field_MKB_CODE":"C53.0; C53.1; C53.8; C53.9; C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9; C54.0; C54.1; C54.2; C54.3; C54.8; C54.9; C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19; C20; C79.3","table_field_CLINICAL_RECOMMENDATIONS":"Вторичное злокачественное новообразование головного мозга и мозговых оболочек, 2020, КР534/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Иринотекан: (иринотекан 125, цикл 21 день)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":328,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":73,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Митомицин: (митомицин 7,5)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":329,"table_field_ID_FFOMS":"sh0124","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":74,"subscribed":null,"table_field_MKB_CODE":"C53.0; C53.1; C53.8; C53.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Цисплатин: (цисплатин 50)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":330,"table_field_ID_FFOMS":"sh0224","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":75,"subscribed":null,"table_field_MKB_CODE":"C53.0; C53.1; C53.8; C53.9; C44.0; C44.1; C44.2; C44.3; C44.4; C44.5; C44.6; C44.7; C44.8; C44.9; D04.0; D04.1; D04.2; D04.3; D04.4; D04.5; D04.6; D04.7; D04.8; D04.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Иринотекан + цисплатин: (иринотекан 60 + цисплатин 40)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":331,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":76,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Паклитаксел + топотекан + бевацизумаб","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":332,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":77,"subscribed":null,"table_field_MKB_CODE":"C53.0; C53.1; C53.8; C53.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак шейки матки, 2020, КР537/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Карбоплатин: (карбоплатин 4-7)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":958,"table_field_ID_FFOMS":"sh0707","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":78,"subscribed":null,"table_field_MKB_CODE":"C53.0; C53.1; C53.8; C53.9; C02.0; C02.1; C02.2; C02.3; C02.8; C02.9; C03.0; C03.1; C03.9; C04.0; C04.1; C04.8; C04.9; C05.0; C06.0; C06.1; C06.2; C06.8; C06.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественные новообразования полости рта, 2020, КР164/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Гемцитабин: (гемцитабин 750-1000, цикл 28 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":815,"table_field_ID_FFOMS":"sh0631; sh0631.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":79,"subscribed":null,"table_field_MKB_CODE":"C53.0; C53.1; C53.8; C53.9; C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9; C54.0; C54.1; C54.2; C54.3; C54.8; C54.9; C25.0; C25.1; C25.2; C25.3; C25.4; C25.7; C25.8; C25.9; C48.0","table_field_CLINICAL_RECOMMENDATIONS":"Рак поджелудочной железы, 2021, КР335/4; Забрюшинные неорганные саркомы, 2020, КР618/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Атезолизумаб: (атезолизумаб 1200)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":333,"table_field_ID_FFOMS":"sh0450","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":80,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9; C67.0; C67.1; C67.2; C67.3; C67.4; C67.5; C67.6; C67.7; C67.8; C67.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Осимертиниб","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":334,"table_field_ID_FFOMS":"sh0491","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":81,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественное новообразование бронхов и легкого, 2021, КР30/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"CarPac (PaC, P + карбо) + бевацизумаб: (бевацизумаб 7,5-15 + карбоплатин 5-6 + паклитаксел 175-200)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":816,"table_field_ID_FFOMS":"sh0497","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":82,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественное новообразование бронхов и легкого, 2021, КР30/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Пембролизумаб: (пембролиумаб 200)","table_field_COMMENTS":"В связи с тем, что меланома может развиваться в различных органах (не только в коже), по Международной статистической классификации болезней и проблем, связанных со здоровьем (МКБ-10), такие опухоли классифицируются в соответствии с органом первичного происхождения","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1009,"table_field_ID_FFOMS":"sh0504","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":83,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9; C61; C67.0; C67.1; C67.2; C67.3; C67.4; C67.5; C67.6; C67.7; C67.8; C67.9; C43.0; C43.1; C43.2; C43.3; C43.4; C43.5; C43.6; C43.7; C43.8; C43.9; C51.0; C51.1; C51.2; C51.8; C51.9; C60.9; C63.2; C69.0; D03.0; D03.1; D03.2; D03.3; D03.4; D03.5; D03.6; D03.7; D03.8; D03.9; C44.0; C44.1; C44.2; C44.3; C44.4; C44.5; C44.6; C44.7; C44.8; C44.9; D04.0; D04.1; D04.2; D04.3; D04.4; D04.5; D04.6; D04.7; D04.8; D04.9; C15.0; C15.1; C15.2; C15.3; C15.4; C15.5; C15.8; C15.9; C16.0; C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19; C20; C25.0; C25.1; C25.2; C25.3; C25.4; C25.7; C25.8; C25.9; C22.0; C32.0; C32.1; C32.2; C32.3; C32.8; C32.9; C00.0; C00.1; C00.2; C00.3; C00.4; C00.5; C00.6; C00.8; C00.9 ; C76.0; C76.1; C76.2; C76.3; C76.4; C76.5; C76.7; C76.8; C77.0; C77.1; C77.2; C77.3; C77.4; C77.5; C77.8; C77.9; C78.0; C78.1; C78.2; C78.3; C78.4; C78.5; C78.6; C78.7; C78.8; C79.0; C79.1; C79.2; C79.3; C79.4; C79.5; C79.6; C79.7; C79.8; C79.9; C80.0; C80.9; C02.0; C02.1; C02.2; C02.3; C02.8; C02.9; C03.0; C03.1; C03.9; C04.0; C04.1; C04.8; C04.9; C05.0; C06.0; C06.1; C06.2; C06.8; C06.9; C81.0; C81.1; C81.2; C81.3; C81.4; C81.7; C81.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак пищевода и кардии, 2021, КР237/5; Рак поджелудочной железы, 2021, КР335/4; Меланома кожи и слизистых оболочек, 2020, КР546/1; Опухоли невыявленной первичной локализации, 2021, КР504/2; Злокачественные новообразования полости рта, 2020, КР164/1; Лимфома Ходжкина, 2020, КР139/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Карбоплатин + пеметрексед","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":335,"table_field_ID_FFOMS":"sh0701","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":84,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9","table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Церитиниб: (церитиниб 750)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":336,"table_field_ID_FFOMS":"sh0539","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":85,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Карбоплатин + этопозид: (карбоплатин 4-6 + этопозид 100-120)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":817,"table_field_ID_FFOMS":"sh0555","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":86,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9; C76.0; C76.1; C76.2; C76.3; C76.4; C76.5; C76.7; C76.8; C77.0; C77.1; C77.2; C77.3; C77.4; C77.5; C77.8; C77.9; C78.0; C78.1; C78.2; C78.3; C78.4; C78.5; C78.6; C78.7; C78.8; C79.0; C79.1; C79.2; C79.3; C79.4; C79.5; C79.6; C79.7; C79.8; C79.9; C80.0; C80.9","table_field_CLINICAL_RECOMMENDATIONS":"Опухоли невыявленной первичной локализации, 2021, КР504/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"EP: (цисплатин 60-80 + этопозид 120)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":818,"table_field_ID_FFOMS":"sh0556","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":87,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9; C76.0; C76.1; C76.2; C76.3; C76.4; C76.5; C76.7; C76.8; C77.0; C77.1; C77.2; C77.3; C77.4; C77.5; C77.8; C77.9; C78.0; C78.1; C78.2; C78.3; C78.4; C78.5; C78.6; C78.7; C78.8; C79.0; C79.1; C79.2; C79.3; C79.4; C79.5; C79.6; C79.7; C79.8; C79.9; C80.0; C80.9","table_field_CLINICAL_RECOMMENDATIONS":"Опухоли невыявленной первичной локализации, 2021, КР504/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Винорелбин: (винорелбин 60-80)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":819,"table_field_ID_FFOMS":"sh0565; sh0565.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":88,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Ниволумаб: (ниволумаб 3)","table_field_COMMENTS":"В связи с тем, что меланома может развиваться в различных органах (не только в коже), по Международной статистической классификации болезней и проблем, связанных со здоровьем (МКБ-10), такие опухоли классифицируются в соответствии с органом первичного происхождения ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1010,"table_field_ID_FFOMS":"sh0583","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":89,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9; C67.0; C67.1; C67.2; C67.3; C67.4; C67.5; C67.6; C67.7; C67.8; C67.9; C64; C43.0; C43.1; C43.2; C43.3; C43.4; C43.5; C43.6; C43.7; C43.8; C43.9; C51.0; C51.1; C51.2; C51.8; C51.9; C60.9; C63.2; C69.0; D03.0; D03.1; D03.2; D03.3; D03.4; D03.5; D03.6; D03.7; D03.8; D03.9; D22.0; D22.1; D22.2; D22.3; D22.4; D22.5; D22.6; D22.7; D22.9; Q82.5; C44.0; C44.1; C44.2; C44.3; C44.4; C44.5; C44.6; C44.7; C44.8; C44.9; D04.0; D04.1; D04.2; D04.3; D04.4; D04.5; D04.6; D04.7; D04.8; D04.9; C15.0; C15.1; C15.2; C15.3; C15.4; C15.5; C15.8; C15.9; C16.0; C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19; C22.0; C32.0; C32.1; C32.2; C32.3; C32.8; C32.9; C00.0; C00.1; C00.2; C00.3; C00.4; C00.5; C00.6; C00.8; C00.9; C76.0; C76.1; C76.2; C76.3; C76.4; C76.5; C76.7; C76.8; C77.0; C77.1; C77.2; C77.3; C77.4; C77.5; C77.8; C77.9; C78.0; C78.1; C78.2; C78.3; C78.4; C78.5; C78.6; C78.7; C78.8; C79.0; C79.1; C79.2; C79.3; C79.4; C79.5; C79.6; C79.7; C79.8; C79.9; C80.0; C80.9; C02.0; C02.1; C02.2; C02.3; C02.8; C02.9; C03.0; C03.1; C03.9; C04.0; C04.1; C04.8; C04.9; C05.0; C06.0; C06.1; C06.2; C06.8; C06.9; C81.0; C81.1; C81.2; C81.3; C81.4; C81.7; C81.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак пищевода и кардии, 2021, КР237/5; Меланома кожи и слизистых оболочек, 2020, КР73/3; Меланома кожи и слизистых оболочек, 2020, КР546/1; Опухоли невыявленной первичной локализации, 2021, КР504/2; Злокачественные новообразования полости рта, 2020, КР164/1; Лимфома Ходжкина, 2020, КР139/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Алектиниб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":959,"table_field_ID_FFOMS":"sh0592","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":90,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9","table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Атезолизумаб + бевацизумаб + карбоплатин + паклитаксел: (атезолизумаб 1200 + бевацизумаб 7,5 + карбоплатин 5 + паклитаксел 175)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1011,"table_field_ID_FFOMS":"sh0593","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":91,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Пембролизумаб + пеметрексед + цисплатин","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":337,"table_field_ID_FFOMS":"sh0595","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":92,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9","table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Пембролизумаб + пеметрексед + карбоплатин","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":338,"table_field_ID_FFOMS":"sh0596","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":93,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9","table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Иринотекан: (иринотекан 100)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":339,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":94,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Этопозид: (этопозид 50, 1-7 дни приёма)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":340,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":95,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"IP","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":341,"table_field_ID_FFOMS":"sh0702; sh0702.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":96,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9","table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Гемцитабин: (гемцитабин 750-1250)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":342,"table_field_ID_FFOMS":"sh0632; sh0632.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":97,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9","table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"DC: (доцетаксел 60-75 + цисплатин 75)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":960,"table_field_ID_FFOMS":"sh0644","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":98,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9; C15.0; C15.1; C15.2; C15.3; C15.4; C15.5; C15.8; C15.9; C16.0; C76.0; C76.1; C76.2; C76.3; C76.4; C76.5; C76.7; C76.8; C77.0; C77.1; C77.2; C77.3; C77.4; C77.5; C77.8; C77.9; C78.0; C78.1; C78.2; C78.3; C78.4; C78.5; C78.6; C78.7; C78.8; C79.0; C79.1; C79.2; C79.3; C79.4; C79.5; C79.6; C79.7; C79.8; C79.9; C80.0; C80.9; C02.0; C02.1; C02.2; C02.3; C02.8; C02.9; C03.0; C03.1; C03.9; C04.0; C04.1; C04.8; C04.9; C05.0; C06.0; C06.1; C06.2; C06.8; C06.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак пищевода и кардии, 2021, КР237/5; Опухоли невыявленной первичной локализации, 2021, КР504/2; Злокачественные новообразования полости рта, 2020, КР164/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Ниволумаб: (ниволумаб 240)","table_field_COMMENTS":"В связи с тем, что меланома может развиваться в различных органах (не только в коже), по Международной статистической классификации болезней и проблем, связанных со здоровьем (МКБ-10), такие опухоли классифицируются в соответствии с органом первичного происхождения","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1012,"table_field_ID_FFOMS":"sh0661","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":99,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9; C67.0; C67.1; C67.2; C67.3; C67.4; C67.5; C67.6; C67.7; C67.8; C67.9; C64; C43.0; C43.1; C43.2; C43.3; C43.4; C43.5; C43.6; C43.7; C43.8; C43.9; C51.0; C51.1; C51.2; C51.8; C51.9; C60.9; C63.2; C69.0; D03.0; D03.1; D03.2; D03.3; D03.4; D03.5; D03.6; D03.7; D03.8; D03.9; C15.0; C15.1; C15.2; C15.3; C15.4; C15.5; C15.8; C15.9; C16.0; C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19; C20; C22.0; C76.0; C76.1; C76.2; C76.3; C76.4; C76.5; C76.7; C76.8; C77.0; C77.1; C77.2; C77.3; C77.4; C77.5; C77.8; C77.9; C78.0; C78.1; C78.2; C78.3; C78.4; C78.5; C78.6; C78.7; C78.8; C79.0; C79.1; C79.2; C79.3; C79.4; C79.5; C79.6; C79.7; C79.8; C79.9; C80.0; C80.9; C81.0; C81.1; C81.2; C81.3; C81.4; C81.7; C81.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак пищевода и кардии, 2021, КР237/5; Меланома кожи и слизистых оболочек, 2020, КР546/1; Опухоли невыявленной первичной локализации, 2021, КР504/2; Лимфома Ходжкина, 2020, КР139/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Ниволумаб: (ниволумаб 480)","table_field_COMMENTS":"В связи с тем, что меланома может развиваться в различных органах (не только в коже), по Международной статистической классификации болезней и проблем, связанных со здоровьем (МКБ-10), такие опухоли классифицируются в соответствии с органом первичного происхождения","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1013,"table_field_ID_FFOMS":"sh0662","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":100,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9; C67.0; C67.1; C67.2; C67.3; C67.4; C67.5; C67.6; C67.7; C67.8; C67.9; C64; C43.0; C43.1; C43.2; C43.3; C43.4; C43.5; C43.6; C43.7; C43.8; C43.9; C51.0; C51.1; C51.2; C51.8; C51.9; C60.9; C63.2; C69.0; D03.0; D03.1; D03.2; D03.3; D03.4; D03.5; D03.6; D03.7; D03.8; D03.9; C22.0; C76.0; C76.1; C76.2; C76.3; C76.4; C76.5; C76.7; C76.8; C77.0; C77.1; C77.2; C77.3; C77.4; C77.5; C77.8; C77.9; C78.0; C78.1; C78.2; C78.3; C78.4; C78.5; C78.6; C78.7; C78.8; C79.0; C79.1; C79.2; C79.3; C79.4; C79.5; C79.6; C79.7; C79.8; C79.9; C80.0; C80.9; C81.0; C81.1; C81.2; C81.3; C81.4; C81.7; C81.9","table_field_CLINICAL_RECOMMENDATIONS":"Меланома кожи и слизистых оболочек, 2020, КР546/1; Опухоли невыявленной первичной локализации, 2021, КР504/2; Лимфома Ходжкина, 2020, КР139/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CAV, VAC: (винкристин 1,4 + доксорубицин 50 + циклофосфамид 600-1000)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":343,"table_field_ID_FFOMS":"sh0677","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":101,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Доцетаксел + нинтеданиб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":820,"table_field_ID_FFOMS":"sh0465","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":102,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественное новообразование бронхов и легкого, 2021, КР30/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Фторурацил: (фторурацил 800)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":344,"table_field_ID_FFOMS":"sh0389","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":103,"subscribed":null,"table_field_MKB_CODE":"C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"mDCF: (доцетаксел 40 + фторурацил 1000 + цисплатин 40)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":345,"table_field_ID_FFOMS":"sh0900","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":104,"subscribed":null,"table_field_MKB_CODE":"C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Рамуцирумаб","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":734,"table_field_ID_FFOMS":"sh0506","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":105,"subscribed":null,"table_field_MKB_CODE":"C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9; C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19; C20","table_field_CLINICAL_RECOMMENDATIONS":"Рак желудка, 2020, КР574/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Паклитаксел + рамуцирумаб","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":735,"table_field_ID_FFOMS":"sh0575; sh0575.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":106,"subscribed":null,"table_field_MKB_CODE":"C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак желудка, 2020, КР574/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"FOLFIRINOX","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":821,"table_field_ID_FFOMS":"sh0628","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":108,"subscribed":null,"table_field_MKB_CODE":"C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9; C25.0; C25.1; C25.2; C25.3; C25.4; C25.7; C25.8; C25.9; C76.0; C76.1; C76.2; C76.3; C76.4; C76.5; C76.7; C76.8; C77.0; C77.1; C77.2; C77.3; C77.4; C77.5; C77.8; C77.9; C78.0; C78.1; C78.2; C78.3; C78.4; C78.5; C78.6; C78.7; C78.8; C79.0; C79.1; C79.2; C79.3; C79.4; C79.5; C79.6; C79.7; C79.8; C79.9; C80.0; C80.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак желудка, 2020, КР574/1; Рак поджелудочной железы, 2021, КР335/4; Опухоли невыявленной первичной локализации, 2021, КР504/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"FOLFIRI: (иринотекан 180 + кальция фолинат 400 + фторурацил 400 + фторурацил 1000-1300, 46-часовая инфузия)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":346,"table_field_ID_FFOMS":"sh0646","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":109,"subscribed":null,"table_field_MKB_CODE":"C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9; C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19; C20","table_field_CLINICAL_RECOMMENDATIONS":"Рак желудка, 2020, КР574/1; Злокачественные новообразования ободочной кишки и ректосигмоидного отдела, КР396/1; Рак прямой кишки, 2020, КР554/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"XELOX (CAPOX, CapeOx): (капецитабин 1000 + оксалиплатин 100-130)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":822,"table_field_ID_FFOMS":"sh0653","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":110,"subscribed":null,"table_field_MKB_CODE":"C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9; C15.0; C15.1; C15.2; C15.3; C15.4; C15.5; C15.8; C15.9; C16.0; C20; C25.0; C25.1; C25.2; C25.3; C25.4; C25.7; C25.8; C25.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак пищевода и кардии, 2021, КР237/5; Рак поджелудочной железы, 2021, КР335/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"T-XELOX","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":736,"table_field_ID_FFOMS":"sh0658","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":111,"subscribed":null,"table_field_MKB_CODE":"C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак желудка, 2020, КР574/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"mFOLFOX6","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":823,"table_field_ID_FFOMS":"sh0663","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":112,"subscribed":null,"table_field_MKB_CODE":"C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9; C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19; C20; C25.0; C25.1; C25.2; C25.3; C25.4; C25.7; C25.8; C25.9; C76.0; C76.1; C76.2; C76.3; C76.4; C76.5; C76.7; C76.8; C77.0; C77.1; C77.2; C77.3; C77.4; C77.5; C77.8; C77.9; C78.0; C78.1; C78.2; C78.3; C78.4; C78.5; C78.6; C78.7; C78.8; C79.0; C79.1; C79.2; C79.3; C79.4; C79.5; C79.6; C79.7; C79.8; C79.9; C80.0; C80.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак желудка, 2020, КР574/1; Злокачественные новообразования ободочной кишки и ректосигмоидного отдела, КР396/1; Рак прямой кишки, 2020, КР554/2; Рак поджелудочной железы, 2021, КР335/4; Опухоли невыявленной первичной локализации, 2021, КР504/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"XP","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":824,"table_field_ID_FFOMS":"sh0685","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":113,"subscribed":null,"table_field_MKB_CODE":"C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9; C15.0; C15.1; C15.2; C15.3; C15.4; C15.5; C15.8; C15.9; C16.0","table_field_CLINICAL_RECOMMENDATIONS":"Рак желудка, 2020, КР574/1; Рак пищевода и кардии, 2021, КР237/5","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CarPac (PaC, P + карбо): (пакитаксел 80 + карбоплатин 5-6)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":825,"table_field_ID_FFOMS":"sh0673; sh0673.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":114,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Доксорубицин + карбоплатин: (доксорубицин 30-50 + карбоплатин 5-6)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":347,"table_field_ID_FFOMS":"sh0640","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":115,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Доксорубицин + цисплатин: (доксорубицин 30-60 + цисплатин 40-75)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":348,"table_field_ID_FFOMS":"sh0641","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":116,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9; C54.0; C54.1; C54.2; C54.3; C54.8; C54.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"GemOX: (гемцитабин 750-1000 + оксалиплатин 100-130)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1014,"table_field_ID_FFOMS":"sh0635; sh0635.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":117,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9; C81.0; C81.1; C81.2; C81.3; C81.4; C81.7; C81.9","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома Ходжкина, 2020, КР139/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Топотекан: (топотекан 1,25-1,5)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":349,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":118,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9; C54.0; C54.1; C54.2; C54.3; C54.8; C54.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак яичников / рак маточной трубы / первичный рак брюшины, 2020, КР547/2; Рак тела матки и саркомы матки, 2021, КР460/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"CarPac (PaC, P + карбо) + трастузумаб: (карбоплатин 5-6 + паклитаксел 175 + трастузумаб 6)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":826,"table_field_ID_FFOMS":"sh0494","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":119,"subscribed":null,"table_field_MKB_CODE":"C54.0; C54.1; C54.2; C54.3; C54.8; C54.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак тела матки и саркомы матки, 2021, КР460/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Трабектедин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":827,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":120,"subscribed":null,"table_field_MKB_CODE":"C54.0; C54.1; C54.2; C54.3; C54.8; C54.9; C48.0","table_field_CLINICAL_RECOMMENDATIONS":"Рак тела матки и саркомы матки, 2021, КР460/3; Забрюшинные неорганные саркомы, 2020, КР618/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Трипторелин: (трипторелин 11,25)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":350,"table_field_ID_FFOMS":"sh0534","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":121,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Сорафениб: (сорафениб 400, приём 1 раз в день)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":351,"table_field_ID_FFOMS":"sh0508","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":122,"subscribed":null,"table_field_MKB_CODE":"C64","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Сунитиниб: (сунитиниб 37,5)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":828,"table_field_ID_FFOMS":"sh0509","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":123,"subscribed":null,"table_field_MKB_CODE":"C64; C48.0","table_field_CLINICAL_RECOMMENDATIONS":"Рак паренхимы почки, 2021, КР10/3; Забрюшинные неорганные саркомы, 2020, КР618/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Сунитиниб: (сунитиниб 50, цикл 21 день)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":737,"table_field_ID_FFOMS":"sh0511","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":124,"subscribed":null,"table_field_MKB_CODE":"C64","table_field_CLINICAL_RECOMMENDATIONS":"Рак паренхимы почки, 2021, КР10/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Сунитиниб: (сунитиниб 50, цикл 42 дня)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":352,"table_field_ID_FFOMS":"sh0512","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":125,"subscribed":null,"table_field_MKB_CODE":"C64","table_field_CLINICAL_RECOMMENDATIONS":"Рак паренхимы почки, 2021, КР10/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Акситиниб: (акситиниб 5-10)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":353,"table_field_ID_FFOMS":"sh0621","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":126,"subscribed":null,"table_field_MKB_CODE":"C64","table_field_CLINICAL_RECOMMENDATIONS":"Рак паренхимы почки, 2021, КР10/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"43"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"43 (Иммунотерапия)","table_field_NAME_REGIMEN":"Интерферон альфа: (интерферон альфа 3-5 млн)","table_field_COMMENTS":"В связи с тем, что меланома может развиваться в различных органах (не только в коже), по Международной статистической классификации болезней и проблем, связанных со здоровьем (МКБ-10), такие опухоли классифицируются в соответствии с органом первичного происхождения","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":961,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":127,"subscribed":null,"table_field_MKB_CODE":"C43.0; C43.1; C43.2; C43.3; C43.4; C43.5; C43.6; C43.7; C43.8; C43.9; C51.0; C51.1; C51.2; C51.8; C51.9; C60.9; C63.2; C69.0; D03.0; D03.1; D03.2; D03.3; D03.4; D03.5; D03.6; D03.7; D03.8; D03.9; D22.0; D22.1; D22.2; D22.3; D22.4; D22.5; D22.6; D22.7; D22.9; Q82.5; C91.4","table_field_CLINICAL_RECOMMENDATIONS":"Меланома кожи и слизистых оболочек, 2020, КР546/1; Меланома кожи и слизистых оболочек, 2020, КР73/3; Волосатоклеточный лейкоз, 2020, КР130/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Карбоплатин: (карбоплатин 2)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":962,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":128,"subscribed":null,"table_field_MKB_CODE":"C44.0; C44.1; C44.2; C44.3; C44.4; C44.5; C44.6; C44.7; C44.8; C44.9; D04.0; D04.1; D04.2; D04.3; D04.4; D04.5; D04.6; D04.7; D04.8; D04.9; C32.0; C32.1; C32.2; C32.3; C32.8; C32.9","table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"FLOT: (фторурацил 2600, 24-часовая инфузия + оксалиплатин 85 + кальция фолинат 200 + доцетаксел 50)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":829,"table_field_ID_FFOMS":"sh0588","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":129,"subscribed":null,"table_field_MKB_CODE":"C15.0; C15.1; C15.2; C15.3; C15.4; C15.5; C15.8; C15.9; C16.0; C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак пищевода и кардии, 2021, КР237/5","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"XELIRI (CAPIRI): (иринотекан 180-200 + капецитабин 1600-2000)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":830,"table_field_ID_FFOMS":"sh0706","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":130,"subscribed":null,"table_field_MKB_CODE":"C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19; C25.0; C25.1; C25.2; C25.3; C25.4; C25.7; C25.8; C25.9; C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9; C20","table_field_CLINICAL_RECOMMENDATIONS":"Рак желудка, 2020, КР574/1; Рак поджелудочной железы, 2021, КР335/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб: (бевацизумаб 5-10)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":354,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":131,"subscribed":null,"table_field_MKB_CODE":"C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19; C20","table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"FOLFIRI + рамуцирумаб: (иринотекан 180 + кальция фолинат 400 + рамуцирумаб 8 + фторурацил 400 + фторурацил 1200, цикл 14 дней)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":355,"table_field_ID_FFOMS":"sh0619","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":132,"subscribed":null,"table_field_MKB_CODE":"C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19; C20","table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"FOLFIRI + афлиберцепт","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":356,"table_field_ID_FFOMS":"sh0647","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":133,"subscribed":null,"table_field_MKB_CODE":"C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19; C20","table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"FOLFIRI + бевацизумаб","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":357,"table_field_ID_FFOMS":"sh0648","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":134,"subscribed":null,"table_field_MKB_CODE":"C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19; C20","table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"GemCap: (гемцитабин 1000 + капецитабин 1660)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":831,"table_field_ID_FFOMS":"sh0629","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":135,"subscribed":null,"table_field_MKB_CODE":"C25.0; C25.1; C25.2; C25.3; C25.4; C25.7; C25.8; C25.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак поджелудочной железы, 2021, КР335/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Nab-паклитаксел + гемцитабин","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":832,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":136,"subscribed":null,"table_field_MKB_CODE":"C25.0; C25.1; C25.2; C25.3; C25.4; C25.7; C25.8; C25.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак поджелудочной железы, 2021, КР335/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"GC, GP: (гемцитабин 1000-1250 + цисплатин 25-40)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":833,"table_field_ID_FFOMS":"sh0636; sh0636.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":137,"subscribed":null,"table_field_MKB_CODE":"C22.0","table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Цисплатин + фторурацил + цетуксимаб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":963,"table_field_ID_FFOMS":"sh0398; sh0398.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":138,"subscribed":null,"table_field_MKB_CODE":"C32.0; C32.1; C32.2; C32.3; C32.8; C32.9; C00.0; C00.1; C00.2; C00.3; C00.4; C00.5; C00.6; C00.8; C00.9; C02.0; C02.1; C02.2; C02.3; C02.8; C02.9; C03.0; C03.1; C03.9; C04.0; C04.1; C04.8; C04.9; C05.0; C06.0; C06.1; C06.2; C06.8; C06.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественные новообразования полости рта, 2020, КР164/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"CarPac (PaC, P + карбо) + цетуксимаб: (карбоплатин 2,5 + паклитаксел 75-100 + цетуксимаб 250)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":834,"table_field_ID_FFOMS":"sh0674; sh0674.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":139,"subscribed":null,"table_field_MKB_CODE":"C32.0; C32.1; C32.2; C32.3; C32.8; C32.9","table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Метотрексат: (метотрексат 30-40)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":964,"table_field_ID_FFOMS":"sh0582","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":140,"subscribed":null,"table_field_MKB_CODE":"C32.0; C32.1; C32.2; C32.3; C32.8; C32.9; C02.0; C02.1; C02.2; C02.3; C02.8; C02.9; C03.0; C03.1; C03.9; C04.0; C04.1; C04.8; C04.9; C05.0; C06.0; C06.1; C06.2; C06.8; C06.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественные новообразования полости рта, 2020, КР164/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Топотекан: (топотекан 3,7-4)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":358,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":141,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Этопозид: (этопозид 50 мг, 1-21 дни приёма)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":359,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":142,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Дактиномицин: (дактиномицин 500)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":360,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":143,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Доксорубицин: (доксорубицин 20-30)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":361,"table_field_ID_FFOMS":"sh0699","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":144,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Доксорубицин: (доксорубицин 30)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":362,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":145,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Иматиниб: (иматиниб 400, 1 раз в день)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":965,"table_field_ID_FFOMS":"sh0467","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":146,"subscribed":null,"table_field_MKB_CODE":"C92.1","table_field_CLINICAL_RECOMMENDATIONS":"Хронический миелолейкоз, 2020, КР142/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Ланреотид","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":363,"table_field_ID_FFOMS":"sh0474","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":147,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Ломустин: (ломустин 110)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":364,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":148,"subscribed":null,"table_field_MKB_CODE":"C70; C71; C72; D18; D32; D33; D43","table_field_CLINICAL_RECOMMENDATIONS":"Первичные опухоли центральной нервной системы, 2020, КР578/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Ломустин: (ломустин 80)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":365,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":149,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Октреотид: (октреотид 20)","table_field_COMMENTS":"Кодирование нейроэндокринных опухолей по МКБ-10 происходит в соответствии с органной принадлежностью опухоли","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":966,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":150,"subscribed":null,"table_field_MKB_CODE":"C15.0; C15.1; C15.2; C15.3; C15.4; C15.5; C15.8; C15.9; C16.0; C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9; C17.0; C17.1; C17.2; C17.3; C17.8; C17.9; C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19.9; C20.9; C21.0; C21.1; C21.2; C21.8; C23.9; C24.0; C24.1; C24.8; C24.9; C25.0; C25.1; C25.2; C25.3; C25.4; C25.7; C25.8; C25.9; C26.0; C26.8; C26.9; C34.0; C34.1; C34.2; C34.3; C34.8; C34.9; C37.9; C73.9; C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; C44.0; C44.1; C44.2; C44.3; C44.4; C44.5; C44.6; C44.7; C44.8; C44.9; C51.0; C51.1; C51.2; C51.8; C51.9; C52.9; C53.0; C53.1; C53.8; C53.9; C54.0; C54.1; C54.2; C54.3; C54.8; C54.9; C55.9; C56.9; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9; C61.9; C64.9; C65.9; C66.9; C67.0; C67.1; C67.2; C67.3; C67.4; C67.5; C67.6; C67.7; C67.8; C67.9; C68.0; C68.1; C68.8; C68.9; C74.3","table_field_CLINICAL_RECOMMENDATIONS":"Нейроэндокринные опухоли, 2020, КР610/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Октреотид: (октреотид 30)","table_field_COMMENTS":"Кодирование нейроэндокринных опухолей по МКБ-10 происходит в соответствии с органной принадлежностью опухоли","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":967,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":151,"subscribed":null,"table_field_MKB_CODE":"C15.0; C15.1; C15.2; C15.3; C15.4; C15.5; C15.8; C15.9; C16.0; C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9; C17.0; C17.1; C17.2; C17.3; C17.8; C17.9; C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19.9; C20.9; C21.0; C21.1; C21.2; C21.8; C23.9; C24.0; C24.1; C24.8; C24.9; C25.0; C25.1; C25.2; C25.3; C25.4; C25.7; C25.8; C25.9; C26.0; C26.8; C26.9; C34.0; C34.1; C34.2; C34.3; C34.8; C34.9; C37.9; C73.9; C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; C44.0; C44.1; C44.2; C44.3; C44.4; C44.5; C44.6; C44.7; C44.8; C44.9; C51.0; C51.1; C51.2; C51.8; C51.9; C52.9; C53.0; C53.1; C53.8; C53.9; C54.0; C54.1; C54.2; C54.3; C54.8; C54.9; C55.9; C56.9; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9; C61.9; C64.9; C65.9; C66.9; C67.0; C67.1; C67.2; C67.3; C67.4; C67.5; C67.6; C67.7; C67.8; C67.9; C68.0; C68.1; C68.8; C68.9; C74.3","table_field_CLINICAL_RECOMMENDATIONS":"Нейроэндокринные опухоли, 2020, КР610/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Октреотид: (октреотид 300)","table_field_COMMENTS":"Кодирование нейроэндокринных опухолей по МКБ-10 происходит в соответствии с органной принадлежностью опухоли","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":968,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":152,"subscribed":null,"table_field_MKB_CODE":"C15.0; C15.1; C15.2; C15.3; C15.4; C15.5; C15.8; C15.9; C16.0; C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9; C17.0; C17.1; C17.2; C17.3; C17.8; C17.9; C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19.9; C20.9; C21.0; C21.1; C21.2; C21.8; C23.9; C24.0; C24.1; C24.8; C24.9; C25.0; C25.1; C25.2; C25.3; C25.4; C25.7; C25.8; C25.9; C26.0; C26.8; C26.9; C34.0; C34.1; C34.2; C34.3; C34.8; C34.9; C37.9; C73.9; C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; C44.0; C44.1; C44.2; C44.3; C44.4; C44.5; C44.6; C44.7; C44.8; C44.9; C51.0; C51.1; C51.2; C51.8; C51.9; C52.9; C53.0; C53.1; C53.8; C53.9; C54.0; C54.1; C54.2; C54.3; C54.8; C54.9; C55.9; C56.9; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9; C61.9; C64.9; C65.9; C66.9; C67.0; C67.1; C67.2; C67.3; C67.4; C67.5; C67.6; C67.7; C67.8; C67.9; C68.0; C68.1; C68.8; C68.9; C74.3","table_field_CLINICAL_RECOMMENDATIONS":"Нейроэндокринные опухоли, 2020, КР610/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Темозоломид: (темозоломид 100, цикл 28 дней)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":969,"table_field_ID_FFOMS":"sh0578; sh0578.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":153,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Этопозид: (этопозид 50 мг/м2, 1-21 дни приёма)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":366,"table_field_ID_FFOMS":"sh0580","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":154,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Нинтеданиб","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":367,"table_field_ID_FFOMS":"sh0581","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":155,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественное новообразование бронхов и легкого, 2021, КР30/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Дактиномицин: (дактиномицин 300)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":368,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":156,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Винорелбин: (винорелбин 25-30, цикл 7 дней)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":369,"table_field_ID_FFOMS":"sh0616","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":157,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Тамоксифен + трастузумаб: (тамоксифен 20 + трастузумаб 6)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":370,"table_field_ID_FFOMS":"sh0372","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":158,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + топотекан: (бевацизумаб 7,5-15 + топотекан 1,25)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":371,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":159,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак яичников / рак маточной трубы / первичный рак брюшины, 2020, КР547/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + топотекан: (бевацизумаб 7,5-15 + топотекан 3,7-4)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":372,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":160,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Торемифен + трастузумаб","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":373,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":161,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Гозерелин + флутамид: (гозерелин 10,8 + флутамид 250)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":374,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":162,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Лейпрорелин + флутамид: (лейпрорелин 22,5 + флутамид 250)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":375,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":163,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Лейпрорелин + флутамид: (лейпрорелин 45 + флутамид 250)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":376,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":164,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Бусерелин + ципротерон","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":377,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":165,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Гозерелин + ципротерон: (гозерелин 10,8 + ципротерон 250)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":378,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":166,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Гозерелин + ципротерон: (гозерелин 3,6 + ципротерон 250)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":379,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":167,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Лейпрорелин + ципротерон: (лейпрорелин 22,5 + ципротерон 250)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":380,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":168,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Лейпрорелин + ципротерон: (лейпрорелин 45 + ципротерон 250)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":381,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":169,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Лейпрорелин + ципротерон: (лейпрорелин 7,5 + ципротерон 250)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":382,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":170,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Трипторелин + ципротерон","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":383,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":171,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Цетуксимаб + цисплатин","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":384,"table_field_ID_FFOMS":"sh0399; sh0399.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":172,"subscribed":null,"table_field_MKB_CODE":"C00.0; C00.1; C00.2; C00.3; C00.4; C00.5; C00.6; C00.8; C00.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Трастузумаб + эксеместан","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":385,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":173,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Гозерелин + энзалутамид: (гозерелин 10,8 + энзалутамид 160)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":386,"table_field_ID_FFOMS":"sh0414","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":174,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Лейпрорелин + энзалутамид: (лейпрорелин 22,5 + энзалутамид 160)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":387,"table_field_ID_FFOMS":"sh0415","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":175,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Лейпрорелин + энзалутамид: (лейпрорелин 45 + энзалутамид 160)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":388,"table_field_ID_FFOMS":"sh0416","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":176,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Трастузумаб + эрибулин","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":389,"table_field_ID_FFOMS":"sh0418; sh0418.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":177,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Трастузумаб + этопозид: (трастузумаб 6 + этопозид 100)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":390,"table_field_ID_FFOMS":"sh0419","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":178,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Абиратерон + трипторелин: (абиратерон 1000 + трипторелин 11,25)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":391,"table_field_ID_FFOMS":"sh0445","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":179,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Анастрозол + бусерелин","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":392,"table_field_ID_FFOMS":"sh0447","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":180,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Анастрозол + гозерелин","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":393,"table_field_ID_FFOMS":"sh0448","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":181,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Анастрозол + лейпрорелин","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":394,"table_field_ID_FFOMS":"sh0449","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":182,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Бикалутамид + гозерелин: (бикалутамид 50 + гозерелин 3,6)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":395,"table_field_ID_FFOMS":"sh0452","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":183,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Бикалутамид + трипторелин: (бикалутамид 50 + трипторелин 11,25)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":396,"table_field_ID_FFOMS":"sh0453","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":184,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Доцетаксел + трипторелин: (доцетаксел 75 + трипторелин 11,25)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":397,"table_field_ID_FFOMS":"sh0466","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":185,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"43"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"43 (Иммунотерапия)","table_field_NAME_REGIMEN":"Интерферон альфа + ланреотид","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":398,"table_field_ID_FFOMS":"sh0469","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":186,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"43"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"43 (Иммунотерапия)","table_field_NAME_REGIMEN":"Интерферон альфа + октреотид: (интерферон альфа 3-5 + октреотид 20)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":399,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":187,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"43"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"43 (Иммунотерапия)","table_field_NAME_REGIMEN":"Интерферон альфа + октреотид: (интерферон альфа 3-5 + октреотид 30)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":400,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":188,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Ифосфамид + месна: (ифосфамид 1600-2500 + месна 1920-3000)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":401,"table_field_ID_FFOMS":"sh0472","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":189,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Ланреотид + сунитиниб","table_field_COMMENTS":"Кодирование нейроэндокринных опухолей по МКБ-10 происходит в соответствии с органной принадлежностью опухоли","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":970,"table_field_ID_FFOMS":"sh0475","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":190,"subscribed":null,"table_field_MKB_CODE":"C15.0; C15.1; C15.2; C15.3; C15.4; C15.5; C15.8; C15.9; C16.0; C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9; C17.0; C17.1; C17.2; C17.3; C17.8; C17.9; C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19.9; C20.9; C21.0; C21.1; C21.2; C21.8; C23.9; C24.0; C24.1; C24.8; C24.9; C25.0; C25.1; C25.2; C25.3; C25.4; C25.7; C25.8; C25.9; C26.0; C26.8; C26.9; C34.0; C34.1; C34.2; C34.3; C34.8; C34.9; C37.9; C73.9; C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; C44.0; C44.1; C44.2; C44.3; C44.4; C44.5; C44.6; C44.7; C44.8; C44.9; C51.0; C51.1; C51.2; C51.8; C51.9; C52.9; C53.0; C53.1; C53.8; C53.9; C54.0; C54.1; C54.2; C54.3; C54.8; C54.9; C55.9; C56.9; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9; C61.9; C64.9; C65.9; C66.9; C67.0; C67.1; C67.2; C67.3; C67.4; C67.5; C67.6; C67.7; C67.8; C67.9; C68.0; C68.1; C68.8; C68.9; C74.3","table_field_CLINICAL_RECOMMENDATIONS":"Нейроэндокринные опухоли, 2020, КР610/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Ланреотид + эверолимус","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":402,"table_field_ID_FFOMS":"sh0476","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":191,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Бусерелин + летрозол","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":403,"table_field_ID_FFOMS":"sh0478","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":192,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Гозерелин + летрозол","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":404,"table_field_ID_FFOMS":"sh0479","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":193,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Лейпрорелин + летрозол","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":405,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":194,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Ломустин + прокарбазин","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":406,"table_field_ID_FFOMS":"sh0482","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":195,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Кальция фолинат + метотрексат","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":407,"table_field_ID_FFOMS":"sh0486","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":196,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + паклитаксел: (бевацизумаб 7,5-15 + паклитаксел 60)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":408,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":197,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Октреотид + сунитиниб","table_field_COMMENTS":"Кодирование нейроэндокринных опухолей по МКБ-10 происходит в соответствии с органной принадлежностью опухоли","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":971,"table_field_ID_FFOMS":"sh0510","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":198,"subscribed":null,"table_field_MKB_CODE":"C15.0; C15.1; C15.2; C15.3; C15.4; C15.5; C15.8; C15.9; C16.0; C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9; C17.0; C17.1; C17.2; C17.3; C17.8; C17.9; C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19.9; C20.9; C21.0; C21.1; C21.2; C21.8; C23.9; C24.0; C24.1; C24.8; C24.9; C25.0; C25.1; C25.2; C25.3; C25.4; C25.7; C25.8; C25.9; C26.0; C26.8; C26.9; C34.0; C34.1; C34.2; C34.3; C34.8; C34.9; C37.9; C73.9; C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; C44.0; C44.1; C44.2; C44.3; C44.4; C44.5; C44.6; C44.7; C44.8; C44.9; C51.0; C51.1; C51.2; C51.8; C51.9; C52.9; C53.0; C53.1; C53.8; C53.9; C54.0; C54.1; C54.2; C54.3; C54.8; C54.9; C55.9; C56.9; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9; C61.9; C64.9; C65.9; C66.9; C67.0; C67.1; C67.2; C67.3; C67.4; C67.5; C67.6; C67.7; C67.8; C67.9; C68.0; C68.1; C68.8; C68.9; C74.3","table_field_CLINICAL_RECOMMENDATIONS":"Нейроэндокринные опухоли, 2020, КР610/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"TemCap: (капецитабин 2000 + темозоломид 150)","table_field_COMMENTS":"Кодирование нейроэндокринных опухолей по МКБ-10 происходит в соответствии с органной принадлежностью опухоли","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":972,"table_field_ID_FFOMS":"sh0518","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":199,"subscribed":null,"table_field_MKB_CODE":"C15.0; C15.1; C15.2; C15.3; C15.4; C15.5; C15.8; C15.9; C16.0; C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9; C17.0; C17.1; C17.2; C17.3; C17.8; C17.9; C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19.9; C20.9; C21.0; C21.1; C21.2; C21.8; C23.9; C24.0; C24.1; C24.8; C24.9; C25.0; C25.1; C25.2; C25.3; C25.4; C25.7; C25.8; C25.9; C26.0; C26.8; C26.9; C34.0; C34.1; C34.2; C34.3; C34.8; C34.9; C37.9; C73.9; C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; C44.0; C44.1; C44.2; C44.3; C44.4; C44.5; C44.6; C44.7; C44.8; C44.9; C51.0; C51.1; C51.2; C51.8; C51.9; C52.9; C53.0; C53.1; C53.8; C53.9; C54.0; C54.1; C54.2; C54.3; C54.8; C54.9; C55.9; C56.9; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9; C61.9; C64.9; C65.9; C66.9; C67.0; C67.1; C67.2; C67.3; C67.4; C67.5; C67.6; C67.7; C67.8; C67.9; C68.0; C68.1; C68.8; C68.9; C74.3","table_field_CLINICAL_RECOMMENDATIONS":"Нейроэндокринные опухоли, 2020, КР610/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Карбоплатин + темозоломид","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":409,"table_field_ID_FFOMS":"sh0520","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":200,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Темозоломид + цисплатин: (темозоломид 150 + цисплатин 80)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":410,"table_field_ID_FFOMS":"sh0522","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":201,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Ланреотид + темозоломид","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":411,"table_field_ID_FFOMS":"sh0523","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":202,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Октреотид + темозоломид: (октреотид 20 + темозоломид 150-200)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":412,"table_field_ID_FFOMS":"sh0524","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":203,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Октреотид + темозоломид: (октреотид 30 + темозоломид 150-200)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":413,"table_field_ID_FFOMS":"sh0525","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":204,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Бусерелин + торемифен","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":414,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":205,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Гозерелин + торемифен","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":415,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":206,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Лейпрорелин + торемифен","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":416,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":207,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Пертузумаб + трастузумаб","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":417,"table_field_ID_FFOMS":"sh0533","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":208,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Трипторелин + флутамид: (трипторелин 11,25 + флутамид 250)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":418,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":209,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CF, PF: (фторурацил 1000 + цисплатин 100, прием цисплатина в 1-й день)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":835,"table_field_ID_FFOMS":"sh0537","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":210,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Трастузумаб + фулвестрант","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":419,"table_field_ID_FFOMS":"sh0538","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":211,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CF, PF: (фторурацил 1000 + цисплатин 50-75)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":836,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":212,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Октреотид + эверолимус: (октреотид 20 + эверолимус 10)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":420,"table_field_ID_FFOMS":"sh0545","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":213,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Октреотид + эверолимус: (октреотид 30 + эверолимус 10)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":421,"table_field_ID_FFOMS":"sh0546","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":214,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Гозерелин + эксеместан","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":422,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":215,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Лейпрорелин + эксеместан","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":423,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":216,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Трипторелин + энзалутамид: (трипторелин 11,25 + энзалутамид 160)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":424,"table_field_ID_FFOMS":"sh0551","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":217,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Винорелбин + цисплатин: (винорелбин 60-80 + цисплатин 75-80)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":425,"table_field_ID_FFOMS":"sh0564; sh0564.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":218,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественное новообразование бронхов и легкого, 2021, КР30/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + иринотекан: (бевацизумаб 5-10 + иринотекан 125)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":426,"table_field_ID_FFOMS":"sh0570; sh0570.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":219,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + ломустин: (бевацизумаб 5-10 + ломустин 90)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":427,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":220,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"P + трастузумаб: (паклитаксел 80 + трастузумаб 6, цикл 21 день)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":428,"table_field_ID_FFOMS":"sh0577; sh0577.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":221,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Атезолизумаб + бевацизумаб: (атезолизумаб 1200 + бевацизумаб 7,5)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":429,"table_field_ID_FFOMS":"sh0594","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":222,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Пембролизумаб + пеметрексед","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":430,"table_field_ID_FFOMS":"sh0597","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":223,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественное новообразование бронхов и легкого, 2021, КР30/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Ипилимумаб + ниволумаб: (ипилимумаб 3 + ниволумаб 1)","table_field_COMMENTS":"В связи с тем, что меланома может развиваться в различных органах (не только в коже), по Международной статистической классификации болезней и проблем, связанных со здоровьем (МКБ-10), такие опухоли классифицируются в соответствии с органом первичного происхождения","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":837,"table_field_ID_FFOMS":"sh0604","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":224,"subscribed":null,"table_field_MKB_CODE":"C43.0; C43.1; C43.2; C43.3; C43.4; C43.5; C43.6; C43.7; C43.8; C43.9; C51.0; C51.1; C51.2; C51.8; C51.9; C60.9; C63.2; C69.0; D03.0; D03.1; D03.2; D03.3; D03.4; D03.5; D03.6; D03.7; D03.8; D03.9","table_field_CLINICAL_RECOMMENDATIONS":"Меланома кожи и слизистых оболочек, 2020, КР546/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Цисплатин + этопозид: (цисплатин 25 + этопозид 80)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":431,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":225,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + иринотекан: (бевацизумаб 5-10 + иринотекан 200)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":432,"table_field_ID_FFOMS":"sh0611; sh0611.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":226,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CF, PF: (фторурацил 150 + цисплатин 75)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":838,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":227,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CF, PF: (фторурацил 1000 + цисплатин 75)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":839,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":228,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Иринотекан + темозоломид: (иринотекан 250 + темозоломид 100-150)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":433,"table_field_ID_FFOMS":"sh0676","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":229,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + ломустин: (бевацизумаб 5-10 + ломустин 40)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":434,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":230,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Темозоломид + цисплатин: (темозоломид 150 + цисплатин 20)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":435,"table_field_ID_FFOMS":"sh0521","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":231,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Кальция фолинат + паклитаксел + трастузумаб + фторурацил + цисплатин","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":436,"table_field_ID_FFOMS":"sh0360","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":232,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + паклитаксел + цисплатин: (бевацизумаб 7,5-15 + паклитаксел 60-80 + цисплатин 75)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":437,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":233,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"CarPac (PaC, P + карбо) + бевацизумаб: (бевацизумаб 7,5-15 + карбоплатин 6 + паклитаксел 80)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":840,"table_field_ID_FFOMS":"sh0371; sh0371.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":234,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бусерелин + тамоксифен + трастузумаб","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":438,"table_field_ID_FFOMS":"sh0373","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":235,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Гозерелин + тамоксифен + трастузумаб","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":439,"table_field_ID_FFOMS":"sh0374","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":236,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Лейпрорелин + тамоксифен + трастузумаб","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":440,"table_field_ID_FFOMS":"sh0375","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":237,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + карбоплатин + топотекан","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":441,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":238,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бусерелин + торемифен + трастузумаб","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":442,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":239,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Гозерелин + торемифен + трастузумаб","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":443,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":240,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Метотрексат + трастузумаб + циклофосфамид: (метотрексат 2,5 + трастузумаб 6 + циклофосфамид 50)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":444,"table_field_ID_FFOMS":"sh0390","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":241,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + доксорубицин + циклофосфамид + цисплатин","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":445,"table_field_ID_FFOMS":"sh0403","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":242,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бусерелин + трастузумаб + эксеместан","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":446,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":243,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Гозерелин + трастузумаб + эксеместан","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":447,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":244,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Лейпрорелин + трастузумаб + эксеместан","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":448,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":245,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + карбоплатин + этопозид: (бевацизумаб 7,5 + карбоплатин 5 + этопозид 100)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":449,"table_field_ID_FFOMS":"sh0420","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":246,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"De Gramont + панитумумаб","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":450,"table_field_ID_FFOMS":"sh0426","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":247,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"EOF","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":451,"table_field_ID_FFOMS":"sh0428","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":248,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"GemCap: (гемцитабин 1000 + капецитабин 1250)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":452,"table_field_ID_FFOMS":"sh0434","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":249,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"HD AI: (доксорубицин 25 + ифосфамид 2500 + месна 750 + филграстим 300, дни приема филграстима 5-16)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":841,"table_field_ID_FFOMS":"sh0435","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":250,"subscribed":null,"table_field_MKB_CODE":"C48.0","table_field_CLINICAL_RECOMMENDATIONS":"Забрюшинные неорганные саркомы, 2020, КР618/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"HD I: (ифосфамид 2000 + месна 2400 + филграстим 300)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":453,"table_field_ID_FFOMS":"sh0436","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":251,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"HD MTX","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":454,"table_field_ID_FFOMS":"sh0437","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":252,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"HD VAI","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":455,"table_field_ID_FFOMS":"sh0438","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":253,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"MAID: (дакарбазин 300 + доксорубицин 20 + ифосфамид 2000 + месна 7200)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":456,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":254,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Анастрозол + пертузумаб + трастузумаб","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":457,"table_field_ID_FFOMS":"sh0446","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":255,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CAV, VAC: (винкристин 1,5 + доксорубицин 75 + филграстим 300 + циклофосфамид 1200)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":458,"table_field_ID_FFOMS":"sh0454","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":256,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Блеомицин + доксорубицин + цисплатин: (блеомицин 15 + доксорубицин 50 + цисплатин 20)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":459,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":257,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Блеомицин + доксорубицин + винкристин","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":460,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":258,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Доксорубицин + филграстим + цисплатин","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":461,"table_field_ID_FFOMS":"sh0463","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":259,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"IE: (ифосфамид 1800 + месна 2160 + этопозид 100, цикл 21 день)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":462,"table_field_ID_FFOMS":"sh0473","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":260,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Лапатиниб + летрозол + трастузумаб: (лапатиниб 1000 + летрозол 2,5 + трастузумаб 6)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":463,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":261,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Лапатиниб + летрозол + трастузумаб: (лапатиниб 1000 + летрозол 2,5 + трастузумаб 2)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":464,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":262,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Летрозол + пертузумаб + трастузумаб","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":465,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":263,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Винкристин + ломустин + прокарбазин","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":466,"table_field_ID_FFOMS":"sh0485","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":264,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Ифосфамид + паклитаксел + цисплатин","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":467,"table_field_ID_FFOMS":"sh0493","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":265,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Паклитаксел + трастузумаб + пертузумаб: (паклитаксел 175 + трастузумаб 6 + пертузумаб 420)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":468,"table_field_ID_FFOMS":"sh0496","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":266,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + паклитаксел + цисплатин: (бевацизумаб 7,5-15 + паклитаксел 175-200 + цисплатин 75-80)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":469,"table_field_ID_FFOMS":"sh0499","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":267,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Пертузумаб + тамоксифен + трастузумаб","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":470,"table_field_ID_FFOMS":"sh0513","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":268,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Капецитабин + ланреотид + темозоломид","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":471,"table_field_ID_FFOMS":"sh0515","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":269,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Капецитабин + октреотид + темозоломид: (капецитабин 2000 + октреотид 20 + темозоломид 150)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":472,"table_field_ID_FFOMS":"sh0516","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":270,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Капецитабин + октреотид + темозоломид: (капецитабин 2000 + октреотид 30 + темозоломид 150)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":473,"table_field_ID_FFOMS":"sh0517","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":271,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Пертузумаб + торемифен + трастузумаб","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":474,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":272,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Лейпрорелин + торемифен + трастузумаб","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":475,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":273,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Трастузумаб + фторурацил + цисплатин","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":476,"table_field_ID_FFOMS":"sh0544","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":274,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Пертузумаб + трастузумаб + эксеместан","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":477,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":275,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Винкристин + дактиномицин + кальция фолинат + метотрексат + циклофосфамид + этопозид","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":478,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":276,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Дактиномицин + кальция фолинат + метотрексат + цисплатин + этопозид","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":479,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":277,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"De Gramont + цетуксимаб: (кальция фолинат 400 + фторурацил 400 + фторурацил 1200 + цетуксимаб 250)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":480,"table_field_ID_FFOMS":"sh0557; sh0557.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":278,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"GD, GemTax: (гемцитабин 900 + доцетаксел 100 + филграстим 300)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":842,"table_field_ID_FFOMS":"sh0561","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":279,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"mDCF + трастузумаб","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":481,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":280,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Паклитаксел + цисплатин + этопозид","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":482,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":281,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Кальция фолинат + трастузумаб + фторурацил","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":483,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":282,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"FLOT + трастузумаб: (фторурацил 2600, 24-часовая инфузия + оксалиплатин 85 + кальция фолинат 200 + доцетаксел 50 + трастузумаб 2)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":484,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":283,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"FLOT + трастузумаб: (фторурацил 1300, 48-часовая инфузия + оксалиплатин 85 + кальция фолинат 200 + доцетаксел 50 + трастузумаб 2)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":485,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":284,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"FLOT: (фторурацил 1300, 48-часовая инфузия + оксалиплатин 85 + кальция фолинат 200 + доцетаксел 50)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":486,"table_field_ID_FFOMS":"sh0589","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":285,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Дакарбазин + фторурацил + эпирубицин","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":487,"table_field_ID_FFOMS":"sh0590","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":286,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"TemCap + бевацизумаб: (бевацизумаб 5 + капецитабин 2000 + темозоломид 150)","table_field_COMMENTS":"Кодирование нейроэндокринных опухолей по МКБ-10 происходит в соответствии с органной принадлежностью опухоли","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":973,"table_field_ID_FFOMS":"sh0591","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":287,"subscribed":null,"table_field_MKB_CODE":"C15.0; C15.1; C15.2; C15.3; C15.4; C15.5; C15.8; C15.9; C16.0; C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9; C17.0; C17.1; C17.2; C17.3; C17.8; C17.9; C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19.9; C20.9; C21.0; C21.1; C21.2; C21.8; C23.9; C24.0; C24.1; C24.8; C24.9; C25.0; C25.1; C25.2; C25.3; C25.4; C25.7; C25.8; C25.9; C26.0; C26.8; C26.9; C34.0; C34.1; C34.2; C34.3; C34.8; C34.9; C37.9; C73.9; C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; C44.0; C44.1; C44.2; C44.3; C44.4; C44.5; C44.6; C44.7; C44.8; C44.9; C51.0; C51.1; C51.2; C51.8; C51.9; C52.9; C53.0; C53.1; C53.8; C53.9; C54.0; C54.1; C54.2; C54.3; C54.8; C54.9; C55.9; C56.9; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9; C61.9; C64.9; C65.9; C66.9; C67.0; C67.1; C67.2; C67.3; C67.4; C67.5; C67.6; C67.7; C67.8; C67.9; C68.0; C68.1; C68.8; C68.9; C74.3","table_field_CLINICAL_RECOMMENDATIONS":"Нейроэндокринные опухоли, 2020, КР610/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + карбоплатин + пеметрексед: (бевацизумаб 7,5 + карбоплатин 5 + пеметрексед 500)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":488,"table_field_ID_FFOMS":"sh0601","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":288,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Доксорубицин + циклофосфамид + цисплатин: (доксорубицин 40-50 + циклофосфамид 500 + цисплатин 100)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":489,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":289,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CarPac (PaC, P + карбо): (паклитаксел 135 + паклитаксел 60 + карбоплатин 6)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":843,"table_field_ID_FFOMS":"sh0605","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":290,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"FLOT + трастузумаб: (фторурацил 400 + фторурацил 1200 + оксалиплатин 85 + кальция фолинат 200 + доцетаксел 50 + трастузумаб 2)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":490,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":291,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"FOLFIRI + октреотид","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":491,"table_field_ID_FFOMS":"sh0617","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":292,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"FOLFIRI + панитумумаб","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":492,"table_field_ID_FFOMS":"sh0618","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":293,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"FOLFIRI + цетуксимаб: (иринотекан 180 + кальция фолинат 400 + фторурацил 400 + фторурацил 1000-1300 + цетуксимаб 250)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":493,"table_field_ID_FFOMS":"sh0620; sh0620.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":294,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Ифосфамид + месна + паклитаксел + филграстим + цисплатин: (ифосфамид 1500 + месна 1500 + паклитаксел 175 + филграстим 5 + цисплатин 25)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":494,"table_field_ID_FFOMS":"sh0630","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":295,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + гемцитабин + цисплатин: (бевацизумаб 7,5-15 + гемцитабин 1000-1250 + цисплатин 75-80)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":495,"table_field_ID_FFOMS":"sh0638; sh0638.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":296,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Доцетаксел + цетуксимаб + цисплатин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":974,"table_field_ID_FFOMS":"sh0645; sh0645.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":297,"subscribed":null,"table_field_MKB_CODE":"C00.0; C00.1; C00.2; C00.3; C00.4; C00.5; C00.6; C00.8; C00.9; C02.0; C02.1; C02.2; C02.3; C02.8; C02.9; C03.0; C03.1; C03.9; C04.0; C04.1; C04.8; C04.9; C05.0; C06.0; C06.1; C06.2; C06.8; C06.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественные новообразования полости рта, 2020, КР164/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"FOLFIRI + трастузумаб: (иринотекан 180 + кальция фолинат 400 + трастузумаб 2 + фторурацил 400 + фторурацил 1000-1300)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":496,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":298,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"XELIRI (CAPIRI) + бевацизумаб: (бевацизумаб 7,5 + иринотекан 180-200 + капецитабин 1600-1800)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":497,"table_field_ID_FFOMS":"sh0652","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":299,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"XELOX (CAPOX, CapeOx) + бевацизумаб","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":844,"table_field_ID_FFOMS":"sh0654","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":300,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"XELOX (CAPOX, CapeOx) + ланреотид","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":845,"table_field_ID_FFOMS":"sh0655","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":301,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"XELOX (CAPOX, CapeOx) + октреотид: (капецитабин 1000 + оксалиплатин 100-130 + октреотид 20)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":846,"table_field_ID_FFOMS":"sh0656","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":302,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"XELOX (CAPOX, CapeOx) + октреотид: (капецитабин 1000 + оксалиплатин 100-130 + октреотид 30)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":847,"table_field_ID_FFOMS":"sh0657","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":303,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"mFOLFOX6 + бевацизумаб","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":498,"table_field_ID_FFOMS":"sh0664","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":304,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"mFOLFOX6 + ланреотид","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":499,"table_field_ID_FFOMS":"sh0665","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":305,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"mFOLFOX6 + октреотид: (оксалиплатин 85 + кальция фолинат 200-400 + фторурацил 400 + фторурацил 1200 + октреотид 20)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":500,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":306,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"mFOLFOX6 + октреотид: (оксалиплатин 85 + кальция фолинат 200-400 + фторурацил 400 + фторурацил 1200 + октреотид 30)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":501,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":307,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"mFOLFOX6 + панитумумаб","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":502,"table_field_ID_FFOMS":"sh0668","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":308,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"mFOLFOX6 + трастузумаб: (кальция фолинат 200-400 + оксалиплатин 85 + трастузумаб 2 + фторурацил 400 + фторурацил 1200)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":503,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":309,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"mFOLFOX6 + цетуксимаб: (кальция фолинат 200-400 + оксалиплатин 85 + фторурацил 400 + фторурацил 1200 + цетуксимаб 250)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":504,"table_field_ID_FFOMS":"sh0670; sh0670.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":310,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Капецитабин + цисплатин + эпирубицин","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":505,"table_field_ID_FFOMS":"sh0678","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":311,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Капецитабин + трастузумаб + цисплатин + эпирубицин","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":506,"table_field_ID_FFOMS":"sh0679","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":312,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Гемцитабин + оксалиплатин + ланреотид","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":507,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":313,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Гемцитабин + оксалиплатин + октреотид: (гемцитабин 750-1000 + оксалиплатин 100-130 + октреотид 30)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":508,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":314,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Гемцитабин + оксалиплатин + октреотид: (гемцитабин 750-1000 + оксалиплатин 100-130 + октреотид 20)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":509,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":315,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + цисплатин + этопозид: (бевацизумаб 7,5 + цисплатин 60-80 + этопозид 120)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":510,"table_field_ID_FFOMS":"sh0687","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":316,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"HD AI: (доксорубицин 25 + ифосфамид 2500 + месна 750 + филграстим 300, дни приема филграстима 5-14)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":511,"table_field_ID_FFOMS":"sh0688","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":317,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"FOLFIRI: (иринотекан 180 + кальция фолинат 400 + фторурацил 400 + фторурацил 1000-1300, 48-часовая инфузия)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":512,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":318,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Абиратерон","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":513,"table_field_ID_FFOMS":"sh0001","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":319,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Абиратерон + бусерелин","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":514,"table_field_ID_FFOMS":"sh0002","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":320,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Абиратерон + гозерелин: (абиратерон 1000 + гозерелин 3,6)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":515,"table_field_ID_FFOMS":"sh0003","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":321,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Абиратерон + дегареликс","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":516,"table_field_ID_FFOMS":"sh0004","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":322,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Абиратерон + лейпрорелин: (абиратерон 1000 + лейпрорелин 7,5)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":517,"table_field_ID_FFOMS":"sh0005","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":323,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Абиратерон + трипторелин: (абиратерон 1000 + трипторелин 3,75)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":518,"table_field_ID_FFOMS":"sh0006","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":324,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Арабинопиранозилметил нитрозомочевина","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":519,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":325,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Афатиниб","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":520,"table_field_ID_FFOMS":"sh0010","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":326,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9; C00.0; C00.1; C00.2; C00.3; C00.4; C00.5; C00.6; C00.8; C00.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Бикалутамид: (бикалутамид 150)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":521,"table_field_ID_FFOMS":"sh0012","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":327,"subscribed":null,"table_field_MKB_CODE":"C07; C08.0; C08.1; C08.8; C08.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественные опухоли слюнных желез, 2020, КР116/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Бикалутамид + бусерелин","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":522,"table_field_ID_FFOMS":"sh0013","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":328,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Бикалутамид + гозерелин: (бикалутамид 50 + гозерелин 10,8)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":523,"table_field_ID_FFOMS":"sh0014","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":329,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Бикалутамид + дегареликс","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":524,"table_field_ID_FFOMS":"sh0015","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":330,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Бикалутамид + лейпрорелин: (бикалутамид 50 + лейпрорелин 7,5)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":525,"table_field_ID_FFOMS":"sh0016","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":331,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Бикалутамид + трипторелин: (бикалутамид 1000 + трипторелин 3,75)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":526,"table_field_ID_FFOMS":"sh0017","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":332,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"BEP: (блеомицин 10 + цисплатин 20 + этопозид 100)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":848,"table_field_ID_FFOMS":"sh0018","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":333,"subscribed":null,"table_field_MKB_CODE":"C76.0; C76.1; C76.2; C76.3; C76.4; C76.5; C76.7; C76.8; C77.0; C77.1; C77.2; C77.3; C77.4; C77.5; C77.8; C77.9; C78.0; C78.1; C78.2; C78.3; C78.4; C78.5; C78.6; C78.7; C78.8; C79.0; C79.1; C79.2; C79.3; C79.4; C79.5; C79.6; C79.7; C79.8; C79.9; C80.0; C80.9","table_field_CLINICAL_RECOMMENDATIONS":"Опухоли невыявленной первичной локализации, 2021, КР504/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"43"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"43 (Иммунотерапия)","table_field_NAME_REGIMEN":"Вакцина для лечения рака мочевого пузыря БЦЖ: (БЦЖ 120)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":527,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":334,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Вандетаниб","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":528,"table_field_ID_FFOMS":"sh0021","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":335,"subscribed":null,"table_field_MKB_CODE":"C73","table_field_CLINICAL_RECOMMENDATIONS":"Медуллярный рак щитовидной железы, 2020, КР332/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Вемурафениб: (вемурафениб 960)","table_field_COMMENTS":"В связи с тем, что меланома может развиваться в различных органах (не только в коже), по Международной статистической классификации болезней и проблем, связанных со здоровьем (МКБ-10), такие опухоли классифицируются в соответствии с органом первичного происхождения","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":975,"table_field_ID_FFOMS":"sh0022","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":336,"subscribed":null,"table_field_MKB_CODE":"C43.0; C43.1; C43.2; C43.3; C43.4; C43.5; C43.6; C43.7; C43.8; C43.9; C51.0; C51.1; C51.2; C51.8; C51.9; C60.9; C63.2; C69.0; D03.0; D03.1; D03.2; D03.3; D03.4; D03.5; D03.6; D03.7; D03.8; D03.9; D22.0; D22.1; D22.2; D22.3; D22.4; D22.5; D22.6; D22.7; D22.9; Q82.5","table_field_CLINICAL_RECOMMENDATIONS":"Меланома кожи и слизистых оболочек, 2020, КР73/3; Меланома кожи и слизистых оболочек, 2020, КР546/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Вемурафениб + кобиметиниб","table_field_COMMENTS":"В связи с тем, что меланома может развиваться в различных органах (не только в коже), по Международной статистической классификации болезней и проблем, связанных со здоровьем (МКБ-10), такие опухоли классифицируются в соответствии с органом первичного происхождения","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":849,"table_field_ID_FFOMS":"sh0023","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":337,"subscribed":null,"table_field_MKB_CODE":"C43.0; C43.1; C43.2; C43.3; C43.4; C43.5; C43.6; C43.7; C43.8; C43.9; C51.0; C51.1; C51.2; C51.8; C51.9; C60.9; C63.2; C69.0; D03.0; D03.1; D03.2; D03.3; D03.4; D03.5; D03.6; D03.7; D03.8; D03.9","table_field_CLINICAL_RECOMMENDATIONS":"Меланома кожи и слизистых оболочек, 2020, КР546/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Винорелбин: (винорелбин 25-30, цикл 28 дней)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":529,"table_field_ID_FFOMS":"sh0025; sh0025.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":338,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9","table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Винорелбин + карбоплатин","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":530,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":339,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Винорелбин + трастузумаб: (винорелбин 25 + трастузумаб 6)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":531,"table_field_ID_FFOMS":"sh0027; sh0027.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":340,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Винорелбин + цисплатин: (винорелбин 25-30 + цисплатин 75-80)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":738,"table_field_ID_FFOMS":"sh0028; sh0028.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":341,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественное новообразование бронхов и легкого, 2021, КР30/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Винфлунин","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":532,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":342,"subscribed":null,"table_field_MKB_CODE":"C67.0; C67.1; C67.2; C67.3; C67.4; C67.5; C67.6; C67.7; C67.8; C67.9","table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Висмодегиб","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":976,"table_field_ID_FFOMS":"sh0030","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":343,"subscribed":null,"table_field_MKB_CODE":"C44.0; C44.1; C44.2; C44.3; C44.4; C44.5; C44.6; C44.7; C44.8; C44.9","table_field_CLINICAL_RECOMMENDATIONS":"Базальноклеточный рак кожи, 2020, КР467/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"43"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"43 (Иммунотерапия)","table_field_NAME_REGIMEN":"Интерферон альфа-2b: (интерферон альфа-2b 20 млн)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":533,"table_field_ID_FFOMS":"sh0031","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":344,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"43"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"43 (Иммунотерапия)","table_field_NAME_REGIMEN":"Интерферон альфа-2b: (интерферон альфа-2b 10 млн)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":534,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":345,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Гемцитабин: (гемцитабин 1000-3000)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":535,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":346,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + гемцитабин + карбоплатин: (бевацизумаб 7,5-15 + гемцитабин 1000 + карбоплатин 5-6)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":536,"table_field_ID_FFOMS":"sh0040; sh0040.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":347,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"GemOX: (гемцитабин 1000 + оксалиплатин 85)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":537,"table_field_ID_FFOMS":"sh0042; sh0042.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":348,"subscribed":null,"table_field_MKB_CODE":"C22.0","table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Гефитиниб","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":538,"table_field_ID_FFOMS":"sh0046","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":349,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественное новообразование бронхов и легкого, 2021, КР30/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Дабрафениб","table_field_COMMENTS":"В связи с тем, что меланома может развиваться в различных органах (не только в коже), по Международной статистической классификации болезней и проблем, связанных со здоровьем (МКБ-10), такие опухоли классифицируются в соответствии с органом первичного происхождения","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":850,"table_field_ID_FFOMS":"sh0048","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":350,"subscribed":null,"table_field_MKB_CODE":"C43.0; C43.1; C43.2; C43.3; C43.4; C43.5; C43.6; C43.7; C43.8; C43.9; C51.0; C51.1; C51.2; C51.8; C51.9; C60.9; C63.2; C69.0; D03.0; D03.1; D03.2; D03.3; D03.4; D03.5; D03.6; D03.7; D03.8; D03.9","table_field_CLINICAL_RECOMMENDATIONS":"Меланома кожи и слизистых оболочек, 2020, КР546/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Дабрафениб + траметиниб","table_field_COMMENTS":"В связи с тем, что меланома может развиваться в различных органах (не только в коже), по Международной статистической классификации болезней и проблем, связанных со здоровьем (МКБ-10), такие опухоли классифицируются в соответствии с органом первичного происхождения","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":851,"table_field_ID_FFOMS":"sh0049","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":351,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9; C43.0; C43.1; C43.2; C43.3; C43.4; C43.5; C43.6; C43.7; C43.8; C43.9; C51.0; C51.1; C51.2; C51.8; C51.9; C60.9; C63.2; C69.0; D03.0; D03.1; D03.2; D03.3; D03.4; D03.5; D03.6; D03.7; D03.8; D03.9","table_field_CLINICAL_RECOMMENDATIONS":"Меланома кожи и слизистых оболочек, 2020, КР546/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Дакарбазин: (дакарбазин 1000)","table_field_COMMENTS":"В связи с тем, что меланома может развиваться в различных органах (не только в коже), по Международной статистической классификации болезней и проблем, связанных со здоровьем (МКБ-10), такие опухоли классифицируются в соответствии с органом первичного происхождения","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":852,"table_field_ID_FFOMS":"sh0050","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":352,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9; C43.0; C43.1; C43.2; C43.3; C43.4; C43.5; C43.6; C43.7; C43.8; C43.9; C51.0; C51.1; C51.2; C51.8; C51.9; C60.9; C63.2; C69.0; D03.0; D03.1; D03.2; D03.3; D03.4; D03.5; D03.6; D03.7; D03.8; D03.9","table_field_CLINICAL_RECOMMENDATIONS":"Меланома кожи и слизистых оболочек, 2020, КР546/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Дакарбазин: (дакарбазин 250)","table_field_COMMENTS":"В связи с тем, что меланома может развиваться в различных органах (не только в коже), по Международной статистической классификации болезней и проблем, связанных со здоровьем (МКБ-10), такие опухоли классифицируются в соответствии с органом первичного происхождения","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":853,"table_field_ID_FFOMS":"sh0051","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":353,"subscribed":null,"table_field_MKB_CODE":"C43.0; C43.1; C43.2; C43.3; C43.4; C43.5; C43.6; C43.7; C43.8; C43.9; C51.0; C51.1; C51.2; C51.8; C51.9; C60.9; C63.2; C69.0; D03.0; D03.1; D03.2; D03.3; D03.4; D03.5; D03.6; D03.7; D03.8; D03.9; D22.0; D22.1; D22.2; D22.3; D22.4; D22.5; D22.6; D22.7; D22.9; Q82.5","table_field_CLINICAL_RECOMMENDATIONS":"Меланома кожи и слизистых оболочек, 2020, КР73/3; Меланома кожи и слизистых оболочек, 2020, КР546/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Дегареликс","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":539,"table_field_ID_FFOMS":"sh0052","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":354,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"EOX","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":739,"table_field_ID_FFOMS":"sh0057","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":355,"subscribed":null,"table_field_MKB_CODE":"C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак желудка, 2020, КР574/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Бусерелин + доцетаксел","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":540,"table_field_ID_FFOMS":"sh0061","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":356,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Гозерелин + доцетаксел: (гозерелин 3,6 + доцетаксел 75)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":541,"table_field_ID_FFOMS":"sh0062","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":357,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Дегареликс + доцетаксел","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":542,"table_field_ID_FFOMS":"sh0063","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":358,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Доксорубицин + доцетаксел: (доксорубицин 20 + доцетаксел 75)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":543,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":359,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Доцетаксел + лейпрорелин: (доцетаксел 75 + лейпрорелин 7,5)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":544,"table_field_ID_FFOMS":"sh0068","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":360,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Доцетаксел + трипторелин: (доцетаксел 75 + трипторелин 3,75)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":545,"table_field_ID_FFOMS":"sh0071","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":361,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"DCF","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":854,"table_field_ID_FFOMS":"sh0074","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":362,"subscribed":null,"table_field_MKB_CODE":"C15.0; C15.1; C15.2; C15.3; C15.4; C15.5; C15.8; C15.9; C16.0; C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак желудка, 2020, КР574/1; Рак пищевода и кардии, 2021, КР237/5","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Доцетаксел + фторурацил + цисплатин","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":546,"table_field_ID_FFOMS":"sh0075","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":363,"subscribed":null,"table_field_MKB_CODE":"C32.0; C32.1; C32.2; C32.3; C32.8; C32.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Иматиниб: (иматиниб 400, 2 раза в день)","table_field_COMMENTS":"В связи с тем, что меланома может развиваться в различных органах (не только в коже), по Международной статистической классификации болезней и проблем, связанных со здоровьем (МКБ-10), такие опухоли классифицируются в соответствии с органом первичного происхождения","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":855,"table_field_ID_FFOMS":"sh0077","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":364,"subscribed":null,"table_field_MKB_CODE":"C43.0; C43.1; C43.2; C43.3; C43.4; C43.5; C43.6; C43.7; C43.8; C43.9; C51.0; C51.1; C51.2; C51.8; C51.9; C60.9; C63.2; C69.0; D03.0; D03.1; D03.2; D03.3; D03.4; D03.5; D03.6; D03.7; D03.8; D03.9","table_field_CLINICAL_RECOMMENDATIONS":"Меланома кожи и слизистых оболочек, 2020, КР546/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + интерферон альфа","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":547,"table_field_ID_FFOMS":"sh0078","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":365,"subscribed":null,"table_field_MKB_CODE":"C64","table_field_CLINICAL_RECOMMENDATIONS":"Рак паренхимы почки, 2021, КР10/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"43"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"43 (Иммунотерапия)","table_field_NAME_REGIMEN":"Интерферон альфа-2b: (интерферон альфа-2b 3-5 млн)","table_field_COMMENTS":"В связи с тем, что меланома может развиваться в различных органах (не только в коже), по Международной статистической классификации болезней и проблем, связанных со здоровьем (МКБ-10), такие опухоли классифицируются в соответствии с органом первичного происхождения","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":856,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":366,"subscribed":null,"table_field_MKB_CODE":"C43.0; C43.1; C43.2; C43.3; C43.4; C43.5; C43.6; C43.7; C43.8; C43.9; C51.0; C51.1; C51.2; C51.8; C51.9; C60.9; C63.2; C69.0; D03.0; D03.1; D03.2; D03.3; D03.4; D03.5; D03.6; D03.7; D03.8; D03.9","table_field_CLINICAL_RECOMMENDATIONS":"Меланома кожи и слизистых оболочек, 2020, КР546/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"43"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"43 (Иммунотерапия)","table_field_NAME_REGIMEN":"Интерферон альфа: (интерферон альфа 9 млн)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":548,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":367,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Ипилимумаб","table_field_COMMENTS":"В связи с тем, что меланома может развиваться в различных органах (не только в коже), по Международной статистической классификации болезней и проблем, связанных со здоровьем (МКБ-10), такие опухоли классифицируются в соответствии с органом первичного происхождения","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":857,"table_field_ID_FFOMS":"sh0081","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":368,"subscribed":null,"table_field_MKB_CODE":"C43.0; C43.1; C43.2; C43.3; C43.4; C43.5; C43.6; C43.7; C43.8; C43.9; C51.0; C51.1; C51.2; C51.8; C51.9; C60.9; C63.2; C69.0; D03.0; D03.1; D03.2; D03.3; D03.4; D03.5; D03.6; D03.7; D03.8; D03.9; D22.0; D22.1; D22.2; D22.3; D22.4; D22.5; D22.6; D22.7; D22.9; Q82.5","table_field_CLINICAL_RECOMMENDATIONS":"Меланома кожи и слизистых оболочек, 2020, КР73/3; Меланома кожи и слизистых оболочек, 2020, КР546/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Иринотекан: (иринотекан 250-350)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":549,"table_field_ID_FFOMS":"sh0083","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":369,"subscribed":null,"table_field_MKB_CODE":"C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9; C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19; C20; C34.0; C34.1; C34.2; C34.3; C34.8; C34.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Иринотекан: (иринотекан 125, цикл 28 дней, дни приёма: 1,8,15,22)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":550,"table_field_ID_FFOMS":"sh0084; sh0084.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":370,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественное новообразование бронхов и легкого, 2021, КР30/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + иринотекан: (бевацизумаб 7,5 + иринотекан 250-350)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":551,"table_field_ID_FFOMS":"sh0085","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":371,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"FOLFIRI.3","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":858,"table_field_ID_FFOMS":"sh0689","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":372,"subscribed":null,"table_field_MKB_CODE":"C25.0; C25.1; C25.2; C25.3; C25.4; C25.7; C25.8; C25.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак поджелудочной железы, 2021, КР335/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Иринотекан + панитумумаб","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":552,"table_field_ID_FFOMS":"sh0087","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":373,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Иринотекан + цетуксимаб: (иринотекан 150-180 + цетуксимаб 250)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":553,"table_field_ID_FFOMS":"sh0088; sh0088.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":374,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Иринотекан + цисплатин (иринотекан 60 + цисплатин 60, цикл 21 день)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":554,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":375,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Иринотекан + цисплатин (иринотекан 60 + цисплатин 60, цикл 28 дней)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":555,"table_field_ID_FFOMS":"sh0090; sh0090.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":376,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Ифосфамид","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":556,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":377,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Ифосфамид + паклитаксел","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":557,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":378,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Ифосфамид + цисплатин","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":558,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":379,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"VeIP","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":559,"table_field_ID_FFOMS":"sh0094","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":380,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Кабазитаксел: (кабазитаксел 25)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":740,"table_field_ID_FFOMS":"sh0096","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":381,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Модифицированный De Gramont, LV5FU2: (кальция фолинат 200 + фторурацил 400 + фторурацил 1200)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":560,"table_field_ID_FFOMS":"sh0690","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":382,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + капецитабин","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":561,"table_field_ID_FFOMS":"sh0691","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":383,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Капецитабин + трастузумаб","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":562,"table_field_ID_FFOMS":"sh0104","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":384,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Кризотиниб: (кризотиниб 250)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4746,"table_field_ID_FFOMS":"sh0109","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":385,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9; C84.5; C84.6; C84.7; C84.9; C86.0; C86.5","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественное новообразование бронхов и легкого, 2021, КР30/3; Нодальные Т-клеточные лимфомы, 2020, КР138/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Ленватиниб: (ленватиниб 24)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":563,"table_field_ID_FFOMS":"sh0114","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":386,"subscribed":null,"table_field_MKB_CODE":"C73","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Ленватиниб + эверолимус","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":564,"table_field_ID_FFOMS":"sh0115","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":387,"subscribed":null,"table_field_MKB_CODE":"C64","table_field_CLINICAL_RECOMMENDATIONS":"Рак паренхимы почки, 2021, КР10/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"MVAC, M-VAC","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":977,"table_field_ID_FFOMS":"sh0121; sh0121.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":388,"subscribed":null,"table_field_MKB_CODE":"C67.0; C67.1; C67.2; C67.3; C67.4; C67.5; C67.6; C67.7; C67.8; C67.9; C68.0","table_field_CLINICAL_RECOMMENDATIONS":" Рак уретры, 2020, КР450/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Митоксантрон","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":565,"table_field_ID_FFOMS":"sh0122","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":389,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Митомицин: (митомицин 40)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":566,"table_field_ID_FFOMS":"sh0123","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":390,"subscribed":null,"table_field_MKB_CODE":"C67.0; C67.1; C67.2; C67.3; C67.4; C67.5; C67.6; C67.7; C67.8; C67.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Иринотекан + митомицин: (иринотекан 125 + митомицин 6)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":567,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":391,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Оксалиплатин","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":568,"table_field_ID_FFOMS":"sh0128","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":392,"subscribed":null,"table_field_MKB_CODE":"C54.0; C54.1; C54.2; C54.3; C54.8; C54.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак тела матки и саркомы матки, 2021, КР460/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"FOLFOX4: (кальция фолинат 200 + оксалиплатин 85 + фторурацил 400 + фторурацил 600, цикл 14 дней)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":569,"table_field_ID_FFOMS":"sh0130","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":393,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Олапариб: (олапариб 400)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":570,"table_field_ID_FFOMS":"sh0134","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":394,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Пазопаниб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":859,"table_field_ID_FFOMS":"sh0135","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":395,"subscribed":null,"table_field_MKB_CODE":"C54.0; C54.1; C54.2; C54.3; C54.8; C54.9; C64; C48.0","table_field_CLINICAL_RECOMMENDATIONS":"Рак тела матки и саркомы матки, 2021, КР460/3; Рак паренхимы почки, 2021, КР10/3; Забрюшинные неорганные саркомы, 2020, КР618/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"P: (паклитаксел 80, цикл 28 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":860,"table_field_ID_FFOMS":"sh0139; sh0139.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":396,"subscribed":null,"table_field_MKB_CODE":"C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9; C34.0; C34.1; C34.2; C34.3; C34.8; C34.9; C48.0","table_field_CLINICAL_RECOMMENDATIONS":"Забрюшинные неорганные саркомы, 2020, КР618/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"TGO","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":571,"table_field_ID_FFOMS":"sh0140; sh0140.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":397,"subscribed":null,"table_field_MKB_CODE":" ","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CarPac (PaC, P + карбо): (паклитаксел 135-175 + карбоплатин 5-6)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":861,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":398,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"CarPac (PaC, P + карбо) + трастузумаб: (карбоплатин 2 + паклитаксел 60 + трастузумаб 2)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":862,"table_field_ID_FFOMS":"sh0145","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":399,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"P + цисплатин: (паклитаксел 135 + цисплатин 75 + паклитаксел 60)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":863,"table_field_ID_FFOMS":"sh0153","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":400,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Кальция фолинат + паклитаксел + фторурацил + цисплатин","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":572,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":401,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Фулвестрант + палбоциклиб + бусерелин","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":573,"table_field_ID_FFOMS":"sh0156","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":402,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Фулвестрант + палбоциклиб + гозерелин","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":574,"table_field_ID_FFOMS":"sh0157","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":403,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Фулвестрант + палбоциклиб + лейпрорелин","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":575,"table_field_ID_FFOMS":"sh0158","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":404,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Панитумумаб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":864,"table_field_ID_FFOMS":"sh0159","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":405,"subscribed":null,"table_field_MKB_CODE":"C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19; C20; C44.0; C44.1; C44.2; C44.3; C44.4; C44.5; C44.6; C44.7; C44.8; C44.9; D04.0; D04.1; D04.2; D04.3; D04.4; D04.5; D04.6; D04.7; D04.8; D04.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Пембролизумаб: (пембролиумаб 2)","table_field_COMMENTS":"В связи с тем, что меланома может развиваться в различных органах (не только в коже), по Международной статистической классификации болезней и проблем, связанных со здоровьем (МКБ-10), такие опухоли классифицируются в соответствии с органом первичного происхождения","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":865,"table_field_ID_FFOMS":"sh0160","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":406,"subscribed":null,"table_field_MKB_CODE":"C15.0; C15.1; C15.2; C15.3; C15.4; C15.5; C15.8; C15.9; C16.0; C44.0; C44.1; C44.2; C44.3; C44.4; C44.5; C44.6; C44.7; C44.8; C44.9; D04.0; D04.1; D04.2; D04.3; D04.4; D04.5; D04.6; D04.7; D04.8; D04.9; C43.0; C43.1; C43.2; C43.3; C43.4; C43.5; C43.6; C43.7; C43.8; C43.9; C51.0; C51.1; C51.2; C51.8; C51.9; C60.9; C63.2; C69.0; D03.0; D03.1; D03.2; D03.3; D03.4; D03.5; D03.6; D03.7; D03.8; D03.9; D22.0; D22.1; D22.2; D22.3; D22.4; D22.5; D22.6; D22.7; D22.9; Q82.5; C76.0; C76.1; C76.2; C76.3; C76.4; C76.5; C76.7; C76.8; C77.0; C77.1; C77.2; C77.3; C77.4; C77.5; C77.8; C77.9; C78.0; C78.1; C78.2; C78.3; C78.4; C78.5; C78.6; C78.7; C78.8; C79.0; C79.1; C79.2; C79.3; C79.4; C79.5; C79.6; C79.7; C79.8; C79.9; C80.0; C80.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак пищевода и кардии, 2021, КР237/5; Меланома кожи и слизистых оболочек, 2020, КР73/3; Опухоли невыявленной первичной локализации, 2021, КР504/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Пеметрексед","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":576,"table_field_ID_FFOMS":"sh0161","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":407,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9; C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Пеметрексед + цисплатин","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":741,"table_field_ID_FFOMS":"sh0162","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":408,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественное новообразование бронхов и легкого, 2021, КР30/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + пеметрексед + цисплатин: (бевацизумаб 7,5 + пеметрексед 500 + цисплатин 75)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":742,"table_field_ID_FFOMS":"sh0163","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":409,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественное новообразование бронхов и легкого, 2021, КР30/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Регорафениб: (регорафениб 160)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":577,"table_field_ID_FFOMS":"sh0164","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":410,"subscribed":null,"table_field_MKB_CODE":"C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19; C20; C22.0","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Сорафениб: (сорафениб 400, приём 2 раза в день)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":866,"table_field_ID_FFOMS":"sh0165","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":411,"subscribed":null,"table_field_MKB_CODE":"C22.0; C64; C48.0","table_field_CLINICAL_RECOMMENDATIONS":"Забрюшинные неорганные саркомы, 2020, КР618/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Тамоксифен: (тамоксифен 20, приём 2 раза в день)","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":867,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":412,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Бусерелин + тамоксифен","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":578,"table_field_ID_FFOMS":"sh0169","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":413,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Гозерелин + тамоксифен","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":579,"table_field_ID_FFOMS":"sh0170","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":414,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Лейпрорелин + тамоксифен","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":580,"table_field_ID_FFOMS":"sh0171","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":415,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Темозоломид: (темозоломид 150-300)","table_field_COMMENTS":"В связи с тем, что меланома может развиваться в различных органах (не только в коже), по Международной статистической классификации болезней и проблем, связанных со здоровьем (МКБ-10), такие опухоли классифицируются в соответствии с органом первичного происхождения. Кодирование нейроэндокринных опухолей по МКБ-10 происходит в соответствии с органной принадлежностью опухоли","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":978,"table_field_ID_FFOMS":"sh0693","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":416,"subscribed":null,"table_field_MKB_CODE":"C43.0; C43.1; C43.2; C43.3; C43.4; C43.5; C43.6; C43.7; C43.8; C43.9; C51.0; C51.1; C51.2; C51.8; C51.9; C60.9; C63.2; C69.0; D03.0; D03.1; D03.2; D03.3; D03.4; D03.5; D03.6; D03.7; D03.8; D03.9; C54.0; C54.1; C54.2; C54.3; C54.8; C54.9; C15.0; C15.1; C15.2; C15.3; C15.4; C15.5; C15.8; C15.9; C16.0; C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9; C17.0; C17.1; C17.2; C17.3; C17.8; C17.9; C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19.9; C20.9; C21.0; C21.1; C21.2; C21.8; C23.9; C24.0; C24.1; C24.8; C24.9; C25.0; C25.1; C25.2; C25.3; C25.4; C25.7; C25.8; C25.9; C26.0; C26.8; C26.9; C34.0; C34.1; C34.2; C34.3; C34.8; C34.9; C37.9; C73.9; C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; C44.0; C44.1; C44.2; C44.3; C44.4; C44.5; C44.6; C44.7; C44.8; C44.9; C52.9; C53.0; C53.1; C53.8; C53.9; C55.9; C56.9; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9; C61.9; C64.9; C65.9; C66.9; C67.0; C67.1; C67.2; C67.3; C67.4; C67.5; C67.6; C67.7; C67.8; C67.9; C68.0; C68.1; C68.8; C68.9; C74.3","table_field_CLINICAL_RECOMMENDATIONS":"Рак тела матки и саркомы матки, 2021, КР460/3; Меланома кожи и слизистых оболочек, 2020, КР546/1; Нейроэндокринные опухоли, 2020, КР610/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Темсиролимус","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":581,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":417,"subscribed":null,"table_field_MKB_CODE":"C64","table_field_CLINICAL_RECOMMENDATIONS":"Рак паренхимы почки, 2021, КР10/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Тиотепа","table_field_COMMENTS":" ","table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":582,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":418,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Топотекан: (топотекан 1,5)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":1,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":419,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Карбоплатин + топотекан","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":2,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":420,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак яичников / рак маточной трубы / первичный рак брюшины, 2020, КР547/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"T-XP","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":583,"table_field_ID_FFOMS":"sh0180","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":421,"subscribed":null,"table_field_MKB_CODE":"C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак желудка, 2020, КР574/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Флутамид","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":3,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":422,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Бусерелин + флутамид: (бусерелин 3,75 + флутамид 250)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":4,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":423,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Гозерелин + флутамид: (гозерелин 3,6 + флутамид 250)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":5,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":424,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Дегареликс + флутамид: (дегареликс 80 + флутамид 250)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":6,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":425,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Лейпрорелин + флутамид: (лейпрорелин 7,5 + флутамид 250)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":7,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":426,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Трипторелин + флутамид: (трипторелин 3,75 + флутамид 250)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":8,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":427,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"AIO","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":9,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":428,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Модифицированный De Gramont, LV5FU2: (кальция фолинат 400 + фторурацил 400 + фторурацил 1200)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":584,"table_field_ID_FFOMS":"sh0191","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":429,"subscribed":null,"table_field_MKB_CODE":"C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Roswell Park","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":10,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":430,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Мейо","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":868,"table_field_ID_FFOMS":"sh0695","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":431,"subscribed":null,"table_field_MKB_CODE":"C25.0; C25.1; C25.2; C25.3; C25.4; C25.7; C25.8; C25.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак поджелудочной железы, 2021, КР335/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"AIO + бевацизумаб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":11,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":432,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"De Gramont + бевацизумаб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":12,"table_field_ID_FFOMS":"sh0195","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":433,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Rosswell Park + бевацизумаб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":13,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":434,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Мейо + бевацизумаб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":14,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":435,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"FLOX: (кальция фолинат 250 + оксалиплатин 85 + фторурацил 500)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":585,"table_field_ID_FFOMS":"sh0880; sh0880.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":436,"subscribed":null,"table_field_MKB_CODE":"C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19; C20","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественные новообразования ободочной кишки и ректосигмоидного отдела, КР396/1; Рак прямой кишки, 2020, КР554/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"FLOX + бевацизумаб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":15,"table_field_ID_FFOMS":"sh0204; sh0204.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":437,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"FOLFOXIRI","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":586,"table_field_ID_FFOMS":"sh0206","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":438,"subscribed":null,"table_field_MKB_CODE":"C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19; C20","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественные новообразования ободочной кишки и ректосигмоидного отдела, КР396/1; Рак прямой кишки, 2020, КР554/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"FOLFOXIRI + бевацизумаб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":16,"table_field_ID_FFOMS":"sh0207","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":439,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"FOLFOXIRI + панитумумаб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":17,"table_field_ID_FFOMS":"sh0208","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":440,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"FOLFOXIRI + цетуксимаб: (иринотекан 165 + кальция фолинат 200 + оксалиплатин 85 + фторурацил 1600 + цетуксимаб 250)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":18,"table_field_ID_FFOMS":"sh0209; sh0209.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":441,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"FLOT: (фторурацил 1200 + фторурацил 400 + оксалиплатин 85 + кальция фолинат 200 + доцетаксел 50)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":587,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":442,"subscribed":null,"table_field_MKB_CODE":" ","table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Бусерелин + фулвестрант","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":19,"table_field_ID_FFOMS":"sh0215","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":443,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Гозерелин + фулвестрант","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":20,"table_field_ID_FFOMS":"sh0216","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":444,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Лейпрорелин + фулвестрант","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":21,"table_field_ID_FFOMS":"sh0217","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":445,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Цетуксимаб: (цетуксимаб 250, нагрузочная доза 400, цикл 7 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":588,"table_field_ID_FFOMS":"sh0218","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":446,"subscribed":null,"table_field_MKB_CODE":"C44.0; C44.1; C44.2; C44.3; C44.4; C44.5; C44.6; C44.7; C44.8; C44.9; D04.0; D04.1; D04.2; D04.3; D04.4; D04.5; D04.6; D04.7; D04.8; D04.9; C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19; C20; C32.0; C32.1; C32.2; C32.3; C32.8; C32.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Ципротерон","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":22,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":447,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Цисплатин: (цисплатин 100, цикл 28 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":23,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":448,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Винбластин + дакарбазин + цисплатин","table_field_COMMENTS":"В связи с тем, что меланома может развиваться в различных органах (не только в коже), по Международной статистической классификации болезней и проблем, связанных со здоровьем (МКБ-10), такие опухоли классифицируются в соответствии с органом первичного происхождения","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":869,"table_field_ID_FFOMS":"sh0226","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":449,"subscribed":null,"table_field_MKB_CODE":"C43.0; C43.1; C43.2; C43.3; C43.4; C43.5; C43.6; C43.7; C43.8; C43.9; C51.0; C51.1; C51.2; C51.8; C51.9; C60.9; C63.2; C69.0; D03.0; D03.1; D03.2; D03.3; D03.4; D03.5; D03.6; D03.7; D03.8; D03.9","table_field_CLINICAL_RECOMMENDATIONS":"Меланома кожи и слизистых оболочек, 2020, КР546/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"43"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"43 (Иммунотерапия)","table_field_NAME_REGIMEN":"PIAF","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":24,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":450,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Доксорубицин + циклофосфамид + цисплатин: (доксорубицин 40-50 + циклофосфамид 500 + цисплатин 100)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":25,"table_field_ID_FFOMS":"sh0229","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":451,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Ифосфамид + месна + цисплатин: (ифосфамид 5000 + месна 1200 + цисплатин 50)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":26,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":452,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"MCV: (винбластин 3 + метотрексат 30 + цисплатин 100)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":979,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":453,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CF, PF: (фторурацил 1000 + цисплатин 100, прием цисплатина в дни 1,2,3,4)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":980,"table_field_ID_FFOMS":"sh0238","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":454,"subscribed":null,"table_field_MKB_CODE":"C32.0; C32.1; C32.2; C32.3; C32.8; C32.9; C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9; C00.0; C00.1; C00.2; C00.3; C00.4; C00.5; C00.6; C00.8; C00.9; C02.0; C02.1; C02.2; C02.3; C02.8; C02.9; C03.0; C03.1; C03.9; C04.0; C04.1; C04.8; C04.9; C05.0; C06.0; C06.1; C06.2; C06.8; C06.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественные новообразования полости рта, 2020, КР164/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Эверолимус","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":870,"table_field_ID_FFOMS":"sh0240","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":455,"subscribed":null,"table_field_MKB_CODE":"C64; C48.0","table_field_CLINICAL_RECOMMENDATIONS":"Забрюшинные неорганные саркомы, 2020, КР618/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Эксеместан + эверолимус + бусерелин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":27,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":456,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Эксеместан + эверолимус + гозерелин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":28,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":457,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Эксеместан + эверолимус + лейпрорелин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":29,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":458,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Энзалутамид","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":30,"table_field_ID_FFOMS":"sh0246","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":459,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Бусерелин + энзалутамид","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":31,"table_field_ID_FFOMS":"sh0247","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":460,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Гозерелин + энзалутамид: (гозерелин 3,6 + энзалутамид 160)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":32,"table_field_ID_FFOMS":"sh0248","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":461,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Дегареликс + энзалутамид","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":33,"table_field_ID_FFOMS":"sh0249","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":462,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Лейпрорелин + энзалутамид: (лейпрорелин 7,5 + энзалутамид 160)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":34,"table_field_ID_FFOMS":"sh0250","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":463,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Трипторелин + энзалутамид: (трипторелин 3,75 + энзалутамид 160)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":35,"table_field_ID_FFOMS":"sh0251","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":464,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Эпирубицин: (эпирубицин 30-80)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":36,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":465,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Эрлотиниб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":37,"table_field_ID_FFOMS":"sh0256","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":466,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественное новообразование бронхов и легкого, 2021, КР30/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Этопозид: (этопозид 120)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":38,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":467,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"PEI","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":39,"table_field_ID_FFOMS":"sh0258","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":468,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"ELF","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":40,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":469,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Карбоплатин + этопозид: (карбоплатин 5-6 + этопозид 100, дни приёма этопозида 1-7)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":41,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":470,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Цисплатин + этопозид: (цисплатин 75 + этопозид 100, цикл 21 день, дни приема этопозида 1-7)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":42,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":471,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Цисплатин + этопозид: (цисплатин 75 + этопозид 100, цикл 28 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":589,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":472,"subscribed":null,"table_field_MKB_CODE":" ","table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Иринотекан + митомицин: (иринотекан 140 + митомицин 7)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":43,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":473,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Гозерелин: (гозерелин 10,8, цикл 90 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":44,"table_field_ID_FFOMS":"sh0272","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":474,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"CF + трастузумаб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":45,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":475,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"DCF + трастузумаб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":46,"table_field_ID_FFOMS":"sh0275","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":476,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"EAP","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":47,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":477,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"EOF + трастузумаб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":48,"table_field_ID_FFOMS":"sh0278","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":478,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"EOX + трастузумаб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":49,"table_field_ID_FFOMS":"sh0279","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":479,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"EP: (цисплатин 20 + этопозид 100)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":871,"table_field_ID_FFOMS":"sh0280","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":480,"subscribed":null,"table_field_MKB_CODE":"C76.0; C76.1; C76.2; C76.3; C76.4; C76.5; C76.7; C76.8; C77.0; C77.1; C77.2; C77.3; C77.4; C77.5; C77.8; C77.9; C78.0; C78.1; C78.2; C78.3; C78.4; C78.5; C78.6; C78.7; C78.8; C79.0; C79.1; C79.2; C79.3; C79.4; C79.5; C79.6; C79.7; C79.8; C79.9; C80.0; C80.9","table_field_CLINICAL_RECOMMENDATIONS":"Опухоли невыявленной первичной локализации, 2021, КР504/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"FOLFOX4 + трастузумаб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":50,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":481,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"IF","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":51,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":482,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"IF + трастузумаб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":52,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":483,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Абиратерон + гозерелин: (абиратерон 1000 + гозерелин 10,8)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":53,"table_field_ID_FFOMS":"sh0290","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":484,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Абиратерон + лейпрорелин: (абиратерон 1000 + лейпрорелин 22,5)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":54,"table_field_ID_FFOMS":"sh0291","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":485,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Абиратерон + лейпрорелин: (абиратерон 1000 + лейпрорелин 45)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":55,"table_field_ID_FFOMS":"sh0292","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":486,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Анастрозол + трастузумаб: (анастрозол 1 + трастузумаб 6)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":212,"table_field_ID_FFOMS":"sh0293","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":487,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Анастрозол + бусерелин + трастузумаб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":56,"table_field_ID_FFOMS":"sh0294","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":488,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Анастрозол + гозерелин + трастузумаб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":57,"table_field_ID_FFOMS":"sh0295","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":489,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Анастрозол + лейпрорелин + трастузумаб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":58,"table_field_ID_FFOMS":"sh0296","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":490,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Анастрозол + эверолимус","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":59,"table_field_ID_FFOMS":"sh0297","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":491,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Анастрозол + бусерелин + эверолимус","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":60,"table_field_ID_FFOMS":"sh0298","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":492,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Анастрозол + гозерелин + эверолимус","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":61,"table_field_ID_FFOMS":"sh0299","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":493,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Анастрозол + лейпрорелин + эверолимус","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":62,"table_field_ID_FFOMS":"sh0300","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":494,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Бикалутамид + лейпрорелин: (бикалутамид 50 + лейпрорелин 22,5)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":63,"table_field_ID_FFOMS":"sh0301","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":495,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Бикалутамид + лейпрорелин: (бикалутамид 50 + лейпрорелин 45)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":64,"table_field_ID_FFOMS":"sh0302","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":496,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + винорелбин + цисплатин: (бевацизумаб 7,5 + винорелбин 25-30 + цисплатин 75-80)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":65,"table_field_ID_FFOMS":"sh0303; sh0303.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":497,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Винорелбин + трастузумаб: (винорелбин 60→ 80 + трастузумаб 6)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":66,"table_field_ID_FFOMS":"sh0305; sh0305.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":498,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Винорелбин + трастузумаб: (винорелбин 60→ 80 + трастузумаб 2)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":67,"table_field_ID_FFOMS":"sh0305; sh0305.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":499,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Гемцитабин + трастузумаб + цисплатин: (гемцитабин 1000 + трастузумаб 6 + цисплатин 75)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":590,"table_field_ID_FFOMS":"sh0306; sh0306.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":500,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Гемцитабин + карбоплатин + трастузумаб: (гемцитабин 1000 + карбоплатин 5 + трастузумаб 6)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":591,"table_field_ID_FFOMS":"sh0308; sh0308.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":501,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + гемцитабин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":68,"table_field_ID_FFOMS":"sh0311; sh0311.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":502,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + гемцитабин + цисплатин: (бевацизумаб 7,5 + гемцитабин 1000-1250 + цисплатин 40)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":69,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":503,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Гемцитабин + трастузумаб: (гемцитабин 800-1200 + трастузумаб 6, цикл 21 день)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":592,"table_field_ID_FFOMS":"sh0317; sh0317.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":505,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + доксорубицин + карбоплатин: (бевацизумаб 7,5-15 + доксорубицин 30-40 + карбоплатин 5-6)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":70,"table_field_ID_FFOMS":"sh0696","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":506,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + доксорубицин + цисплатин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":593,"table_field_ID_FFOMS":"sh0697","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":507,"subscribed":null,"table_field_MKB_CODE":" ","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Доксорубицин + капецитабин + оксалиплатин +трастузумаб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":71,"table_field_ID_FFOMS":"sh0323","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":508,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Доксорубицин + капецитабин + оксалиплатин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":72,"table_field_ID_FFOMS":"sh0324","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":509,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Доксорубицин + оксалиплатин + трастузумаб + фторурацил","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":73,"table_field_ID_FFOMS":"sh0325","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":510,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Доксорубицин + оксалиплатин + фторурацил","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":74,"table_field_ID_FFOMS":"sh0326","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":511,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Доксорубицин + капецитабин + трастузумаб + цисплатин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":75,"table_field_ID_FFOMS":"sh0327","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":512,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Доксорубицин + капецитабин + цисплатин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":76,"table_field_ID_FFOMS":"sh0328","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":513,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + доксорубицин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":77,"table_field_ID_FFOMS":"sh0331","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":514,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Доцетаксел + капецитабин + трастузумаб + цисплатин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":78,"table_field_ID_FFOMS":"sh0332","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":515,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Доцетаксел + капецитабин + цисплатин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":872,"table_field_ID_FFOMS":"sh0333","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":516,"subscribed":null,"table_field_MKB_CODE":"C15.0; C15.1; C15.2; C15.3; C15.4; C15.5; C15.8; C15.9; C16.0","table_field_CLINICAL_RECOMMENDATIONS":"Рак пищевода и кардии, 2021, КР237/5","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + доцетаксел: (бевацизумаб 7,5 + доцетаксел 75)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":594,"table_field_ID_FFOMS":"sh0335","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":517,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Гозерелин + доцетаксел: (гозерелин 10,8 + доцетаксел 75)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":79,"table_field_ID_FFOMS":"sh0336","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":518,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Доцетаксел + лейпрорелин: (доцетаксел 75 + лейпрорелин 22,5)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":80,"table_field_ID_FFOMS":"sh0338","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":519,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Доцетаксел + лейпрорелин: (доцетаксел 75 + лейпрорелин 45)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":81,"table_field_ID_FFOMS":"sh0339","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":520,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + доцетаксел + цисплатин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":82,"table_field_ID_FFOMS":"sh0341","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":521,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Доцетаксел + трастузумаб + цисплатин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":83,"table_field_ID_FFOMS":"sh0342","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":522,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Иксабепилон + трастузумаб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":84,"table_field_ID_FFOMS":"sh0343","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":523,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Иринотекан: (иринотекан 150-200)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":743,"table_field_ID_FFOMS":"sh0698","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":524,"subscribed":null,"table_field_MKB_CODE":"C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак желудка, 2020, КР574/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + карбоплатин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":85,"table_field_ID_FFOMS":"sh0347","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":525,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Лейпрорелин: (лейпрорелин 22,5)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":86,"table_field_ID_FFOMS":"sh0348","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":526,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Лейпрорелин: (лейпрорелин 45)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":87,"table_field_ID_FFOMS":"sh0349","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":527,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Лейпрорелин: (лейпрорелин 7,5)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":88,"table_field_ID_FFOMS":"sh0350","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":528,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Летрозол + трастузумаб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":89,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":529,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бусерелин + летрозол + трастузумаб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":90,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":530,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Гозерелин + летрозол + трастузумаб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":91,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":531,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Лейпрорелин + летрозол + трастузумаб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":92,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":532,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Летрозол + эверолимус","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":93,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":533,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бусерелин + летрозол + эверолимус","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":94,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":534,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Гозерелин + летрозол + эверолимус","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":95,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":535,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Лейпрорелин + летрозол + эверолимус","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":96,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":536,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"CarPac (PaC, P + карбо) + бевацизумаб: (бевацизумаб 7,5-15 + карбоплатин 2 + паклитаксел 60)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":873,"table_field_ID_FFOMS":"sh0368","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":537,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + топотекан + цисплатин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":97,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":538,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Дакарбазин + доксорубицин + филграстим","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":98,"table_field_ID_FFOMS":"sh0464","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":539,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Бусерелин + эксеместан","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":99,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":540,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"GemOX: (гемцитабин 1000 + оксалиплатин 100)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":100,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":541,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Ифосфамид + месна + цисплатин + этопозид","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":101,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":542,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Циклофосфамид + цисплатин + этопозид","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":102,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":543,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CF, PF: (фторурацил 1000 + цисплатин 100, прием цисплатина во 2-й день)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":874,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":544,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Доксорубицин + митотан + цисплатин + этопозид: (доксорубицин 20 + митотан 1-8 + цисплатин 40 + этопозид 100)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":213,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":545,"subscribed":null,"table_field_MKB_CODE":"C74.0; C74.1; C74.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак коры надпочечника (Адренокортикальный рак), 2020, КР341/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Ифосфамид + месна + паклитаксел + филграстим + цисплатин: (ифосфамид 1500 + месна 1200 + паклитаксел 120 + филграстим 5 + цисплатин 25)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":103,"table_field_ID_FFOMS":"sh0614","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":546,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Гемцитабин + капецитабин + митотан: (гемцитабин 800 + капецитабин 1500 + митотан 1-8)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":214,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":547,"subscribed":null,"table_field_MKB_CODE":"C74.0; C74.1; C74.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак коры надпочечника (Адренокортикальный рак), 2020, КР341/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Гемцитабин + митотан + фторурацил","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":215,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":548,"subscribed":null,"table_field_MKB_CODE":"C74.0; C74.1; C74.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак коры надпочечника (Адренокортикальный рак), 2020, КР341/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Митотан","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":216,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":549,"subscribed":null,"table_field_MKB_CODE":"C74.0; C74.1; C74.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак коры надпочечника (Адренокортикальный рак), 2020, КР341/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Доксорубицин + митотан + цисплатин + этопозид: (доксорубицин 40 + митотан 1-8 + цисплатин 40 + этопозид 100)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":217,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":550,"subscribed":null,"table_field_MKB_CODE":"C74.0; C74.1; C74.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак коры надпочечника (Адренокортикальный рак), 2020, КР341/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Тамоксифен: (тамоксифен 20-40)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":875,"table_field_ID_FFOMS":"sh0692","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":551,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9; C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9; C54.0; C54.1; C54.2; C54.3; C54.8; C54.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4; Рак тела матки и саркомы матки, 2021, КР460/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Акситиниб + пембролизумаб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":104,"table_field_ID_FFOMS":"sh0708","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":552,"subscribed":null,"table_field_MKB_CODE":"C64","table_field_CLINICAL_RECOMMENDATIONS":"Рак паренхимы почки, 2021, КР10/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Ипилимумаб + ниволумаб: (ипилимумаб 1 + ниволумаб 3, цикл ниволумаба 21 день)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":595,"table_field_ID_FFOMS":"sh0709","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":553,"subscribed":null,"table_field_MKB_CODE":"C64; C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19; C20","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Кабозантиниб: (кабозантиниб 60)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":744,"table_field_ID_FFOMS":"sh0710","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":554,"subscribed":null,"table_field_MKB_CODE":"C64; C22.0","table_field_CLINICAL_RECOMMENDATIONS":"Рак паренхимы почки, 2021, КР10/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"GC, GP: (гемцитабин 1000 + цисплатин 70, введение цисплатина в 1 день, цикл 28 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":876,"table_field_ID_FFOMS":"sh0712; sh0712.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":555,"subscribed":null,"table_field_MKB_CODE":"C67.0; C67.1; C67.2; C67.3; C67.4; C67.5; C67.6; C67.7; C67.8; C67.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"DD-MVAC: (винбластин 3 + доксорубицин 30 + метотрексат 30 + цисплатин 70 + филграстим 6)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":596,"table_field_ID_FFOMS":"sh0713","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":556,"subscribed":null,"table_field_MKB_CODE":"C67.0; C67.1; C67.2; C67.3; C67.4; C67.5; C67.6; C67.7; C67.8; C67.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"43"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"43 (Иммунотерапия)","table_field_NAME_REGIMEN":"Вакцина для лечения рака мочевого пузыря БЦЖ: (БЦЖ 50-100, цикл 30 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":597,"table_field_ID_FFOMS":"sh0711","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":557,"subscribed":null,"table_field_MKB_CODE":"C67.0; C67.1; C67.2; C67.3; C67.4; C67.5; C67.6; C67.7; C67.8; C67.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Атезолизумаб: (атезолизумаб 840)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":598,"table_field_ID_FFOMS":"sh0714","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":558,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9; C67.0; C67.1; C67.2; C67.3; C67.4; C67.5; C67.6; C67.7; C67.8; C67.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Атезолизумаб: (атезолизумаб 1680)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":599,"table_field_ID_FFOMS":"sh0715","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":559,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9; C67.0; C67.1; C67.2; C67.3; C67.4; C67.5; C67.6; C67.7; C67.8; C67.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Митомицин: (митомицин 40, цикл 30 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":600,"table_field_ID_FFOMS":"sh0716","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":560,"subscribed":null,"table_field_MKB_CODE":"C67.0; C67.1; C67.2; C67.3; C67.4; C67.5; C67.6; C67.7; C67.8; C67.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"GC, GP: (гемцитабин 1000 + цисплатин 70, введение цисплатина во 2 день, цикл 28 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":877,"table_field_ID_FFOMS":"sh0717; sh0717.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":561,"subscribed":null,"table_field_MKB_CODE":"C67.0; C67.1; C67.2; C67.3; C67.4; C67.5; C67.6; C67.7; C67.8; C67.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"DD-MVAC: (винбластин 3 + доксорубицин 30 + метотрексат 30 + цисплатин 70 + филграстим 5)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":601,"table_field_ID_FFOMS":"sh0718","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":562,"subscribed":null,"table_field_MKB_CODE":"C67.0; C67.1; C67.2; C67.3; C67.4; C67.5; C67.6; C67.7; C67.8; C67.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Доцетаксел + лейпрорелин: (доцетаксел 75 + лейпрорелин 3,75)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":105,"table_field_ID_FFOMS":"sh0719","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":563,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Доцетаксел + лейпрорелин: (доцетаксел 75 + лейпрорелин 11,25)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":106,"table_field_ID_FFOMS":"sh0720","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":564,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Лейпрорелин + энзалутамид: (лейпрорелин 3,75 + энзалутамид 160)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":107,"table_field_ID_FFOMS":"sh0721","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":565,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Лейпрорелин + энзалутамид: (лейпрорелин 11,25 + энзалутамид 160)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":108,"table_field_ID_FFOMS":"sh0722","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":566,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Абиратерон + лейпрорелин: (абиратерон 1000 + лейпрорелин 3,75)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":109,"table_field_ID_FFOMS":"sh0723","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":567,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Абиратерон + лейпрорелин: (абиратерон 1000 + лейпрорелин 11,25)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":110,"table_field_ID_FFOMS":"sh0724","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":568,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Апалутамид + гозерелин: (апалутамид 240 + гозерелин 3,6)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":111,"table_field_ID_FFOMS":"sh0725","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":569,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Апалутамид + лейпрорелин: (апалутамид 240 + лейпрорелин 3,75)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":112,"table_field_ID_FFOMS":"sh0726","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":570,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Апалутамид + лейпрорелин: (апалутамид 240 + лейпрорелин 7,5)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":113,"table_field_ID_FFOMS":"sh0727","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":571,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Апалутамид + трипторелин: (апалутамид 240 + трипторелин 3,75)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":114,"table_field_ID_FFOMS":"sh0728","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":572,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Апалутамид + бусерелин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":115,"table_field_ID_FFOMS":"sh0729","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":573,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Апалутамид + гозерелин: (апалутамид 240 + гозерелин 10,8)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":116,"table_field_ID_FFOMS":"sh0730","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":574,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Апалутамид + лейпрорелин: (апалутамид 240 + лейпрорелин 22,5)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":117,"table_field_ID_FFOMS":"sh0731","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":575,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Апалутамид + лейпрорелин: (апалутамид 240 + лейпрорелин 11,25)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":118,"table_field_ID_FFOMS":"sh0732","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":576,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Апалутамид + трипторелин: (апалутамид 240 + трипторелин 11,25)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":119,"table_field_ID_FFOMS":"sh0733","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":577,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Апалутамид + лейпрорелин: (апалутамид 240 + лейпрорелин 45)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":120,"table_field_ID_FFOMS":"sh0734","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":578,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Апалутамид + дегареликс","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":121,"table_field_ID_FFOMS":"sh0735","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":579,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Лейпрорелин: (лейпрорелин 11,25)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":122,"table_field_ID_FFOMS":"sh0736","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":580,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Гозерелин + кабазитаксел: (гозерелин 3,6 + кабазитаксел 25)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":123,"table_field_ID_FFOMS":"sh0737","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":581,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Кабазитаксел + лейпрорелин: (кабазитаксел 25 + лейпрорелин 3,75)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":124,"table_field_ID_FFOMS":"sh0738","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":582,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Кабазитаксел + лейпрорелин: (кабазитаксел 25 + лейпрорелин 7,5)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":125,"table_field_ID_FFOMS":"sh0739","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":583,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Кабазитаксел + трипторелин: (кабазитаксел 25 + трипторелин 3,75)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":126,"table_field_ID_FFOMS":"sh0740","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":584,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Бусерелин + кабазитаксел","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":127,"table_field_ID_FFOMS":"sh0741","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":585,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Гозерелин + кабазитаксел: (гозерелин 10,8 + кабазитаксел 25)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":128,"table_field_ID_FFOMS":"sh0742","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":586,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Кабазитаксел + лейпрорелин: (кабазитаксел 25 + лейпрорелин 22,5)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":129,"table_field_ID_FFOMS":"sh0743","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":587,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Кабазитаксел + лейпрорелин: (кабазитаксел 25 + лейпрорелин 11,25)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":130,"table_field_ID_FFOMS":"sh0744","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":588,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Кабазитаксел + трипторелин: (кабазитаксел 25 + трипторелин 11,25)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":131,"table_field_ID_FFOMS":"sh0745","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":589,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Кабазитаксел + лейпрорелин: (кабазитаксел 25 + лейпрорелин 45)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":132,"table_field_ID_FFOMS":"sh0746","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":590,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Дегареликс + кабазитаксел","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":133,"table_field_ID_FFOMS":"sh0747","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":591,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Гозерелин + флутамид: (гозерелин 3,6 + флутамид 750)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":134,"table_field_ID_FFOMS":"sh0748","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":592,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Лейпрорелин + флутамид: (лейпрорелин 3,75 + флутамид 750)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":135,"table_field_ID_FFOMS":"sh0749","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":593,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Лейпрорелин + флутамид: (лейпрорелин 7,5 + флутамид 750)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":136,"table_field_ID_FFOMS":"sh0750","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":594,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Трипторелин + флутамид: (трипторелин 3,75 + флутамид 750)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":137,"table_field_ID_FFOMS":"sh0751","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":595,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Бусерелин + флутамид: (бусерелин 3,75 + флутамид 750)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":138,"table_field_ID_FFOMS":"sh0752","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":596,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Гозерелин + флутамид: (гозерелин 10,8 + флутамид 750)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":139,"table_field_ID_FFOMS":"sh0753","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":597,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Лейпрорелин + флутамид: (лейпрорелин 22,5 + флутамид 750)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":140,"table_field_ID_FFOMS":"sh0754","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":598,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Лейпрорелин + флутамид: (лейпрорелин 11,25 + флутамид 750)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":141,"table_field_ID_FFOMS":"sh0755","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":599,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Трипторелин + флутамид: (трипторелин 11,25 + флутамид 750)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":142,"table_field_ID_FFOMS":"sh0756","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":600,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Лейпрорелин + флутамид: (лейпрорелин 45 + флутамид 750)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":143,"table_field_ID_FFOMS":"sh0757","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":601,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Дегареликс + флутамид: (дегареликс 80 + флутамид 750)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":144,"table_field_ID_FFOMS":"sh0758","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":602,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Бикалутамид + лейпрорелин: (бикалутамид 50 + лейпрорелин 3,75)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":145,"table_field_ID_FFOMS":"sh0759","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":603,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Бикалутамид + лейпрорелин: (бикалутамид 50 + лейпрорелин 11,25)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":146,"table_field_ID_FFOMS":"sh0760","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":604,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Бикалутамид: (бикалутамид 50)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":147,"table_field_ID_FFOMS":"sh0761","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":605,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Апалутамид","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":148,"table_field_ID_FFOMS":"sh0762","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":606,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CarPac (PaC, P + карбо) + ифосфамид: (ифосфамид 1200 + карбоплатин 4-5 + паклитаксел 175, цикл 21 день)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":878,"table_field_ID_FFOMS":"sh0763","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":607,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CF, PF: (фторурацил 800-1000 + цисплатин 70-80, цикл 21 день, дни приема фторурацила 2-5)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":879,"table_field_ID_FFOMS":"sh0764","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":608,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Карбоплатин + фторурацил: (карбоплатин 4-5 + фторурацил 800-1000, цикл 21 день, дни приема фторурацила 2-5)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":149,"table_field_ID_FFOMS":"sh0765","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":609,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Цетуксимаб: (цетуксимаб 500, начальная доза 400)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":602,"table_field_ID_FFOMS":"sh0766","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":610,"subscribed":null,"table_field_MKB_CODE":"C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19; C20","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Кальция фолинат + паклитаксел + цисплатин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":150,"table_field_ID_FFOMS":"sh0767","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":611,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Паклитаксел + этопозид","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":151,"table_field_ID_FFOMS":"sh0768","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":612,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Авелумаб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":152,"table_field_ID_FFOMS":"sh0769","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":613,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"MCV: (винбластин 4 + метотрексат 30 + цисплатин 100)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":981,"table_field_ID_FFOMS":"sh0770; sh0770.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":614,"subscribed":null,"table_field_MKB_CODE":"C68.0","table_field_CLINICAL_RECOMMENDATIONS":"Рак уретры, 2020, КР450/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Ифосфамид + месна + паклитаксел + цисплатин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":603,"table_field_ID_FFOMS":"sh0771","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":615,"subscribed":null,"table_field_MKB_CODE":"C53.0; C53.1; C53.8; C53.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CarPac (PaC, P + карбо) + ифосфамид: (ифосфамид 1200 + карбоплатин 4-5 + паклитаксел 175, цикл 28 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":880,"table_field_ID_FFOMS":"sh0772","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":616,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Карбоплатин + фторурацил: (карбоплатин 4-5 + фторурацил 800-1000, цикл 28 дней, дни приема фторурацила 2-5)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":153,"table_field_ID_FFOMS":"sh0773","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":617,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Карбоплатин + фторурацил: (карбоплатин 4-5 + фторурацил 800-1000, цикл 21 дней, дни приема фторурацила 1-4)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":154,"table_field_ID_FFOMS":"sh0774","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":618,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Карбоплатин + фторурацил: (карбоплатин 4-5 + фторурацил 800-1000, цикл 28 дней, дни приема фторурацила 1-4)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":155,"table_field_ID_FFOMS":"sh0776","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":619,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"43"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"43 (Иммунотерапия)","table_field_NAME_REGIMEN":"Вакцина для лечения рака мочевого пузыря БЦЖ: (БЦЖ 50-100, цикл 7 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":604,"table_field_ID_FFOMS":"sh0711","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":620,"subscribed":null,"table_field_MKB_CODE":"C67.0; C67.1; C67.2; C67.3; C67.4; C67.5; C67.6; C67.7; C67.8; C67.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CF, PF: (фторурацил 800-1000 + цисплатин 70-80, цикл 21 день, дни приема фторурацила 1-4)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":881,"table_field_ID_FFOMS":"sh0775","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":621,"subscribed":null,"table_field_MKB_CODE":"C15.0; C15.1; C15.2; C15.3; C15.4; C15.5; C15.8; C15.9; C16.0","table_field_CLINICAL_RECOMMENDATIONS":"Рак пищевода и кардии, 2021, КР237/5","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CF, PF: (фторурацил 800-1000 + цисплатин 70-80, цикл 28 день, дни приема фторурацила 2-5)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":882,"table_field_ID_FFOMS":"sh0777","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":622,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CF, PF: (фторурацил 800-1000 + цисплатин 70-80, цикл 28 день, дни приема фторурацила 1-4)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":883,"table_field_ID_FFOMS":"sh0778","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":623,"subscribed":null,"table_field_MKB_CODE":"C15.0; C15.1; C15.2; C15.3; C15.4; C15.5; C15.8; C15.9; C16.0","table_field_CLINICAL_RECOMMENDATIONS":"Рак пищевода и кардии, 2021, КР237/5","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"GTC: (гемцитабин + паклитаксел + цисплатин)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":982,"table_field_ID_FFOMS":"sh0779; sh0779.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":624,"subscribed":null,"table_field_MKB_CODE":"C68.0","table_field_CLINICAL_RECOMMENDATIONS":"Рак уретры, 2020, КР450/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CarPac (PaC, P + карбо) + гемцитабин: (гемцитабин 1000 + карбоплатин 4-5 + паклитаксел 80)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":884,"table_field_ID_FFOMS":"sh0780; sh0780.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":625,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Ифосфамид + месна + цисплатин: (ифосфамид 1500 + месна 1500 + цисплатин 20)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":156,"table_field_ID_FFOMS":"sh0782","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":626,"subscribed":null,"table_field_MKB_CODE":"C54.0; C54.1; C54.2; C54.3; C54.8; C54.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак тела матки и саркомы матки, 2021, КР460/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"GD, GemTax: (гемцитабин 900 + доцетаксел 100 + филграстим 150)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":885,"table_field_ID_FFOMS":"sh0783","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":627,"subscribed":null,"table_field_MKB_CODE":"C54.0; C54.1; C54.2; C54.3; C54.8; C54.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак тела матки и саркомы матки, 2021, КР460/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Доксорубицин + ифосфамид + месна","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":157,"table_field_ID_FFOMS":"sh0784","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":628,"subscribed":null,"table_field_MKB_CODE":"C54.0; C54.1; C54.2; C54.3; C54.8; C54.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак тела матки и саркомы матки, 2021, КР460/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"ADIC: (дакарбазин 750 + доксорубицин 60, 1-4 дни приема)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":886,"table_field_ID_FFOMS":"sh0785","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":629,"subscribed":null,"table_field_MKB_CODE":"C54.0; C54.1; C54.2; C54.3; C54.8; C54.9; C48.0","table_field_CLINICAL_RECOMMENDATIONS":"Рак тела матки и саркомы матки, 2021, КР460/3; Забрюшинные неорганные саркомы, 2020, КР618/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Гемцитабин + дакарбазин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":887,"table_field_ID_FFOMS":"sh0786","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":630,"subscribed":null,"table_field_MKB_CODE":"C54.0; C54.1; C54.2; C54.3; C54.8; C54.9; C48.0","table_field_CLINICAL_RECOMMENDATIONS":"Рак тела матки и саркомы матки, 2021, КР460/3; Забрюшинные неорганные саркомы, 2020, КР618/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Винорелбин + гемцитабин: (винорелбин 25 + гемцитабин 800)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":605,"table_field_ID_FFOMS":"sh0787; sh0787.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":631,"subscribed":null,"table_field_MKB_CODE":"C54.0; C54.1; C54.2; C54.3; C54.8; C54.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак тела матки и саркомы матки, 2021, КР460/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Ифосфамид + месна: (ифосфамид 1200 + месна 300)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":158,"table_field_ID_FFOMS":"sh0788","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":632,"subscribed":null,"table_field_MKB_CODE":"C54.0; C54.1; C54.2; C54.3; C54.8; C54.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак тела матки и саркомы матки, 2021, КР460/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"P: (паклитаксел 80, цикл 21 день)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":159,"table_field_ID_FFOMS":"sh0789; sh0789.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":633,"subscribed":null,"table_field_MKB_CODE":"C54.0; C54.1; C54.2; C54.3; C54.8; C54.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак тела матки и саркомы матки, 2021, КР460/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Дакарбазин: (дакарбазин 1200)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":888,"table_field_ID_FFOMS":"sh0790","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":634,"subscribed":null,"table_field_MKB_CODE":"C54.0; C54.1; C54.2; C54.3; C54.8; C54.9; C48.0","table_field_CLINICAL_RECOMMENDATIONS":"Рак тела матки и саркомы матки, 2021, КР460/3; Забрюшинные неорганные саркомы, 2020, КР618/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Темозоломид: (темозоломид 50-75)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":160,"table_field_ID_FFOMS":"sh0791","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":635,"subscribed":null,"table_field_MKB_CODE":"C54.0; C54.1; C54.2; C54.3; C54.8; C54.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак тела матки и саркомы матки, 2021, КР460/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"D: (доцетаксел 36)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":161,"table_field_ID_FFOMS":"sh0792; sh0792.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":636,"subscribed":null,"table_field_MKB_CODE":"C54.0; C54.1; C54.2; C54.3; C54.8; C54.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак тела матки и саркомы матки, 2021, КР460/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"PC, P + цисплатин: (паклитаксел 175 + цисплатин 50)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":889,"table_field_ID_FFOMS":"sh0793","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":637,"subscribed":null,"table_field_MKB_CODE":"C54.0; C54.1; C54.2; C54.3; C54.8; C54.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак тела матки и саркомы матки, 2021, КР460/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Ифосфамид + месна + паклитаксел + филграстим","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":162,"table_field_ID_FFOMS":"sh0781","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":638,"subscribed":null,"table_field_MKB_CODE":"C54.0; C54.1; C54.2; C54.3; C54.8; C54.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак тела матки и саркомы матки, 2021, КР460/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"43"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"43 (Иммунотерапия)","table_field_NAME_REGIMEN":"Вакцина для лечения рака мочевого пузыря БЦЖ: (БЦЖ 360)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":163,"table_field_ID_FFOMS":"sh0794","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":639,"subscribed":null,"table_field_MKB_CODE":"C65; C66","table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"M-CAVI","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":164,"table_field_ID_FFOMS":"sh0795; sh0795.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":640,"subscribed":null,"table_field_MKB_CODE":"C65; C66","table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Атезолизумаб + бевацизумаб + карбоплатин + паклитаксел: (атезолизумаб 1200 + бевацизумаб 15 + карбоплатин 6 + паклитаксел 175-200)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":606,"table_field_ID_FFOMS":"sh0796","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":641,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"GC, GP: (гемцитабин 1000 + цисплатин 70, цикл 21 день)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":890,"table_field_ID_FFOMS":"sh0797; sh0797.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":642,"subscribed":null,"table_field_MKB_CODE":"C65; C66","table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"PC, P + цисплатин: (паклитаксел 175 + цисплатин 75)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":891,"table_field_ID_FFOMS":"sh0798","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":643,"subscribed":null,"table_field_MKB_CODE":"C53.0; C53.1; C53.8; C53.9; C54.0; C54.1; C54.2; C54.3; C54.8; C54.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак тела матки и саркомы матки, 2021, КР460/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + паклитаксел + цисплатин: (бевацизумаб 15 + паклитаксел 175 + цисплатин 50)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":607,"table_field_ID_FFOMS":"sh0799","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":644,"subscribed":null,"table_field_MKB_CODE":"C53.0; C53.1; C53.8; C53.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Иринотекан: (иринотекан 125, цикл 28 дней, дни приёма: 1,8,15)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":608,"table_field_ID_FFOMS":"sh0800; sh0800.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":645,"subscribed":null,"table_field_MKB_CODE":"C53.0; C53.1; C53.8; C53.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Ифосфамид + месна: (ифосфамид 1200-1500 + месна 240-300)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":609,"table_field_ID_FFOMS":"sh0801","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":646,"subscribed":null,"table_field_MKB_CODE":"C53.0; C53.1; C53.8; C53.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Ифосфамид + месна + паклитаксел + филграстим + цисплатин: (ифосфамид 1500 + месна 1500 + паклитаксел 120 + филграстим 5 + цисплатин 25)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":165,"table_field_ID_FFOMS":"sh0802","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":647,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CDA","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":166,"table_field_ID_FFOMS":"sh0803","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":648,"subscribed":null,"table_field_MKB_CODE":"C56","table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Ифосфамид + месна + паклитаксел","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":167,"table_field_ID_FFOMS":"sh0804","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":649,"subscribed":null,"table_field_MKB_CODE":"C56","table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Гозерелин: (гозерелин 10,8, цикл 84 дня)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":168,"table_field_ID_FFOMS":"sh0805","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":650,"subscribed":null,"table_field_MKB_CODE":"C56","table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"BEP: (блеомицин 30 + цисплатин 20 + этопозид 100, дни приема блеомицина 1,8,15)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":892,"table_field_ID_FFOMS":"sh0806","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":651,"subscribed":null,"table_field_MKB_CODE":"C56; C76.0; C76.1; C76.2; C76.3; C76.4; C76.5; C76.7; C76.8; C77.0; C77.1; C77.2; C77.3; C77.4; C77.5; C77.8; C77.9; C78.0; C78.1; C78.2; C78.3; C78.4; C78.5; C78.6; C78.7; C78.8; C79.0; C79.1; C79.2; C79.3; C79.4; C79.5; C79.6; C79.7; C79.8; C79.9; C80.0; C80.9","table_field_CLINICAL_RECOMMENDATIONS":"Опухоли невыявленной первичной локализации, 2021, КР504/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Ломустин: (ломустин 130)","table_field_COMMENTS":"В связи с тем, что меланома может развиваться в различных органах (не только в коже), по Международной статистической классификации болезней и проблем, связанных со здоровьем (МКБ-10), такие опухоли классифицируются в соответствии с органом первичного происхождения","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":893,"table_field_ID_FFOMS":"sh0807","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":652,"subscribed":null,"table_field_MKB_CODE":"C43.0; C43.1; C43.2; C43.3; C43.4; C43.5; C43.6; C43.7; C43.8; C43.9; C51.0; C51.1; C51.2; C51.8; C51.9; C60.9; C63.2; C69.0; D03.0; D03.1; D03.2; D03.3; D03.4; D03.5; D03.6; D03.7; D03.8; D03.9","table_field_CLINICAL_RECOMMENDATIONS":"Меланома кожи и слизистых оболочек, 2020, КР546/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Циклофосфамид","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":610,"table_field_ID_FFOMS":"sh0808","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":653,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Олапариб: (олапариб 300)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":611,"table_field_ID_FFOMS":"sh0809","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":654,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Доксорубицин + карбоплатин: (доксорубицин 30 + карбоплатин 5)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":612,"table_field_ID_FFOMS":"sh0810","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":655,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CarPac (PaC, P + карбо): (паклитаксел 60 + карбоплатин 5)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":894,"table_field_ID_FFOMS":"sh0811; sh0811.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":656,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Карбоплатин + этопозид: (карбоплатин 5-6 + этопозид 100, дни приёма этопозида 1-5)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":613,"table_field_ID_FFOMS":"sh0815","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":657,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"FOLFOX4: (кальция фолинат 200 + оксалиплатин 85 + фторурацил 400 + фторурацил 600, цикл 21 день)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":614,"table_field_ID_FFOMS":"sh0817","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":658,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + пеметрексед: (бевацизумаб 7,5 + пеметрексед 500)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":615,"table_field_ID_FFOMS":"sh0827","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":659,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + пеметрексед: (бевацизумаб 15 + пеметрексед 500)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":616,"table_field_ID_FFOMS":"sh0828","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":660,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"CarPac (PaC, P + карбо) + бевацизумаб: (бевацизумаб 7,5 + карбоплатин 5 + паклитаксел 60)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":895,"table_field_ID_FFOMS":"sh0835; sh0835.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":661,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + гемцитабин + карбоплатин: (бевацизумаб 7,5 + гемцитабин 1000 + карбоплатин 4)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":617,"table_field_ID_FFOMS":"sh0841; sh0841.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":662,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + карбоплатин + этопозид: (бевацизумаб 15 + карбоплатин 5-6 + этопозид 100)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":618,"table_field_ID_FFOMS":"sh0851","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":663,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + капецитабин + оксалиплатин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":619,"table_field_ID_FFOMS":"sh0856","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":664,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"FOLFOX4 + бевацизумаб: (бевацизумаб 15 + кальция фолинат 200 + оксалиплатин 85 + фторурацил 400 + фторурацил 600, цикл 21 день)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":620,"table_field_ID_FFOMS":"sh0860","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":665,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Цисплатин: (цисплатин 100, цикл 21 день)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":983,"table_field_ID_FFOMS":"sh0867","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":666,"subscribed":null,"table_field_MKB_CODE":"C11.0; C11.1; C11.2; C11.3; C11.8; C11.9; C01; C02.4; C05.1; C05.2; C09.0; C09.1; C09.8; C09.9; C10.0; C10.1; C10.2; C10.3; C10.4; C10.8; C10.9; C12; C13; C13.0; C13.1; C13.2; C13.8; C13.9; C02.0; C02.1; C02.2; C02.3; C02.8; C02.9; C03.0; C03.1; C03.9; C04.0; C04.1; C04.8; C04.9; C05.0; C06.0; C06.1; C06.2; C06.8; C06.9; C32.0; C32.1; C32.2; C32.3; C32.8; C32.9; C30.0; C30.1; C31.0; C31.1; C31.2; C31.3; C31.8; C31.9; C00.0; C00.1; C00.2; C00.3; C00.4; C00.5; C00.6; C00.8; C00.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественные новообразования полости рта, 2020, КР164/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"DC: (доцетаксел 100 + цисплатин 75)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":896,"table_field_ID_FFOMS":"sh0869","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":667,"subscribed":null,"table_field_MKB_CODE":"C01; C02.4; C05.1; C05.2; C09.0; C09.1; C09.8; C09.9; C10.0; C10.1; C10.2; C10.3; C10.4; C10.8; C10.9; C12; C13; C13.0; C13.1; C13.2; C13.8; C13.9; C32.0; C32.1; C32.2; C32.3; C32.8; C32.9; C11.0; C11.1; C11.2; C11.3; C11.8; C11.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Дурвалумаб: (дурвалумаб 10)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":745,"table_field_ID_FFOMS":"sh0872","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":668,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественное новообразование бронхов и легкого, 2021, КР30/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"FOLFIRI + рамуцирумаб: (иринотекан 180 + кальция фолинат 400 + рамуцирумаб 8 + фторурацил 400 + фторурацил 1200, цикл 28 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":169,"table_field_ID_FFOMS":"sh0882; sh0882.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":669,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"FOLFIRI + цетуксимаб: (иринотекан 180 + кальция фолинат 400 + фторурацил 400 + фторурацил 1200 + цетуксимаб 500)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":621,"table_field_ID_FFOMS":"sh0883","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":670,"subscribed":null,"table_field_MKB_CODE":"C20; C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"FOLFOXIRI + цетуксимаб: (иринотекан 165 + кальция фолинат 200 + оксалиплатин 85 + фторурацил 1600 + цетуксимаб 500)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":622,"table_field_ID_FFOMS":"sh0886","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":671,"subscribed":null,"table_field_MKB_CODE":"C20; C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + карбоплатин + пеметрексед: (бевацизумаб 15 + карбоплатин 5 + пеметрексед 500)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":623,"table_field_ID_FFOMS":"sh0910","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":672,"subscribed":null,"table_field_MKB_CODE":"C45.0, C45.1, C45.2, C45.7, C45.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"XELIRI (CAPIRI) + бевацизумаб: (бевацизумаб 7,5 + иринотекан 180-200 + капецитабин 825)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":170,"table_field_ID_FFOMS":"sh0917","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":673,"subscribed":null,"table_field_MKB_CODE":"C20","table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"XELIRI (CAPIRI): (иринотекан 250 + капецитабин 1000)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":746,"table_field_ID_FFOMS":"sh0920","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":674,"subscribed":null,"table_field_MKB_CODE":"C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак желудка, 2020, КР574/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"XELOX (CAPOX, CapeOx): (капецитабин 825 + оксалиплатин 130)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":897,"table_field_ID_FFOMS":"sh0921","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":675,"subscribed":null,"table_field_MKB_CODE":"C20; C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"AC: (доксорубицин 60 + циклофосфамид 600, цикл 14 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":171,"table_field_ID_FFOMS":"sh0058","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":676,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Гемцитабин: (гемцитабин 750-1000, цикл 7 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":898,"table_field_ID_FFOMS":"sh0923","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":677,"subscribed":null,"table_field_MKB_CODE":"C25.0; C25.1; C25.2; C25.3; C25.4; C25.7; C25.8; C25.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак поджелудочной железы, 2021, КР335/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Деносумаб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":624,"table_field_ID_FFOMS":"sh0926; sh0926.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":678,"subscribed":null,"table_field_MKB_CODE":"C40.0; C40.1; C40.2; C40.3; C40.8; C40.9; C41.0; C41.1; C41.2; C41.3; C41.4; C41.8; C41.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Иринотекан + цетуксимаб: (иринотекан 100 + цетуксимаб 250)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":625,"table_field_ID_FFOMS":"sh0938;sh0938.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":679,"subscribed":null,"table_field_MKB_CODE":"C21.0; C21.1; C21.2; C21.8; C44.5","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Иринотекан + цетуксимаб: (иринотекан 100 + цетуксимаб 500)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":626,"table_field_ID_FFOMS":"sh0939","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":680,"subscribed":null,"table_field_MKB_CODE":"C21.0; C21.1; C21.2; C21.8; C44.5","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Иринотекан + рамуцирумаб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":747,"table_field_ID_FFOMS":"sh0940; sh0940.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":681,"subscribed":null,"table_field_MKB_CODE":"C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак желудка, 2020, КР574/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Иринотекан + цетуксимаб: (иринотекан 180 + цетуксимаб 500)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":627,"table_field_ID_FFOMS":"sh0941","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":682,"subscribed":null,"table_field_MKB_CODE":"C20; C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19; C21.0; C21.1; C21.2; C21.8; C44.5","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Капецитабин: (капецитабин 1250)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":628,"table_field_ID_FFOMS":"sh0944","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":683,"subscribed":null,"table_field_MKB_CODE":"C00.0; C00.1; C00.2; C00.3; C00.4; C00.5; C00.6; C00.8; C00.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"CarPac (PaC, P + карбо) + трастузумаб: (карбоплатин 5,5 + паклитаксел 175 + трастузумаб 4)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":899,"table_field_ID_FFOMS":"sh0949","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":684,"subscribed":null,"table_field_MKB_CODE":"C08.0; C08.1; C08.8; C08.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CarPac (PaC, P + карбо): (паклитаксел 45-50 + карбоплатин 1,5-2)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":900,"table_field_ID_FFOMS":"sh0950","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":685,"subscribed":null,"table_field_MKB_CODE":"C73; C33; C15.0; C15.1; C15.2; C15.3; C15.4; C15.5; C15.8; C15.9; C16.0","table_field_CLINICAL_RECOMMENDATIONS":"Рак пищевода и кардии, 2021, КР237/5","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CarPac (PaC, P + карбо): (паклитаксел 80 + карбоплатин 5)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":901,"table_field_ID_FFOMS":"sh0953; sh0953.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":686,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"CarPac (PaC, P + карбо) + пембролизумаб: (карбоплатин 6 + паклитаксел 200 + пембролизумаб 200)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":902,"table_field_ID_FFOMS":"sh0954","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":687,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Атезолизумаб + бевацизумаб: (атезолизумаб 1200 + бевацизумаб 15)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":629,"table_field_ID_FFOMS":"sh0961","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":688,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Ипилимумаб + ниволумаб: (ипилимумаб 1 + ниволумаб 3, цикл ниволумаба 14 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":748,"table_field_ID_FFOMS":"sh0962","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":689,"subscribed":null,"table_field_MKB_CODE":"C45.0, C45.1, C45.2, C45.7, C45.9","table_field_CLINICAL_RECOMMENDATIONS":"Мезотелиома плевры, брюшины и других локализаций, 2020, КР497/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Трастузумаб: (трастузумаб 4, нагрузочная доза 8)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":630,"table_field_ID_FFOMS":"sh0963","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":690,"subscribed":null,"table_field_MKB_CODE":"C07; C08.0; C08.1; C08.8; C08.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Трастузумаб: (трастузумаб 4)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":631,"table_field_ID_FFOMS":"sh0964","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":691,"subscribed":null,"table_field_MKB_CODE":"C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Трастузумаб: (трастузумаб 6)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":632,"table_field_ID_FFOMS":"sh0965","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":692,"subscribed":null,"table_field_MKB_CODE":"C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Цетуксимаб: (цетуксимаб 250, цикл 14 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":172,"table_field_ID_FFOMS":"sh0967; sh0967.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":693,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Цетуксимаб: (цетуксимаб 500)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":633,"table_field_ID_FFOMS":"sh0969","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":694,"subscribed":null,"table_field_MKB_CODE":"C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19; C20; C21.0; C21.1; C21.2; C21.8; C44.5","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"EC + атезолизумаб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":634,"table_field_ID_FFOMS":"sh0976","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":695,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Рибоциклиб + фулвестрант","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":635,"table_field_ID_FFOMS":"sh0986","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":696,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"AC + филграстим","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":636,"table_field_ID_FFOMS":"sh0990","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":697,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"AC + эмпэгфилграстим","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":637,"table_field_ID_FFOMS":"sh0991","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":698,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Анастрозол + трипторелин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":638,"table_field_ID_FFOMS":"sh1000","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":699,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Тамоксифен + трипторелин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":173,"table_field_ID_FFOMS":"sh1001","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":700,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Палбоциклиб + трипторелин + фулвестрант","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":174,"table_field_ID_FFOMS":"sh1004","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":701,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"P: (паклитаксел 90)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":639,"table_field_ID_FFOMS":"sh1031; sh1031.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":702,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + паклитаксел: (бевацизумаб 15 + паклитаксел 90)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":640,"table_field_ID_FFOMS":"sh1032; sh1032.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":703,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + паклитаксел: (бевацизумаб 10 + паклитаксел 90)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":641,"table_field_ID_FFOMS":"sh1033; sh1033.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":704,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Гемцитабин: (гемцитабин 800-1200, цикл 28 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4747,"table_field_ID_FFOMS":"sh1034; sh1034","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":705,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9; C84.1; C84.0","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4; Синдром Сезари, 2020, КР575/1; Грибовидный микоз, 2020, КР223/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"GemCarbo, CarboGem: (гемцитабин 1000 + карбоплатин 2)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":984,"table_field_ID_FFOMS":"sh1035; sh1035","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":706,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"DC + эмпэгфилграстим","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":642,"table_field_ID_FFOMS":"sh1055","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":707,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"DCH + пертузумаб + эмпэгфилграстим","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":643,"table_field_ID_FFOMS":"sh1060","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":708,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Винорелбин + гемцитабин + цисплатин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":644,"table_field_ID_FFOMS":"sh0812; sh0812.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":709,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Винорелбин + гемцитабин + карбоплатин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":645,"table_field_ID_FFOMS":"sh0813; sh0813.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":710,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Доксорубицин + оксалиплатин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":646,"table_field_ID_FFOMS":"sh0816","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":711,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + этопозид: (бевацизумаб 7,5 + этопозид 100)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":647,"table_field_ID_FFOMS":"sh0818","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":712,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + этопозид: (бевацизумаб 15 + этопозид 100)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":648,"table_field_ID_FFOMS":"sh0819","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":713,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + винорелбин: (бевацизумаб 7,5 + винорелбин 25)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":649,"table_field_ID_FFOMS":"sh0820; sh0820.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":714,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + винорелбин: (бевацизумаб 15 + винорелбин 25)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":650,"table_field_ID_FFOMS":"sh0821","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":715,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + доксорубицин: (бевацизумаб 7,5 + доксорубицин 40-50)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":651,"table_field_ID_FFOMS":"sh0822","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":716,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + доксорубицин: (бевацизумаб 15 + доксорубицин 40-50)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":652,"table_field_ID_FFOMS":"sh0823","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":717,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + паклитаксел: (бевацизумаб 7,5 + паклитаксел 80)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":653,"table_field_ID_FFOMS":"sh0824","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":718,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + паклитаксел: (бевацизумаб 15 + паклитаксел 80)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":654,"table_field_ID_FFOMS":"sh0825","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":719,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + доцетаксел: (бевацизумаб 15 + доцетаксел 75)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":655,"table_field_ID_FFOMS":"sh0826","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":720,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9; C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + циклофосфамид: (бевацизумаб 7,5 + циклофосфамид 50)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":656,"table_field_ID_FFOMS":"sh0829","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":721,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + циклофосфамид: (бевацизумаб 15 + циклофосфамид 50)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":657,"table_field_ID_FFOMS":"sh0830","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":722,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + метотрексат + циклофосфамид: (бевацизумаб 7,5 + метотрексат 2,5 + циклофосфамид 50)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":658,"table_field_ID_FFOMS":"sh0831","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":723,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.10","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + метотрексат + циклофосфамид: (бевацизумаб 15 + метотрексат 2,5 + циклофосфамид 50)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":659,"table_field_ID_FFOMS":"sh0832","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":724,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.11","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + доксорубицин + карбоплатин: (бевацизумаб 7,5 + доксорубицин 30 + карбоплатин 5)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":660,"table_field_ID_FFOMS":"sh0833","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":725,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.11","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + доксорубицин + карбоплатин: (бевацизумаб 15 + доксорубицин 30 + карбоплатин 5)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":661,"table_field_ID_FFOMS":"sh0834","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":726,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.11","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Цисплатин + этопозид: (цисплатин 75 + этопозид 100, цикл 21 день, дни приема этопозида 1-5)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":662,"table_field_ID_FFOMS":"sh0814","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":727,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.11","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"CarPac (PaC, P + карбо) + бевацизумаб: (бевацизумаб 15 + карбоплатин 5 + паклитаксел 60)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":903,"table_field_ID_FFOMS":"sh0836; sh0836.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":728,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.11","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"CarPac (PaC, P + карбо) + бевацизумаб: (бевацизумаб 7,5 + карбоплатин 5 + паклитаксел 80)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":904,"table_field_ID_FFOMS":"sh0837; sh0837.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":729,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.11","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"CarPac (PaC, P + карбо) + бевацизумаб: (бевацизумаб 15 + карбоплатин 5 + паклитаксел 80)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":905,"table_field_ID_FFOMS":"sh0838; sh0838.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":730,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.11","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + доцетаксел + карбоплатин: (бевацизумаб 7,5 + доцетаксел 75 + карбоплатин 5-6)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":663,"table_field_ID_FFOMS":"sh0839","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":731,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.11","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + доцетаксел + карбоплатин: (бевацизумаб 15 + доцетаксел 75 + карбоплатин 5-6)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":664,"table_field_ID_FFOMS":"sh0840","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":732,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.11","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + гемцитабин + карбоплатин: (бевацизумаб 15 + гемцитабин 1000 + карбоплатин 4)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":665,"table_field_ID_FFOMS":"sh0842; sh0842.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":733,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.11","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + винорелбин + гемцитабин + цисплатин: (бевацизумаб 7,5 + винорелбин 25 + гемцитабин 1000 + цисплатин 75)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":666,"table_field_ID_FFOMS":"sh0843; sh0843.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":734,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.11","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + винорелбин + гемцитабин + цисплатин: (бевацизумаб 15 + винорелбин 25 + гемцитабин 1000 + цисплатин 75)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":667,"table_field_ID_FFOMS":"sh0844; sh0844.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":735,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.11","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + винорелбин + гемцитабин + карбоплатин: (бевацизумаб 7,5 + винорелбин 25 + гемцитабин 1000 + карбоплатин 5-6)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":668,"table_field_ID_FFOMS":"sh0845; sh0845.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":736,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.11","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + винорелбин + гемцитабин + карбоплатин: (бевацизумаб 15 + винорелбин 25 + гемцитабин 1000 + карбоплатин 5-6)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":669,"table_field_ID_FFOMS":"sh0846; sh0846.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":737,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.11","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + винорелбин + цисплатин: (бевацизумаб 15 + винорелбин 25 + цисплатин 75)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":175,"table_field_ID_FFOMS":"sh0847; sh0847.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":738,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + цисплатин + этопозид: (бевацизумаб 7,5 + цисплатин 75 + этопозид 100)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":670,"table_field_ID_FFOMS":"sh0848","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":739,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.11","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + цисплатин + этопозид: (бевацизумаб 15 + цисплатин 75 + этопозид 100)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":671,"table_field_ID_FFOMS":"sh0849","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":740,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.11","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + карбоплатин + этопозид: (бевацизумаб 15 + карбоплатин 5-6 + этопозид 100)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":672,"table_field_ID_FFOMS":"sh0850","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":741,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.11","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + доксорубицин + оксалиплатин: (бевацизумаб 7,5 + доксорубицин 30-40 + оксалиплатин 100-130)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":673,"table_field_ID_FFOMS":"sh0852","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":742,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.11","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + доксорубицин + оксалиплатин: (бевацизумаб 15 + доксорубицин 30-40 + оксалиплатин 100-130)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":674,"table_field_ID_FFOMS":"sh0853","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":743,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.11","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + гемцитабин + оксалиплатин: (бевацизумаб 7,5 + гемцитабин 1000 + оксалиплатин 100-130)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":675,"table_field_ID_FFOMS":"sh0854; sh0854.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":744,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.11","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + гемцитабин + оксалиплатин: (бевацизумаб 15 + гемцитабин 1000 + оксалиплатин 100-130)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":676,"table_field_ID_FFOMS":"sh0855; sh0855.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":745,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.11","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + иринотекан + цисплатин: (бевацизумаб 7,5 + иринотекан 60 + цисплатин 60)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":677,"table_field_ID_FFOMS":"sh0857; sh0857.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":746,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.11","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + иринотекан + цисплатин: (бевацизумаб 15 + иринотекан 60 + цисплатин 60)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":678,"table_field_ID_FFOMS":"sh0858; sh0858.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":747,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.11","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"FOLFOX4 + бевацизумаб: (бевацизумаб 7,5 + кальция фолинат 200 + оксалиплатин 85 + фторурацил 400 + фторурацил 600, цикл 21 день)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":679,"table_field_ID_FFOMS":"sh0859","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":748,"subscribed":null,"table_field_MKB_CODE":"C48.0; C48.1; C48.2; C56; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.11","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"TI","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":680,"table_field_ID_FFOMS":"sh0861","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":749,"subscribed":null,"table_field_MKB_CODE":"C38.1; C38.2; C38.3; C38.8; C48.0; C48.8;C62","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CE","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":681,"table_field_ID_FFOMS":"sh0862","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":750,"subscribed":null,"table_field_MKB_CODE":"C38.1; C38.2; C38.3; C38.8; C48.0; C48.8;C62","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Ленватиниб: (ленватиниб 8)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":176,"table_field_ID_FFOMS":"sh0863","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":751,"subscribed":null,"table_field_MKB_CODE":"C22.0","table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Ленватиниб: (ленватиниб 12)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":177,"table_field_ID_FFOMS":"sh0864","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":752,"subscribed":null,"table_field_MKB_CODE":"C22.0","table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Регорафениб: (регорафениб 120)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":178,"table_field_ID_FFOMS":"sh0865","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":753,"subscribed":null,"table_field_MKB_CODE":"C22.0","table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"CarPac (PaC, P + карбо) + цетуксимаб: (карбоплатин 2,5 + паклитаксел 100 + цетуксимаб 250)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":985,"table_field_ID_FFOMS":"sh0866","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":754,"subscribed":null,"table_field_MKB_CODE":"C30.0; C30.1; C31.0; C31.1; C31.2; C31.3; C31.8; C31.9; C01; C02.4; C05.1; C05.2; C09.0; C09.1; C09.8; C09.9; C10.0; C10.1; C10.2; C10.3; C10.4; C10.8; C10.9; C12; C13; C13.0; C13.1; C13.2; C13.8; C13.9; C02.0; C02.1; C02.2; C02.3; C02.8; C02.9; C03.0; C03.1; C03.9; C04.0; C04.1; C04.8; C04.9; C05.0; C06.0; C06.1; C06.2; C06.8; C06.9; C32.0; C32.1; C32.2; C32.3; C32.8; C32.9; C00.0; C00.1; C00.2; C00.3; C00.4; C00.5; C00.6; C00.8; C00.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественные новообразования полости рта, 2020, КР164/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Карбоплатин + фторурацил + цетуксимаб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":986,"table_field_ID_FFOMS":"sh0868; sh0868.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":755,"subscribed":null,"table_field_MKB_CODE":"C00.0; C00.1; C00.2; C00.3; C00.4; C00.5; C00.6; C00.8; C00.9; C01; C02.4; C05.1; C05.2; C09.0; C09.1; C09.8; C09.9; C10.0; C10.1; C10.2; C10.3; C10.4; C10.8; C10.9; C12; C13; C13.0; C13.1; C13.2; C13.8; C13.9; C02.0; C02.1; C02.2; C02.3; C02.8; C02.9; C03.0; C03.1; C03.9; C04.0; C04.1; C04.8; C04.9; C05.0; C06.0; C06.1; C06.2; C06.8; C06.9; C32.0; C32.1; C32.2; C32.3; C32.8; C32.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественные новообразования полости рта, 2020, КР164/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Фторурацил: (фторурацил 1000)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":987,"table_field_ID_FFOMS":"sh0870","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":756,"subscribed":null,"table_field_MKB_CODE":"C00.0; C00.1; C00.2; C00.3; C00.4; C00.5; C00.6; C00.8; C00.9; C01; C02.4; C05.1; C05.2; C09.0; C09.1; C09.8; C09.9; C10.0; C10.1; C10.2; C10.3; C10.4; C10.8; C10.9; C12; C13; C13.0; C13.1; C13.2; C13.8; C13.9; C02.0; C02.1; C02.2; C02.3; C02.8; C02.9; C03.0; C03.1; C03.9; C04.0; C04.1; C04.8; C04.9; C05.0; C06.0; C06.1; C06.2; C06.8; C06.9; C32.0; C32.1; C32.2; C32.3; C32.8; C32.9; C11.0; C11.1; C11.2; C11.3; C11.8; C11.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественные новообразования полости рта, 2020, КР164/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Цисплатин + этопозид: (цисплатин 100 + этопозид 100, цикл 28 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":682,"table_field_ID_FFOMS":"sh0871","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":757,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"ADOC","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":683,"table_field_ID_FFOMS":"sh0873","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":758,"subscribed":null,"table_field_MKB_CODE":"C37.9; C38.1; C38.2; C38.3","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"AI: (доксорубицин 60 + ифосфамид 2500 + месна 750)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":906,"table_field_ID_FFOMS":"sh0874","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":759,"subscribed":null,"table_field_MKB_CODE":"C49.0; C49.1; C49.2; C49.3; C49.4; C49.5; C49.6; C49.8; C49.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"AP","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":684,"table_field_ID_FFOMS":"sh0875","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":760,"subscribed":null,"table_field_MKB_CODE":"C40.0; C40.1; C40.2; C40.3; C40.8; C40.9; C41.0; C41.1; C41.2; C41.3; C41.4; C41.8; C41.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Пембролизумаб: (пембролиумаб 400)","table_field_COMMENTS":"В связи с тем, что меланома может развиваться в различных органах (не только в коже), по Международной статистической классификации болезней и проблем, связанных со здоровьем (МКБ-10), такие опухоли классифицируются в соответствии с органом первичного происхождения","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":907,"table_field_ID_FFOMS":"sh0876","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":761,"subscribed":null,"table_field_MKB_CODE":"C43.0; C43.1; C43.2; C43.3; C43.4; C43.5; C43.6; C43.7; C43.8; C43.9; C51.0; C51.1; C51.2; C51.8; C51.9; C60.9; C63.2; C69.0; D03.0; D03.1; D03.2; D03.3; D03.4; D03.5; D03.6; D03.7; D03.8; D03.9; C15.0; C15.1; C15.2; C15.3; C15.4; C15.5; C15.8; C15.9; C16.0","table_field_CLINICAL_RECOMMENDATIONS":"Рак пищевода и кардии, 2021, КР237/5; Меланома кожи и слизистых оболочек, 2020, КР546/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Пролголимаб","table_field_COMMENTS":"В связи с тем, что меланома может развиваться в различных органах (не только в коже), по Международной статистической классификации болезней и проблем, связанных со здоровьем (МКБ-10), такие опухоли классифицируются в соответствии с органом первичного происхождения","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":908,"table_field_ID_FFOMS":"sh0877","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":762,"subscribed":null,"table_field_MKB_CODE":"C43.0; C43.1; C43.2; C43.3; C43.4; C43.5; C43.6; C43.7; C43.8; C43.9; C51.0; C51.1; C51.2; C51.8; C51.9; C60.9; C63.2; C69.0; D03.0; D03.1; D03.2; D03.3; D03.4; D03.5; D03.6; D03.7; D03.8; D03.9","table_field_CLINICAL_RECOMMENDATIONS":"Меланома кожи и слизистых оболочек, 2020, КР546/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CAV, VAC: (винкристин 1,5 + доксорубицин 50 + циклофосфамид 1000)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":685,"table_field_ID_FFOMS":"sh0878","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":763,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CF, PF: (фторурацил 800 + цисплатин 80)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":909,"table_field_ID_FFOMS":"sh0879","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":764,"subscribed":null,"table_field_MKB_CODE":"C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"FLOX: (кальция фолинат 20 + оксалиплатин 85 + фторурацил 500)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":179,"table_field_ID_FFOMS":"sh0202; sh0202.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":765,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"FOLFCIS","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":686,"table_field_ID_FFOMS":"sh0881","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":766,"subscribed":null,"table_field_MKB_CODE":"C21.0; C21.1; C21.2; C21.8; C44.5","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"mFOLFIRINOX: (иринотекан 180 + кальция фолинат 200 + оксалиплатин 85 + фторурацил 250 + фторурацил 1100)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":687,"table_field_ID_FFOMS":"sh0884","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":767,"subscribed":null,"table_field_MKB_CODE":"C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак желудка, 2020, КР574/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"mFOLFIRINOX: (иринотекан 120-180 + кальция фолинат 400 + оксалиплатин 60-85 +  фторурацил 1000-1200)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":910,"table_field_ID_FFOMS":"sh0885","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":768,"subscribed":null,"table_field_MKB_CODE":"C25.0; C25.1; C25.2; C25.3; C25.4; C25.7; C25.8; C25.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак поджелудочной железы, 2021, КР335/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"GemCap: (гемцитабин 1000 + капецитабин 625)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":688,"table_field_ID_FFOMS":"sh0887","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":769,"subscribed":null,"table_field_MKB_CODE":"C22.1; C23; C24.0","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"GemOX: (гемцитабин 1000 + оксалиплатин 80)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":689,"table_field_ID_FFOMS":"sh0888; sh0888.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":770,"subscribed":null,"table_field_MKB_CODE":"C45.0; C45.1; C45.2; C45.7; C45.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"GD, GemTax: (гемцитабин 900 + доцетаксел 100 + филграстим 5, дни приёма филграстима 9-19)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":911,"table_field_ID_FFOMS":"sh0889","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":771,"subscribed":null,"table_field_MKB_CODE":"C40.0; C40.1; C40.2; C40.3; C40.8; C40.9; C41.0; C41.1; C41.2; C41.3; C41.4; C41.8; C41.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"GD, GemTax: (гемцитабин 900 + доцетаксел 100 + филграстим 5, дни приёма филграстима 9-15)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":912,"table_field_ID_FFOMS":"sh0890","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":772,"subscribed":null,"table_field_MKB_CODE":"C49.0; C49.1; C49.2; C49.3; C49.4; C49.5; C49.6; C49.8; C49.9; C48.0","table_field_CLINICAL_RECOMMENDATIONS":"Забрюшинные неорганные саркомы, 2020, КР618/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + гемцитабин + цисплатин: (бевацизумаб 15 + гемцитабин 1000 + цисплатин 80)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":690,"table_field_ID_FFOMS":"sh0891; sh0891.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":773,"subscribed":null,"table_field_MKB_CODE":"C45.0; C45.1; C45.2; C45.7; C45.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"GC, GP: (гемцитабин 1000 + цисплатин 80)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":913,"table_field_ID_FFOMS":"sh0892; sh0892.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":774,"subscribed":null,"table_field_MKB_CODE":"C45.0; C45.1; C45.2; C45.7; C45.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"HD AI: (доксорубицин 25 + ифосфамид 2500 + месна 2500 + филграстим 300)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":691,"table_field_ID_FFOMS":"sh0893","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":775,"subscribed":null,"table_field_MKB_CODE":"C49.0; C49.1; C49.2; C49.3; C49.4; C49.5; C49.6; C49.8; C49.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"HD I: (ифосфамид 2000 + месна 2000 + филграстим 5)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":692,"table_field_ID_FFOMS":"sh0894","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":776,"subscribed":null,"table_field_MKB_CODE":"C40.0; C40.1; C40.2; C40.3; C40.8; C40.9; C41.0; C41.1; C41.2; C41.3; C41.4; C41.8; C41.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"IE: (ифосфамид 1800 + месна 2160 + этопозид 100, цикл 14 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":693,"table_field_ID_FFOMS":"sh0895","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":777,"subscribed":null,"table_field_MKB_CODE":"C49.0; C49.1; C49.2; C49.3; C49.4; C49.5; C49.6; C49.8; C49.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"IE: (ифосфамид 1800 + месна 2160 + этопозид 100, цикл 28 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":694,"table_field_ID_FFOMS":"sh0896","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":778,"subscribed":null,"table_field_MKB_CODE":"C40.0; C40.1; C40.2; C40.3; C40.8; C40.9; C41.0; C41.1; C41.2; C41.3; C41.4; C41.8; C41.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"MAID: (дакарбазин 300 + доксорубицин 20 + ифосфамид 2000 + месна 2000-2400)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":695,"table_field_ID_FFOMS":"sh0897","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":779,"subscribed":null,"table_field_MKB_CODE":"C49.0; C49.1; C49.2; C49.3; C49.4; C49.5; C49.6; C49.8; C49.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"mDCF: (доцетаксел 40 + кальция фолинат 400 + фторурацил 1000 + цисплатин 40, 48-часовая инфузия)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":914,"table_field_ID_FFOMS":"sh0898","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":780,"subscribed":null,"table_field_MKB_CODE":"C15.0; C15.1; C15.2; C15.3; C15.4; C15.5; C15.8; C15.9; C16.0","table_field_CLINICAL_RECOMMENDATIONS":"Рак пищевода и кардии, 2021, КР237/5","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"mDCF: (доцетаксел 40 + фторурацил 1200 + цисплатин 40)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":696,"table_field_ID_FFOMS":"sh0899","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":781,"subscribed":null,"table_field_MKB_CODE":"C21.0; C21.1; C21.2; C21.8; C44.5","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"mFOLFOX6 + цетуксимаб: (кальция фолинат 400 + оксалиплатин 85 + фторурацил 400 + фторурацил 1200 + цетуксимаб 500)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":697,"table_field_ID_FFOMS":"sh0905","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":782,"subscribed":null,"table_field_MKB_CODE":"C20; C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"De Gramont + цетуксимаб: (кальция фолинат 200 + фторурацил 400 + фторурацил 1200 + цетуксимаб 250)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":698,"table_field_ID_FFOMS":"sh0906; sh0906.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":783,"subscribed":null,"table_field_MKB_CODE":"C20","table_field_CLINICAL_RECOMMENDATIONS":"Рак прямой кишки, 2020, КР554/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"De Gramont + цетуксимаб: (кальция фолинат 200 + фторурацил 400 + фторурацил 1200 + цетуксимаб 500)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":699,"table_field_ID_FFOMS":"sh0908","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":784,"subscribed":null,"table_field_MKB_CODE":"C20","table_field_CLINICAL_RECOMMENDATIONS":"Рак прямой кишки, 2020, КР554/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"De Gramont + цетуксимаб: (кальция фолинат 400 + фторурацил 400 + фторурацил 1200 + цетуксимаб 500)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":700,"table_field_ID_FFOMS":"sh0907","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":785,"subscribed":null,"table_field_MKB_CODE":"C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"OFF","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":915,"table_field_ID_FFOMS":"sh0909; sh0909.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":786,"subscribed":null,"table_field_MKB_CODE":"C25.0; C25.1; C25.2; C25.3; C25.4; C25.7; C25.8; C25.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак поджелудочной железы, 2021, КР335/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + пеметрексед + цисплатин: (бевацизумаб 15 + пеметрексед 500 + цисплатин 75)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":180,"table_field_ID_FFOMS":"sh0911","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":787,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"FOLFIRI + трастузумаб: (иринотекан 180 + кальция фолинат 400 + трастузумаб 4 + фторурацил 400 + фторурацил 1200)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":701,"table_field_ID_FFOMS":"sh0912","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":788,"subscribed":null,"table_field_MKB_CODE":"C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"mFOLFOX6 + трастузумаб: (кальция фолинат 400 + оксалиплатин 85 + трастузумаб 4 + фторурацил 400 + фторурацил 1200)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":702,"table_field_ID_FFOMS":"sh0913","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":789,"subscribed":null,"table_field_MKB_CODE":"C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CAV, VAC: (винкристин 2 + доксорубицин 37,5 + филграстим 300 + циклофосфамид 1200)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":703,"table_field_ID_FFOMS":"sh0914","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":790,"subscribed":null,"table_field_MKB_CODE":"C49.0; C49.1; C49.2; C49.3; C49.4; C49.5; C49.6; C49.8; C49.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CAV, VAC: (винкристин 2 + доксорубицин 75 + циклофосфамид 1200, цикл 21 день)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":704,"table_field_ID_FFOMS":"sh0915","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":791,"subscribed":null,"table_field_MKB_CODE":"C40.0; C40.1; C40.2; C40.3; C40.8; C40.9; C41.0; C41.1; C41.2; C41.3; C41.4; C41.8; C41.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CAV, VAC: (винкристин 2 + доксорубицин 75 + циклофосфамид 1200, цикл 28 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":705,"table_field_ID_FFOMS":"sh0916","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":792,"subscribed":null,"table_field_MKB_CODE":"C40.0; C40.1; C40.2; C40.3; C40.8; C40.9; C41.0; C41.1; C41.2; C41.3; C41.4; C41.8; C41.9","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"XELIRI (CAPIRI) + рамуцирумаб: (иринотекан 200 + капецитабин 1000 + рамуцирумаб 8)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":749,"table_field_ID_FFOMS":"sh0918","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":793,"subscribed":null,"table_field_MKB_CODE":"C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак желудка, 2020, КР574/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"XELIRI (CAPIRI): (иринотекан 180-200 + капецитабин 825)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":706,"table_field_ID_FFOMS":"sh0919","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":794,"subscribed":null,"table_field_MKB_CODE":"C20","table_field_CLINICAL_RECOMMENDATIONS":"Рак прямой кишки, 2020, КР554/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"GemOX: (гемцитабин 1000 + оксалиплатин 85-100)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1015,"table_field_ID_FFOMS":"sh0922","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":795,"subscribed":null,"table_field_MKB_CODE":"C25.0; C25.1; C25.2; C25.3; C25.4; C25.7; C25.8; C25.9; C81.0; C81.1; C81.2; C81.3; C81.4; C81.7; C81.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак поджелудочной железы, 2021, КР335/4; Лимфома Ходжкина, 2020, КР139/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Дабрафениб + траметиниб + панитумумаб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":707,"table_field_ID_FFOMS":"sh0924","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":796,"subscribed":null,"table_field_MKB_CODE":"C20; C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19","table_field_CLINICAL_RECOMMENDATIONS":" ","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Дазатиниб: (дазатиниб 70)","table_field_COMMENTS":"По Международной статистической классификации болезней и проблем, связанных со здоровьем (далее – МКБ 10) гастроинтестинальные стромальные опухоли классифицируются в соответствии с органом первичного происхождения","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":988,"table_field_ID_FFOMS":"sh0925","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":797,"subscribed":null,"table_field_MKB_CODE":"C15.0; C15.1; C15.2; C15.3; C15.4; C15.5; C15.8; C15.9; C16.0; C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9; C17.0; C17.2; C17.3; C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19; C20; C48.0; C48.1; C92.1","table_field_CLINICAL_RECOMMENDATIONS":"Хронический миелолейкоз, 2020, КР142/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Доксорубицин + трастузумаб + цисплатин: (доксорубицин 30 + трастузумаб 4 + цисплатин 50)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":181,"table_field_ID_FFOMS":"sh0928; sh0928.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":798,"subscribed":null,"table_field_MKB_CODE":"C07; C08.0; C08.1; C08.8; C08.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественные опухоли слюнных желез, 2020, КР116/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Доксорубицин + цисплатин: (доксорубицин 30 + цисплатин 50)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":182,"table_field_ID_FFOMS":"sh0929; sh0929.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":799,"subscribed":null,"table_field_MKB_CODE":"C07; C08.0; C08.1; C08.8; C08.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественные опухоли слюнных желез, 2020, КР116/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Блеомицин + доксорубицин + трастузумаб + цисплатин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":183,"table_field_ID_FFOMS":"sh0930","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":800,"subscribed":null,"table_field_MKB_CODE":"C07; C08.0; C08.1; C08.8; C08.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественные опухоли слюнных желез, 2020, КР116/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Блеомицин + доксорубицин + цисплатин: (блеомицин 30 + доксорубицин 50 + цисплатин 20)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":184,"table_field_ID_FFOMS":"sh0931","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":801,"subscribed":null,"table_field_MKB_CODE":"C07; C08.0; C08.1; C08.8; C08.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественные опухоли слюнных желез, 2020, КР116/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Доксорубицин + трастузумаб + цисплатин: (доксорубицин 60 + трастузумаб 4 + цисплатин 40)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":185,"table_field_ID_FFOMS":"sh0932","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":802,"subscribed":null,"table_field_MKB_CODE":"C07; C08.0; C08.1; C08.8; C08.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественные опухоли слюнных желез, 2020, КР116/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Доксорубицин + доцетаксел: (доксорубицин 20 + доцетаксел 20)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":186,"table_field_ID_FFOMS":"sh0933","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":803,"subscribed":null,"table_field_MKB_CODE":"C73","table_field_CLINICAL_RECOMMENDATIONS":"Дифференцированный рак щитовидной железы, 2020, КР329/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Доксорубицин + доцетаксел: (доксорубицин 60 + доцетаксел 60, цикл 21 день)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":187,"table_field_ID_FFOMS":"sh0934","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":804,"subscribed":null,"table_field_MKB_CODE":"C73","table_field_CLINICAL_RECOMMENDATIONS":"Дифференцированный рак щитовидной железы, 2020, КР329/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Доксорубицин + доцетаксел: (доксорубицин 60 + доцетаксел 60, цикл 28 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":188,"table_field_ID_FFOMS":"sh0935","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":805,"subscribed":null,"table_field_MKB_CODE":"C73","table_field_CLINICAL_RECOMMENDATIONS":"Дифференцированный рак щитовидной железы, 2020, КР329/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"mDCF: (доцетаксел 75 + фторурацил 1000 + цисплатин 100)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":189,"table_field_ID_FFOMS":"sh0936","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":806,"subscribed":null,"table_field_MKB_CODE":"C00.0; C00.1; C00.2; C00.3; C00.4; C00.5; C00.6; C00.8; C00.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественные новообразования губы, 2020, КР553/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"DCF + филграстим","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":916,"table_field_ID_FFOMS":"sh0937","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":807,"subscribed":null,"table_field_MKB_CODE":"C15.0; C15.1; C15.2; C15.3; C15.4; C15.5; C15.8; C15.9; C16.0","table_field_CLINICAL_RECOMMENDATIONS":"Рак пищевода и кардии, 2021, КР237/5","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Вемурафениб + иринотекан + цетуксимаб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":190,"table_field_ID_FFOMS":"sh0942","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":808,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Ифосфамид + месна: (ифосфамид 2800 + месна 3360)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":191,"table_field_ID_FFOMS":"sh0943","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":809,"subscribed":null,"table_field_MKB_CODE":"C49.0; C49.1; C49.2; C49.3; C49.4; C49.5; C49.6; C49.8; C49.9","table_field_CLINICAL_RECOMMENDATIONS":"Саркомы мягких тканей, 2020, КР515/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Нилотиниб: (нилотиниб 400)","table_field_COMMENTS":"По Международной статистической классификации болезней и проблем, связанных со здоровьем (далее – МКБ 10) гастроинтестинальные стромальные опухоли классифицируются в соответствии с органом первичного происхождения","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":989,"table_field_ID_FFOMS":"sh0945","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":810,"subscribed":null,"table_field_MKB_CODE":"C15.0; C15.1; C15.2; C15.3; C15.4; C15.5; C15.8; C15.9; C16.0; C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9; C17.0; C17.2; C17.3; C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19; C20; C48.0; C48.1; C92.1","table_field_CLINICAL_RECOMMENDATIONS":"Хронический миелолейкоз, 2020, КР142/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"PCF: (паклитаксел 135 + фторурацил 1000 + цисплатин 75)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":917,"table_field_ID_FFOMS":"sh0946","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":811,"subscribed":null,"table_field_MKB_CODE":"C02.0; C02.1; C02.2; C02.3; C02.8; C02.9; C03.0; C03.1; C03.9; C04.0; C04.1; C04.8; C04.9; C05.0; C06.0; C06.1; C06.2; C06.8; C06.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественные новообразования полости рта, 2020, КР164/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"PCF: (паклитаксел 175 + фторурацил 500 + цисплатин 100, 120-часовая инфузия)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":918,"table_field_ID_FFOMS":"sh0947","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":812,"subscribed":null,"table_field_MKB_CODE":"C00.0; C00.1; C00.2; C00.3; C00.4; C00.5; C00.6; C00.8; C00.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественные новообразования губы, 2020, КР553/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"PCF: (паклитаксел 175 + фторурацил 750-1000 + цисплатин 75)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":919,"table_field_ID_FFOMS":"sh0948","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":813,"subscribed":null,"table_field_MKB_CODE":"C15.0; C15.1; C15.2; C15.3; C15.4; C15.5; C15.8; C15.9; C16.0","table_field_CLINICAL_RECOMMENDATIONS":"Рак пищевода и кардии, 2021, КР237/5","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CarPac (PaC, P + карбо): (паклитаксел 50 + карбоплатин 2)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":920,"table_field_ID_FFOMS":"sh0951; sh0951.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":814,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественное новообразование бронхов и легкого, 2021, КР30/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"CarPac (PaC, P + карбо) + трастузумаб: (карбоплатин 2 + паклитаксел 60-80 + трастузумаб 4)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":921,"table_field_ID_FFOMS":"sh0952","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":815,"subscribed":null,"table_field_MKB_CODE":"C07; C08.0; C08.1; C08.8; C08.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественные опухоли слюнных желез, 2020, КР116/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Регорафениб: (регорафениб 80 + регорафениб 120 + регорафениб 160)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":192,"table_field_ID_FFOMS":"sh0955","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":816,"subscribed":null,"table_field_MKB_CODE":"C20","table_field_CLINICAL_RECOMMENDATIONS":"Рак прямой кишки, 2020, КР554/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Иринотекан + темозоломид: (иринотекан 50 + темозоломид 150)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":193,"table_field_ID_FFOMS":"sh0956","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":817,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Иринотекан + темозоломид: (иринотекан 40 + темозоломид 100)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":194,"table_field_ID_FFOMS":"sh0957","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":818,"subscribed":null,"table_field_MKB_CODE":"C49.0; C49.1; C49.2; C49.3; C49.4; C49.5; C49.6; C49.8; C49.9","table_field_CLINICAL_RECOMMENDATIONS":"Саркомы мягких тканей, 2020, КР515/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бевацизумаб + темозоломид","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":195,"table_field_ID_FFOMS":"sh0958;sh0958.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":819,"subscribed":null,"table_field_MKB_CODE":"C49.0; C49.1; C49.2; C49.3; C49.4; C49.5; C49.6; C49.8; C49.9","table_field_CLINICAL_RECOMMENDATIONS":"Саркомы мягких тканей, 2020, КР515/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Кабозантиниб: (кабозантиниб 140)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":196,"table_field_ID_FFOMS":"sh0959","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":820,"subscribed":null,"table_field_MKB_CODE":"C73","table_field_CLINICAL_RECOMMENDATIONS":"Медуллярный рак щитовидной железы, 2020, КР332/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Церитиниб: (церитиниб 450)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":197,"table_field_ID_FFOMS":"sh0960","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":821,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественное новообразование бронхов и легкого, 2021, КР30/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CF, PF: (фторурацил 1000 + цисплатин 60)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":922,"table_field_ID_FFOMS":"sh0966","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":822,"subscribed":null,"table_field_MKB_CODE":"C21.0; C21.1; C21.2; C21.8; C44.5","table_field_CLINICAL_RECOMMENDATIONS":"Плоскоклеточный рак анального канала, анального края, перианальной кожи, 2020, КР555/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Цетуксимаб: (цетуксимаб 250, нагрузочная доза 450)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":198,"table_field_ID_FFOMS":"sh0968","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":823,"subscribed":null,"table_field_MKB_CODE":"C02.0; C02.1; C02.2; C02.3; C02.8; C02.9; C03.0; C03.1; C03.9; C04.0; C04.1; C04.8; C04.9; C05.0; C06.0; C06.1; C06.2; C06.8; C06.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественные новообразования полости рта, 2020, КР164/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Ифосфамид + цисплатин + этопозид","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":199,"table_field_ID_FFOMS":"sh0970","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":824,"subscribed":null,"table_field_MKB_CODE":"C37.9; C38.1; C38.2; C38.3","table_field_CLINICAL_RECOMMENDATIONS":"Опухоли средостения, 2020, КР502/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Цисплатин: (цисплатин 25)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":200,"table_field_ID_FFOMS":"sh0971","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":825,"subscribed":null,"table_field_MKB_CODE":"C73","table_field_CLINICAL_RECOMMENDATIONS":"Дифференцированный рак щитовидной железы, 2020, КР329/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Доксорубицин + цисплатин: (доксорубицин 50 + цисплатин 50-60)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":201,"table_field_ID_FFOMS":"sh0972","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":826,"subscribed":null,"table_field_MKB_CODE":"C44.0; C44.1; C44.2; C44.3; C44.4; C44.5; C44.6; C44.7; C44.8; C44.9;D04.0; D04.1; D04.2; D04.3; D04.4; D04.5; D04.6; D04.7; D04.8; D04.9","table_field_CLINICAL_RECOMMENDATIONS":"Плоскоклеточный рак кожи, 2020, КР476/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Капецитабин + цисплатин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":202,"table_field_ID_FFOMS":"sh0973","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":827,"subscribed":null,"table_field_MKB_CODE":"C44.0; C44.1; C44.2; C44.3; C44.4; C44.5; C44.6; C44.7; C44.8; C44.9;D04.0; D04.1; D04.2; D04.3; D04.4; D04.5; D04.6; D04.7; D04.8; D04.9","table_field_CLINICAL_RECOMMENDATIONS":"Плоскоклеточный рак кожи, 2020, КР476/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CF, PF: (фторурацил 1000 + цисплатин 75-100)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":923,"table_field_ID_FFOMS":"sh0975","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":828,"subscribed":null,"table_field_MKB_CODE":"C44.0; C44.1; C44.2; C44.3; C44.4; C44.5; C44.6; C44.7; C44.8; C44.9;D04.0; D04.1; D04.2; D04.3; D04.4; D04.5; D04.6; D04.7; D04.8; D04.9","table_field_CLINICAL_RECOMMENDATIONS":"Плоскоклеточный рак кожи, 2020, КР476/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CF, PF: (фторурацил 750 + цисплатин 75)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":924,"table_field_ID_FFOMS":"sh0974","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":829,"subscribed":null,"table_field_MKB_CODE":"C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак желудка, 2020, КР574/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Цисплатин + этопозид: (цисплатин 100 + этопозид 100, цикл 21 день)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":203,"table_field_ID_FFOMS":"sh0977","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":830,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественное новообразование бронхов и легкого, 2021, КР30/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Цисплатин + этопозид: (цисплатин 50 + этопозид 50)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":204,"table_field_ID_FFOMS":"sh0978","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":831,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Ипилимумаб + ниволумаб: (ипилимумаб 1 + ниволумаб 360)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":205,"table_field_ID_FFOMS":"sh0979","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":832,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Абемациклиб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":206,"table_field_ID_FFOMS":"sh0985","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":833,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Абемациклиб + анастрозол","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":207,"table_field_ID_FFOMS":"sh0984","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":834,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Абемациклиб + фулвестрант","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":208,"table_field_ID_FFOMS":"sh0980","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":835,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Абемациклиб + лейпрорелин + фулвестрант","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":209,"table_field_ID_FFOMS":"sh0981","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":836,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Абемациклиб + гозерелин + фулвестрант","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":210,"table_field_ID_FFOMS":"sh0982","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":837,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Абемациклиб + бусерелин + фулвестрант","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":211,"table_field_ID_FFOMS":"sh0983","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":838,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Иксабепилон + капецитабин + трастузумаб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":218,"table_field_ID_FFOMS":"sh0987","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":839,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Иксабепилон + капецитабин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":219,"table_field_ID_FFOMS":"sh0988","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":840,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Гемцитабин + капецитабин + митотан: (гемцитабин 800-1000 + капецитабин 1600-2000 + митотан 1-8)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":220,"table_field_ID_FFOMS":"sh0989","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":841,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"EC + филграстим","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":221,"table_field_ID_FFOMS":"sh0992","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":842,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"EC+ эмпэгфилграстим","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":222,"table_field_ID_FFOMS":"sh0993","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":843,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Паклитаксел + филграстим","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":223,"table_field_ID_FFOMS":"sh0994","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":844,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Паклитаксел + эмпэгфилграстим","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":224,"table_field_ID_FFOMS":"sh0995","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":845,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"P + трастузумаб + филграстим: (паклитаксел 175 + трастузумаб 2 + филграстим 5)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":225,"table_field_ID_FFOMS":"sh0997","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":846,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"P + трастузумаб + эмпэгфилграстим: (паклитаксел 175 + трастузумаб 2 + эмпэгфилграстим 5)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":226,"table_field_ID_FFOMS":"sh0998","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":847,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"P + трастузумаб: (паклитаксел 175 + трастузумаб 2)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":227,"table_field_ID_FFOMS":"sh0999","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":848,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CarPac (PaC, P + карбо): (паклитаксел 80 + карбоплатин 6)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":925,"table_field_ID_FFOMS":"sh1002","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":849,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Трипторелин + фулвестрант","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":228,"table_field_ID_FFOMS":"sh1003","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":850,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Гозерелин + рибоциклиб + фулвестрант","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":229,"table_field_ID_FFOMS":"sh1005","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":851,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Лейпрорелин + рибоциклиб + фулвестрант","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":230,"table_field_ID_FFOMS":"sh1006","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":852,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бусерелин + рибоциклиб + фулвестрант","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":231,"table_field_ID_FFOMS":"sh1007","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":853,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Рибоциклиб + трипторелин + фулвестрант","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":232,"table_field_ID_FFOMS":"sh1008","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":854,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Абемациклиб + трипторелин + фулвестрант","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":233,"table_field_ID_FFOMS":"sh1009","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":855,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Анастрозол + палбоциклиб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":234,"table_field_ID_FFOMS":"sh1010","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":856,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Анастрозол + рибоциклиб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":235,"table_field_ID_FFOMS":"sh1011","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":857,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Анастрозол + гозерелин + палбоциклиб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":236,"table_field_ID_FFOMS":"sh1012","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":858,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Анастрозол + лейпрорелин + палбоциклиб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":237,"table_field_ID_FFOMS":"sh1013","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":859,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Анастрозол + бусерелин + палбоциклиб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":238,"table_field_ID_FFOMS":"sh1014","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":860,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Анастрозол + палбоциклиб + трипторелин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":239,"table_field_ID_FFOMS":"sh1015","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":861,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Анастрозол + гозерелин + рибоциклиб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":240,"table_field_ID_FFOMS":"sh1016","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":862,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Анастрозол + лейпрорелин + рибоциклиб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":241,"table_field_ID_FFOMS":"sh1017","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":863,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Анастрозол + бусерелин + рибоциклиб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":242,"table_field_ID_FFOMS":"sh1018","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":864,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Анастрозол + рибоциклиб + трипторелин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":243,"table_field_ID_FFOMS":"sh1019","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":865,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Абемациклиб + анастрозол + гозерелин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":244,"table_field_ID_FFOMS":"sh1020","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":866,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Абемациклиб + анастрозол + лейпрорелин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":245,"table_field_ID_FFOMS":"sh1021","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":867,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Абемациклиб + анастрозол + бусерелин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":246,"table_field_ID_FFOMS":"sh1022","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":868,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Абемациклиб + анастрозол + трипторелин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":247,"table_field_ID_FFOMS":"sh1023","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":869,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Анастрозол + трипторелин + эверолимус","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":248,"table_field_ID_FFOMS":"sh1024","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":870,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Медроксипрогестерон: (медроксипрогестерон 500-1000)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":249,"table_field_ID_FFOMS":"sh1025","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":871,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Гозерелин + медроксипрогестерон","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":250,"table_field_ID_FFOMS":"sh1026","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":872,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Лейпрорелин + медроксипрогестерон","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":251,"table_field_ID_FFOMS":"sh1027","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":873,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Бусерелин + медроксипрогестерон","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":252,"table_field_ID_FFOMS":"sh1028","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":874,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Медроксипрогестерон + трипторелин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":253,"table_field_ID_FFOMS":"sh1029","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":875,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"EC: (циклофосфамид 600 + эпирубицин 60-75)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":254,"table_field_ID_FFOMS":"sh1030","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":876,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Цисплатин: (цисплатин 75)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":255,"table_field_ID_FFOMS":"sh1036","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":877,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Этопозид: (этопозид 100, цикл 28 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":256,"table_field_ID_FFOMS":"sh1037","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":878,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"CarPac (PaC, P + карбо) + трастузумаб: (карбоплатин 2 + паклитаксел 80 + трастузумаб 2)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":926,"table_field_ID_FFOMS":"sh1038; sh1038.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":879,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"P + трастузумаб: (паклитаксел 90 + трастузумаб 2)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":257,"table_field_ID_FFOMS":"sh1039; sh1039.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":880,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"D + трастузумаб: (доцетаксел 75 + трастузумаб 2)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":258,"table_field_ID_FFOMS":"sh1040; sh1040.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":881,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Гемцитабин + трастузумаб: (гемцитабин 800-1200 + трастузумаб 2)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":259,"table_field_ID_FFOMS":"sh1041; sh1041.1","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":882,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Метотрексат + трастузумаб + циклофосфамид: (метотрексат 2,5 + трастузумаб 2 + циклофосфамид 50)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":260,"table_field_ID_FFOMS":"sh1042","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":883,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Трастузумаб + этопозид: (трастузумаб 6 + этопозид 50)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":261,"table_field_ID_FFOMS":"sh1044","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":884,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Трастузумаб + этопозид: (трастузумаб 2 + этопозид 50)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":262,"table_field_ID_FFOMS":"sh1043","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":885,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Анастрозол + трастузумаб: (анастрозол 1 + трастузумаб 2)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":708,"table_field_ID_FFOMS":"sh1045","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":886,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Анастрозол + лапатиниб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":263,"table_field_ID_FFOMS":"sh1046","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":887,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Анастрозол + лапатиниб + трастузумаб: (анастрозол 1 + лапатиниб 1000 + трастузумаб 6)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":264,"table_field_ID_FFOMS":"sh1047","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":888,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Анастрозол + лапатиниб + трастузумаб: (анастрозол 1 + лапатиниб 1000 + трастузумаб 2)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":265,"table_field_ID_FFOMS":"sh1048","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":889,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Тамоксифен + трастузумаб: (тамоксифен 20 + трастузумаб 2)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":266,"table_field_ID_FFOMS":"sh1049","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":890,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Тамоксифен + трастузумаб + трипторелин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":267,"table_field_ID_FFOMS":"sh1050","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":891,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Пертузумаб + тамоксифен","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":268,"table_field_ID_FFOMS":"sh1051","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":892,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"DC + трастузумаб + филграстим","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":269,"table_field_ID_FFOMS":"sh1052","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":893,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"DC + трастузумаб + эмпэгфилграстим","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":270,"table_field_ID_FFOMS":"sh1053","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":894,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"DC + филграстим","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":271,"table_field_ID_FFOMS":"sh1054","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":895,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"EC: (циклофосфамид 600 + эпирубицин 90-100)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":272,"table_field_ID_FFOMS":"sh1056","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":896,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"DCH + филграстим","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":273,"table_field_ID_FFOMS":"sh1057","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":897,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"DCH + эмпэгфилграстим","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":274,"table_field_ID_FFOMS":"sh1058","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":898,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"DCH + пертузумаб + филграстим","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":275,"table_field_ID_FFOMS":"sh1059","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":899,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Ипилимумаб + карбоплатин + ниволумаб + пеметрексед","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":276,"table_field_ID_FFOMS":"sh1061","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":900,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Ипилимумаб + ниволумаб + пеметрексед + цисплатин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":277,"table_field_ID_FFOMS":"sh1062","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":901,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Ипилимумаб + карбоплатин + ниволумаб + паклитаксел","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":278,"table_field_ID_FFOMS":"sh1063","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":902,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Абемациклиб + эксеместан","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":709,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":903,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Анастрозол + лапатиниб + трастузумаб: (анастрозол 1 + лапатиниб 1000 + трастузумаб п/к)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":710,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":904,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Анастрозол + трастузумаб: (анастрозол 1 + трастузумаб п/к)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":711,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":905,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Nab-паклитаксел + атезолизумаб: (атезолизумаб 840 + nab-паклитаксел 100)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":712,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":906,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Nab-паклитаксел + атезолизумаб: (атезолизумаб 1200 + nab-паклитаксел 100)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":713,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":907,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Nab-паклитаксел + атезолизумаб: (атезолизумаб 1680 + nab-паклитаксел 100)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":714,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":908,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Винорелбин + трастузумаб: (винорелбин 60→80 + трастузумаб п/к)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":715,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":909,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Винорелбин + трастузумаб: (винорелбин 25 + трастузумаб п/к)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":716,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":910,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Гемцитабин + карбоплатин + трастузумаб: (гемцитабин 1000 + карбоплатин 5 + трастузумаб 2)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":717,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":911,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Гемцитабин + карбоплатин + трастузумаб: (гемцитабин 1000 + карбоплатин 5 + трастузумаб п/к)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":718,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":912,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Гемцитабин + трастузумаб: (гемцитабин 800-1200 + трастузумаб п/к)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":719,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":913,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Гемцитабин + трастузумаб: (гемцитабин 800-1200 + трастузумаб 6, цикл гемцитабина 28 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":720,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":914,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Гемцитабин + трастузумаб + цисплатин: (гемцитабин 1000 + трастузумаб 2 + цисплатин 75)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":721,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":915,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Гемцитабин + трастузумаб + цисплатин: (гемцитабин 1000 + трастузумаб п/к + цисплатин 75)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":722,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":916,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"D + трастузумаб + пертузумаб: (доцетаксел 75-100 + пертузумаб 420 + трастузумаб 6)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":723,"table_field_ID_FFOMS":"sh0070","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":917,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"D + трастузумаб + пертузумаб: (доцетаксел 75-100 + пертузумаб 420 + трастузумаб п/к)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":724,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":918,"subscribed":null,"table_field_MKB_CODE":"C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; D05.0; D05.1; D05.7; D05.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак молочной железы, 2021, КР379/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"R-CHOP: (винкристин 1,4 + доксорубицин 50 + преднизолон 100 + ритуксимаб 375→1400 + циклофосфамид 750)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4748,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":919,"subscribed":null,"table_field_MKB_CODE":"С83.3; С83.7; С85.2; С91.8; C82.0; C82.1; C82.2; C82.7; C82.9; C83.1","table_field_CLINICAL_RECOMMENDATIONS":"Агрессивные нефолликулярные лимфомы – диффузная крупноклеточная В-клеточная лимфома, первичная медиастинальная В-клеточная лимфома, лимфома Беркитта, 2020, КР129/2; Фолликулярная лимфома, 2020, КР151/1; Лимфома из клеток мантии, 2020, КР136/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"R-CHOP: (винкристин 1,4 + доксорубицин 50 + преднизолон 100 + ритуксимаб 375 + циклофосфамид 750)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4749,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":920,"subscribed":null,"table_field_MKB_CODE":"С83.3; С83.7; С85.2; С91.8; C82.0; C82.1; C82.2; C82.7; C82.9; C88.0; C81.0; C81.1; C81.2; C81.3; C81.4; C81.7; C81.9; C83.0; C83.1","table_field_CLINICAL_RECOMMENDATIONS":"Агрессивные нефолликулярные лимфомы – диффузная крупноклеточная В-клеточная лимфома, первичная медиастинальная В-клеточная лимфома, лимфома Беркитта, 2020, КР129/2; Фолликулярная лимфома, 2020, КР151/1; Макроглобулинемия Вальденстрема, 2020, КР140/1; Лимфома Ходжкина, 2020, КР139/1; Лимфома маргинальной зоны, 2020, КР137/1; Лимфома из клеток мантии, 2020, КР136/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"R-CHOP: (винкристин 1,4 + доксорубицин 30 + преднизолон 100 + ритуксимаб 375→1400 + циклофосфамид 750)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":750,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":921,"subscribed":null,"table_field_MKB_CODE":"С83.3; С83.7; С85.2; С91.8","table_field_CLINICAL_RECOMMENDATIONS":"Агрессивные нефолликулярные лимфомы – диффузная крупноклеточная В-клеточная лимфома, первичная медиастинальная В-клеточная лимфома, лимфома Беркитта, 2020, КР129/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"R-CHOP: (винкристин 1,4 + доксорубицин 30 + преднизолон 100 + ритуксимаб 375 + циклофосфамид 750)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":751,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":922,"subscribed":null,"table_field_MKB_CODE":"С83.3; С83.7; С85.2; С91.8","table_field_CLINICAL_RECOMMENDATIONS":"Агрессивные нефолликулярные лимфомы – диффузная крупноклеточная В-клеточная лимфома, первичная медиастинальная В-клеточная лимфома, лимфома Беркитта, 2020, КР129/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"R-CEOP: (винкристин 1,4 + преднизолон 40 + ритуксимаб 375→1400 + циклофосфамид 750 + этопозид 50)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":752,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":923,"subscribed":null,"table_field_MKB_CODE":"С83.3; С83.7; С85.2; С91.8","table_field_CLINICAL_RECOMMENDATIONS":"Агрессивные нефолликулярные лимфомы – диффузная крупноклеточная В-клеточная лимфома, первичная медиастинальная В-клеточная лимфома, лимфома Беркитта, 2020, КР129/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"R-CEOP: (винкристин 1,4 + преднизолон 40 + ритуксимаб 375 + циклофосфамид 750 + этопозид 50)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":753,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":924,"subscribed":null,"table_field_MKB_CODE":"С83.3; С83.7; С85.2; С91.8","table_field_CLINICAL_RECOMMENDATIONS":"Агрессивные нефолликулярные лимфомы – диффузная крупноклеточная В-клеточная лимфома, первичная медиастинальная В-клеточная лимфома, лимфома Беркитта, 2020, КР129/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"R-GCVP: (винкристин 1,4 + гемцитабин 750-1000 + преднизолон 100 + ритуксимаб 375→1400 + циклофосфамид 750)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":754,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":925,"subscribed":null,"table_field_MKB_CODE":"С83.3; С83.7; С85.2; С91.8","table_field_CLINICAL_RECOMMENDATIONS":"Агрессивные нефолликулярные лимфомы – диффузная крупноклеточная В-клеточная лимфома, первичная медиастинальная В-клеточная лимфома, лимфома Беркитта, 2020, КР129/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"R-GCVP: (винкристин 1,4 + гемцитабин 750-1000 + преднизолон 100 + ритуксимаб 375 + циклофосфамид 750)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":755,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":926,"subscribed":null,"table_field_MKB_CODE":"С83.3; С83.7; С85.2; С91.8","table_field_CLINICAL_RECOMMENDATIONS":"Агрессивные нефолликулярные лимфомы – диффузная крупноклеточная В-клеточная лимфома, первичная медиастинальная В-клеточная лимфома, лимфома Беркитта, 2020, КР129/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"R-CNOP: (винкристин 1 + митоксантрон 10 + преднизолон 80 + ритуксимаб 375→1400 + циклофосфамид 500)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":756,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":927,"subscribed":null,"table_field_MKB_CODE":"С83.3; С83.7; С85.2; С91.8","table_field_CLINICAL_RECOMMENDATIONS":"Агрессивные нефолликулярные лимфомы – диффузная крупноклеточная В-клеточная лимфома, первичная медиастинальная В-клеточная лимфома, лимфома Беркитта, 2020, КР129/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"R-CNOP: (винкристин 1 + митоксантрон 10 + преднизолон 80 + ритуксимаб 375 + циклофосфамид 500)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":757,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":928,"subscribed":null,"table_field_MKB_CODE":"С83.3; С83.7; С85.2; С91.8","table_field_CLINICAL_RECOMMENDATIONS":"Агрессивные нефолликулярные лимфомы – диффузная крупноклеточная В-клеточная лимфома, первичная медиастинальная В-клеточная лимфома, лимфома Беркитта, 2020, КР129/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"R-CVP: (винкристин 1,4 + преднизолон 40 + ритуксимаб 375→1400 + циклофосфамид 750)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":758,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":929,"subscribed":null,"table_field_MKB_CODE":"С83.3; С83.7; С85.2; С91.8","table_field_CLINICAL_RECOMMENDATIONS":"Агрессивные нефолликулярные лимфомы – диффузная крупноклеточная В-клеточная лимфома, первичная медиастинальная В-клеточная лимфома, лимфома Беркитта, 2020, КР129/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"R-CVP: (винкристин 1,4 + преднизолон 40 + ритуксимаб 375 + циклофосфамид 750)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1016,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":930,"subscribed":null,"table_field_MKB_CODE":"С83.3; С83.7; С85.2; С91.8; C81.0; C81.1; C81.2; C81.3; C81.4; C81.7; C81.9","table_field_CLINICAL_RECOMMENDATIONS":"Агрессивные нефолликулярные лимфомы – диффузная крупноклеточная В-клеточная лимфома, первичная медиастинальная В-клеточная лимфома, лимфома Беркитта, 2020, КР129/2; Лимфома Ходжкина, 2020, КР139/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"BR, RB: (бендамустин 90 + ритуксимаб 375→1400, цикл 28 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4750,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":931,"subscribed":null,"table_field_MKB_CODE":"С83.3; С83.7; С85.2; С91.8; C83.1","table_field_CLINICAL_RECOMMENDATIONS":"Агрессивные нефолликулярные лимфомы – диффузная крупноклеточная В-клеточная лимфома, первичная медиастинальная В-клеточная лимфома, лимфома Беркитта, 2020, КР129/2; Лимфома из клеток мантии, 2020, КР136/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"BR, RB: (бендамустин 90 + ритуксимаб 375, цикл 28 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4751,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":932,"subscribed":null,"table_field_MKB_CODE":"С83.3; С83.7; С85.2; С91.8; C88.0; C83.0; C83.1","table_field_CLINICAL_RECOMMENDATIONS":"Агрессивные нефолликулярные лимфомы – диффузная крупноклеточная В-клеточная лимфома, первичная медиастинальная В-клеточная лимфома, лимфома Беркитта, 2020, КР129/2; Макроглобулинемия Вальденстрема, 2020, КР140/1; Лимфома маргинальной зоны, 2020, КР137/1; Лимфома из клеток мантии, 2020, КР136/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"R-miniCHOP: (винкристин 1 + доксорубицин 25 + преднизолон 40 + ритуксимаб 375→1400 + циклофосфамид 400)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":759,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":933,"subscribed":null,"table_field_MKB_CODE":"С83.3; С83.7; С85.2; С91.8","table_field_CLINICAL_RECOMMENDATIONS":"Агрессивные нефолликулярные лимфомы – диффузная крупноклеточная В-клеточная лимфома, первичная медиастинальная В-клеточная лимфома, лимфома Беркитта, 2020, КР129/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"R-miniCHOP: (винкристин 1 + доксорубицин 25 + преднизолон 40 + ритуксимаб 375 + циклофосфамид 400)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":760,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":934,"subscribed":null,"table_field_MKB_CODE":"С83.3; С83.7; С85.2; С91.8","table_field_CLINICAL_RECOMMENDATIONS":"Агрессивные нефолликулярные лимфомы – диффузная крупноклеточная В-клеточная лимфома, первичная медиастинальная В-клеточная лимфома, лимфома Беркитта, 2020, КР129/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Метотрексат: (метотрексат 3500)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":761,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":935,"subscribed":null,"table_field_MKB_CODE":"С83.3; С83.7; С85.2; С91.8","table_field_CLINICAL_RECOMMENDATIONS":"Агрессивные нефолликулярные лимфомы – диффузная крупноклеточная В-клеточная лимфома, первичная медиастинальная В-клеточная лимфома, лимфома Беркитта, 2020, КР129/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Метотрексат: (метотрексат 8000)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":762,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":936,"subscribed":null,"table_field_MKB_CODE":"С83.3; С83.7; С85.2; С91.8","table_field_CLINICAL_RECOMMENDATIONS":"Агрессивные нефолликулярные лимфомы – диффузная крупноклеточная В-клеточная лимфома, первичная медиастинальная В-клеточная лимфома, лимфома Беркитта, 2020, КР129/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"MT-R: (метотрексат 8000 + ритуксимаб 375 + темозоломид 150)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":763,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":937,"subscribed":null,"table_field_MKB_CODE":"С83.3; С83.7; С85.2; С91.8","table_field_CLINICAL_RECOMMENDATIONS":"Агрессивные нефолликулярные лимфомы – диффузная крупноклеточная В-клеточная лимфома, первичная медиастинальная В-клеточная лимфома, лимфома Беркитта, 2020, КР129/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Метотрексат + цитарабин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":764,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":938,"subscribed":null,"table_field_MKB_CODE":"С83.3; С83.7; С85.2; С91.8","table_field_CLINICAL_RECOMMENDATIONS":"Агрессивные нефолликулярные лимфомы – диффузная крупноклеточная В-клеточная лимфома, первичная медиастинальная В-клеточная лимфома, лимфома Беркитта, 2020, КР129/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Ритуксимаб + темозоломид","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":765,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":939,"subscribed":null,"table_field_MKB_CODE":"С83.3; С83.7; С85.2; С91.8","table_field_CLINICAL_RECOMMENDATIONS":"Агрессивные нефолликулярные лимфомы – диффузная крупноклеточная В-клеточная лимфома, первичная медиастинальная В-клеточная лимфома, лимфома Беркитта, 2020, КР129/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"MATRix: (метотрексат 3500 + ритуксимаб 375 + тиотепа 30 + цитарабин 2000)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":766,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":940,"subscribed":null,"table_field_MKB_CODE":"С83.3; С83.7; С85.2; С91.8","table_field_CLINICAL_RECOMMENDATIONS":"Агрессивные нефолликулярные лимфомы – диффузная крупноклеточная В-клеточная лимфома, первичная медиастинальная В-клеточная лимфома, лимфома Беркитта, 2020, КР129/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CEPP: (преднизолон 60 + прокарбазин 60 + циклофосфамид 600 + этопозид 70)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":767,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":941,"subscribed":null,"table_field_MKB_CODE":"С83.3; С83.7; С85.2; С91.8","table_field_CLINICAL_RECOMMENDATIONS":"Агрессивные нефолликулярные лимфомы – диффузная крупноклеточная В-клеточная лимфома, первичная медиастинальная В-клеточная лимфома, лимфома Беркитта, 2020, КР129/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Винорелбин + гемцитабин: (винорелбин 25 + гемцитабин 800)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":768,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":942,"subscribed":null,"table_field_MKB_CODE":"С83.3; С83.7; С85.2; С91.8","table_field_CLINICAL_RECOMMENDATIONS":"Агрессивные нефолликулярные лимфомы – диффузная крупноклеточная В-клеточная лимфома, первичная медиастинальная В-клеточная лимфома, лимфома Беркитта, 2020, КР129/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"43"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"43 (Иммунотерапия)","table_field_NAME_REGIMEN":"Иммуноглобулин человека нормальный: (иммуноглобулин человека нормальный 0,2-0,4, цикл 21 день)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4752,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":943,"subscribed":null,"table_field_MKB_CODE":"С83.3; С83.7; С85.2; С91.8; C83.0; C84.5; C84.6; C84.7; C84.9; C86.0; C86.5","table_field_CLINICAL_RECOMMENDATIONS":"Агрессивные нефолликулярные лимфомы – диффузная крупноклеточная В-клеточная лимфома, первичная медиастинальная В-клеточная лимфома, лимфома Беркитта, 2020, КР129/2; Лимфома маргинальной зоны, 2020, КР137/1; Нодальные Т-клеточные лимфомы, 2020, КР138/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"43"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"43 (Иммунотерапия)","table_field_NAME_REGIMEN":"Иммуноглобулин человека нормальный: (иммуноглобулин человека нормальный 0,2-0,4, цикл 28 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4753,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":944,"subscribed":null,"table_field_MKB_CODE":"С83.3; С83.7; С85.2; С91.8; C83.0; C84.5; C84.6; C84.7; C84.9; C86.0; C86.5","table_field_CLINICAL_RECOMMENDATIONS":"Агрессивные нефолликулярные лимфомы – диффузная крупноклеточная В-клеточная лимфома, первичная медиастинальная В-клеточная лимфома, лимфома Беркитта, 2020, КР129/2; Лимфома маргинальной зоны, 2020, КР137/1; Нодальные Т-клеточные лимфомы, 2020, КР138/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Ритуксимаб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1017,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":945,"subscribed":null,"table_field_MKB_CODE":"С83.3; С83.7; С85.2; С91.8; C82.0; C82.1; C82.2; C82.7; C82.9; C88.0; C83.0","table_field_CLINICAL_RECOMMENDATIONS":"Агрессивные нефолликулярные лимфомы – диффузная крупноклеточная В-клеточная лимфома, первичная медиастинальная В-клеточная лимфома, лимфома Беркитта, 2020, КР129/2; Фолликулярная лимфома, 2020, КР151/1; Макроглобулинемия Вальденстрема, 2020, КР140/1; Лимфома маргинальной зоны, 2020, КР137/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Доцетаксел + преднизон: (доцетаксел 75 + преднизон 5)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":725,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":946,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"D: (доцетаксел 50)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":726,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":947,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Кабазитаксел + преднизон: (кабазитаксел 25 + преднизон 5)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":727,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":948,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Митоксантрон + преднизон: (митоксантрон 12 + преднизон 5)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":728,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":949,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Золедроновая кислота","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":729,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":950,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CarPac (PaC, P + карбо): (паклитаксел 175 + карбоплатин 5-6)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":927,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":951,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"DA-EPOCH-R, DA-R-EPOCH: (винкристин 0,4 + Г-КСФ 5 + доксорубицин 10 + преднизолон 60 + ритуксимаб 375 + ритуксимаб 1400 + циклофосфамид 750 + этопозид 50)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4754,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":952,"subscribed":null,"table_field_MKB_CODE":"С83.3; С83.7; С85.2; С91.8","table_field_CLINICAL_RECOMMENDATIONS":"Агрессивные нефолликулярные лимфомы – диффузная крупноклеточная В-клеточная лимфома, первичная медиастинальная В-клеточная лимфома, лимфома Беркитта, 2020, КР129/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"DA-EPOCH-R, DA-R-EPOCH: (винкристин 0,4 + Г-КСФ 5 + доксорубицин 10 + преднизолон 60 + ритуксимаб 375 + циклофосфамид 750 + этопозид 50)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4755,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":953,"subscribed":null,"table_field_MKB_CODE":"С83.3; С83.7; С85.2; С91.8","table_field_CLINICAL_RECOMMENDATIONS":"Агрессивные нефолликулярные лимфомы – диффузная крупноклеточная В-клеточная лимфома, первичная медиастинальная В-клеточная лимфома, лимфома Беркитта, 2020, КР129/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"ADIC: (дакарбазин 750 + доксорубицин 60, 1 день приема)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":928,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":954,"subscribed":null,"table_field_MKB_CODE":"C54.0; C54.1; C54.2; C54.3; C54.8; C54.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак тела матки и саркомы матки, 2021, КР460/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Ленватиниб + пембролизумаб: (ленватиниб 20 + пембролизумаб 200)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":769,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":955,"subscribed":null,"table_field_MKB_CODE":"C54.0; C54.1; C54.2; C54.3; C54.8; C54.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак тела матки и саркомы матки, 2021, КР460/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Доксорубицин: (доксорубицин 50)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":770,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":956,"subscribed":null,"table_field_MKB_CODE":"C54.0; C54.1; C54.2; C54.3; C54.8; C54.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак тела матки и саркомы матки, 2021, КР460/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Доксорубицин: (доксорубицин 50-60)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Устаревший","SYS_RECORDID":929,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":957,"subscribed":null,"table_field_MKB_CODE":null,"table_field_CLINICAL_RECOMMENDATIONS":null,"table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Левоноргестрел","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":771,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":958,"subscribed":null,"table_field_MKB_CODE":"C54.0; C54.1; C54.2; C54.3; C54.8; C54.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак тела матки и саркомы матки, 2021, КР460/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Левоноргестрел + медроксипрогестерон","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":772,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":959,"subscribed":null,"table_field_MKB_CODE":"C54.0; C54.1; C54.2; C54.3; C54.8; C54.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак тела матки и саркомы матки, 2021, КР460/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Авелумаб + акситиниб: (авелумаб 10 + акситиниб 5)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":773,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":960,"subscribed":null,"table_field_MKB_CODE":"C64","table_field_CLINICAL_RECOMMENDATIONS":"Рак паренхимы почки, 2021, КР10/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Цитарабин: (цитарабин 20-40)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":783,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":961,"subscribed":null,"table_field_MKB_CODE":"C92.0; C92.3; C92.5; С92.6; C92.7; С92.8; C92.9; С93.0; С94.0; С94.2","table_field_CLINICAL_RECOMMENDATIONS":"Острые миелоидные лейкозы, 2020, КР586/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Сорафениб: (сорафениб 170-300)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":774,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":962,"subscribed":null,"table_field_MKB_CODE":"C92.0; C92.3; C92.5; С92.6; C92.7; С92.8; C92.9; С93.0; С94.0; С94.2","table_field_CLINICAL_RECOMMENDATIONS":"Острые миелоидные лейкозы, 2020, КР586/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"R-CVP: (винкристин 1,4 + преднизолон 100 + ритуксимаб 375→1400 + циклофосфамид 750)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4756,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":963,"subscribed":null,"table_field_MKB_CODE":"C82.0; C82.1; C82.2; C82.7; C82.9; C83.1","table_field_CLINICAL_RECOMMENDATIONS":"Фолликулярная лимфома, 2020, КР151/1; Лимфома из клеток мантии, 2020, КР136/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"R-CVP: (винкристин 1,4 + преднизолон 100 + ритуксимаб 375 + циклофосфамид 750)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4757,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":964,"subscribed":null,"table_field_MKB_CODE":"C82.0; C82.1; C82.2; C82.7; C82.9; C83.0; C83.1","table_field_CLINICAL_RECOMMENDATIONS":"Фолликулярная лимфома, 2020, КР151/1; Лимфома маргинальной зоны, 2020, КР137/1; Лимфома из клеток мантии, 2020, КР136/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"BR, RB: (бендамустин 90 + ритуксимаб 375→1400, цикл 21 день)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":775,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":965,"subscribed":null,"table_field_MKB_CODE":"C82.0; C82.1; C82.2; C82.7; C82.9","table_field_CLINICAL_RECOMMENDATIONS":"Фолликулярная лимфома, 2020, КР151/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"BR, RB: (бендамустин 90 + ритуксимаб 375, цикл 21 день)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":776,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":966,"subscribed":null,"table_field_MKB_CODE":"C82.0; C82.1; C82.2; C82.7; C82.9","table_field_CLINICAL_RECOMMENDATIONS":"Фолликулярная лимфома, 2020, КР151/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"GB, G-B: (бендамустин 90 + обинутузумаб 1000)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1018,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":967,"subscribed":null,"table_field_MKB_CODE":"C82.0; C82.1; C82.2; C82.7; C82.9","table_field_CLINICAL_RECOMMENDATIONS":"Фолликулярная лимфома, 2020, КР151/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"G-CHOP","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":777,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":968,"subscribed":null,"table_field_MKB_CODE":"C82.0; C82.1; C82.2; C82.7; C82.9","table_field_CLINICAL_RECOMMENDATIONS":"Фолликулярная лимфома, 2020, КР151/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"G-CVP","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":778,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":969,"subscribed":null,"table_field_MKB_CODE":"C82.0; C82.1; C82.2; C82.7; C82.9","table_field_CLINICAL_RECOMMENDATIONS":"Фолликулярная лимфома, 2020, КР151/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"R2: (леналидомид 20 + ритуксимаб 375)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4758,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":970,"subscribed":null,"table_field_MKB_CODE":"C82.0; C82.1; C82.2; C82.7; C82.9; C83.1","table_field_CLINICAL_RECOMMENDATIONS":"Фолликулярная лимфома, 2020, КР151/1; Лимфома из клеток мантии, 2020, КР136/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"EP + дурвалумаб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":779,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":971,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественное новообразование бронхов и легкого, 2021, КР30/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"EC + дурвалумаб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":780,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":972,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественное новообразование бронхов и легкого, 2021, КР30/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Дурвалумаб: (дурвалумаб 1500)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":781,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":973,"subscribed":null,"table_field_MKB_CODE":"C34.0; C34.1; C34.2; C34.3; C34.8; C34.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественное новообразование бронхов и легкого, 2021, КР30/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Кабазитаксел: (кабазитаксел 20)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":782,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":974,"subscribed":null,"table_field_MKB_CODE":"C61","table_field_CLINICAL_RECOMMENDATIONS":"Рак предстательной железы, 2021, КР12/3","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Гидроксикарбамид: (гидроксикарбамид 50-100)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":990,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":975,"subscribed":null,"table_field_MKB_CODE":"C92.0; C92.3; C92.5; C92.6; C92.7; C92.8; C92.9; C93.0; C94.0; C94.2","table_field_CLINICAL_RECOMMENDATIONS":"Острые миелоидные лейкозы, 2020, КР131/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Азацитидин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":784,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":976,"subscribed":null,"table_field_MKB_CODE":"C92.0; C92.3; C92.5; C92.6; C92.7; C92.8; C92.9; C93.0; C94.0; C94.2","table_field_CLINICAL_RECOMMENDATIONS":"Острые миелоидные лейкозы, 2020, КР131/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Цитарабин: (цитарабин 10, цикл 28 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":785,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":977,"subscribed":null,"table_field_MKB_CODE":"C92.0; C92.3; C92.5; C92.6; C92.7; C92.8; C92.9; C93.0; C94.0; C94.2","table_field_CLINICAL_RECOMMENDATIONS":"Острые миелоидные лейкозы, 2020, КР131/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Азацитидин + венетоклакс: (азацитидин 75 + венетоклакс 100-400)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":786,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":978,"subscribed":null,"table_field_MKB_CODE":"C92.0; C92.3; C92.5; C92.6; C92.7; C92.8; C92.9; C93.0; C94.0; C94.2","table_field_CLINICAL_RECOMMENDATIONS":"Острые миелоидные лейкозы, 2020, КР131/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Венетоклакс + децитабин: (венетоклакс 100-400 + децитабин 20)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":787,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":979,"subscribed":null,"table_field_MKB_CODE":"C92.0; C92.3; C92.5; C92.6; C92.7; C92.8; C92.9; C93.0; C94.0; C94.2","table_field_CLINICAL_RECOMMENDATIONS":"Острые миелоидные лейкозы, 2020, КР131/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Венетоклакс + цитарабин: (венетоклакс 100-600 + цитарабин 20)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":788,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":980,"subscribed":null,"table_field_MKB_CODE":"C92.0; C92.3; C92.5; C92.6; C92.7; C92.8; C92.9; C93.0; C94.0; C94.2","table_field_CLINICAL_RECOMMENDATIONS":"Острые миелоидные лейкозы, 2020, КР131/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Азацитидин + венетоклакс: (азацитидин 75 + венетоклакс 400)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":789,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":981,"subscribed":null,"table_field_MKB_CODE":"C92.0; C92.3; C92.5; C92.6; C92.7; C92.8; C92.9; C93.0; C94.0; C94.2","table_field_CLINICAL_RECOMMENDATIONS":"Острые миелоидные лейкозы, 2020, КР131/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Венетоклакс + децитабин: (венетоклакс 400 + децитабин 20)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":790,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":982,"subscribed":null,"table_field_MKB_CODE":"C92.0; C92.3; C92.5; C92.6; C92.7; C92.8; C92.9; C93.0; C94.0; C94.2","table_field_CLINICAL_RECOMMENDATIONS":"Острые миелоидные лейкозы, 2020, КР131/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Венетоклакс + цитарабин: (венетоклакс 600 + цитарабин 20)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":791,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":983,"subscribed":null,"table_field_MKB_CODE":"C92.0; C92.3; C92.5; C92.6; C92.7; C92.8; C92.9; C93.0; C94.0; C94.2","table_field_CLINICAL_RECOMMENDATIONS":"Острые миелоидные лейкозы, 2020, КР131/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"A-HAM","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":792,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":984,"subscribed":null,"table_field_MKB_CODE":"C92.0; C92.3; C92.5; C92.6; C92.7; C92.8; C92.9; C93.0; C94.0; C94.2","table_field_CLINICAL_RECOMMENDATIONS":"Острые миелоидные лейкозы, 2020, КР131/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Цитарабин: (цитарабин 10, цикл 21 день)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":793,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":985,"subscribed":null,"table_field_MKB_CODE":"C92.0; C92.3; C92.5; C92.6; C92.7; C92.8; C92.9; C93.0; C94.0; C94.2","table_field_CLINICAL_RECOMMENDATIONS":"Острые миелоидные лейкозы, 2020, КР131/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Метотрексат: (метотрексат 100)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":794,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":986,"subscribed":null,"table_field_MKB_CODE":"C84.1","table_field_CLINICAL_RECOMMENDATIONS":"Синдром Сезари, 2020, КР575/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Вориностат: (вориностат 200-400)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4759,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":987,"subscribed":null,"table_field_MKB_CODE":"C84.1; C84.0","table_field_CLINICAL_RECOMMENDATIONS":"Синдром Сезари, 2020, КР575/1; Грибовидный микоз, 2020, КР223/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Брентуксимаб ведотин: (брентуксимаб ведотин 1,8)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4760,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":988,"subscribed":null,"table_field_MKB_CODE":"C84.1; C81.0; C81.1; C81.2; C81.3; C81.4; C81.7; C81.9; C84.0; C84.5; C84.6; C84.7; C84.9; C86.0; C86.5","table_field_CLINICAL_RECOMMENDATIONS":"Синдром Сезари, 2020, КР575/1; Лимфома Ходжкина, 2020, КР139/1; Грибовидный микоз, 2020, КР223/1; Нодальные Т-клеточные лимфомы, 2020, КР138/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Метотрексат: (метотрексат 25)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":795,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":989,"subscribed":null,"table_field_MKB_CODE":"C84.0","table_field_CLINICAL_RECOMMENDATIONS":"Грибовидный микоз, 2020, КР223/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"BR: (бортезомиб 1,6 + ритуксимаб 375)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":796,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":990,"subscribed":null,"table_field_MKB_CODE":"C88.0","table_field_CLINICAL_RECOMMENDATIONS":"Макроглобулинемия Вальденстрема, 2020, КР140/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"BDR: (бортезомиб 1,3 + дексаметазон 40 + ритуксимаб 375)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4761,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":991,"subscribed":null,"table_field_MKB_CODE":"C88.0","table_field_CLINICAL_RECOMMENDATIONS":"Макроглобулинемия Вальденстрема, 2020, КР140/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"RCD: (дексаметазон 20 + ритуксимаб 375 + циклофосфамид 100)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4762,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":992,"subscribed":null,"table_field_MKB_CODE":"C88.0","table_field_CLINICAL_RECOMMENDATIONS":"Макроглобулинемия Вальденстрема, 2020, КР140/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"CPR: (преднизолон 100 + ритуксимаб 375 + циклофосфамид 1000)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4763,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":993,"subscribed":null,"table_field_MKB_CODE":"C88.0","table_field_CLINICAL_RECOMMENDATIONS":"Макроглобулинемия Вальденстрема, 2020, КР140/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Флударабин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":797,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":994,"subscribed":null,"table_field_MKB_CODE":"C88.0","table_field_CLINICAL_RECOMMENDATIONS":"Макроглобулинемия Вальденстрема, 2020, КР140/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"FR","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":798,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":995,"subscribed":null,"table_field_MKB_CODE":"C88.0","table_field_CLINICAL_RECOMMENDATIONS":"Макроглобулинемия Вальденстрема, 2020, КР140/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Кладрибин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":991,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":996,"subscribed":null,"table_field_MKB_CODE":"C88.0; C91.4","table_field_CLINICAL_RECOMMENDATIONS":"Макроглобулинемия Вальденстрема, 2020, КР140/1; Волосатоклеточный лейкоз, 2020, КР130/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Кладрибин + ритуксимаб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":992,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":997,"subscribed":null,"table_field_MKB_CODE":"C88.0; C91.4","table_field_CLINICAL_RECOMMENDATIONS":"Макроглобулинемия Вальденстрема, 2020, КР140/1; Волосатоклеточный лейкоз, 2020, КР130/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Хлорамбуцил","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":799,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":998,"subscribed":null,"table_field_MKB_CODE":"C88.0","table_field_CLINICAL_RECOMMENDATIONS":"Макроглобулинемия Вальденстрема, 2020, КР140/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Преднизолон + хлорамбуцил: (преднизолон 50 + хлорамбуцил 6-8, цикл 28 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":800,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":999,"subscribed":null,"table_field_MKB_CODE":"C88.0","table_field_CLINICAL_RECOMMENDATIONS":"Макроглобулинемия Вальденстрема, 2020, КР140/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Преднизолон + хлорамбуцил: (преднизолон 50 + хлорамбуцил 6-8, цикл 42 дня)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":801,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1000,"subscribed":null,"table_field_MKB_CODE":"C88.0","table_field_CLINICAL_RECOMMENDATIONS":"Макроглобулинемия Вальденстрема, 2020, КР140/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Ибрутиниб: (ибрутиниб 420)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4764,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1001,"subscribed":null,"table_field_MKB_CODE":"C88.0","table_field_CLINICAL_RECOMMENDATIONS":"Макроглобулинемия Вальденстрема, 2020, КР140/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"FOLFOX: (кальция фолинат 400 + оксалиплатин 85 + фторурацил 400 + фторурацил 1600)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":930,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1002,"subscribed":null,"table_field_MKB_CODE":"C15.0; C15.1; C15.2; C15.3; C15.4; C15.5; C15.8; C15.9; C16.0","table_field_CLINICAL_RECOMMENDATIONS":"Рак пищевода и кардии, 2021, КР237/5","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Паклитаксел + фторурацил","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":931,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1003,"subscribed":null,"table_field_MKB_CODE":"C15.0; C15.1; C15.2; C15.3; C15.4; C15.5; C15.8; C15.9; C16.0","table_field_CLINICAL_RECOMMENDATIONS":"Рак пищевода и кардии, 2021, КР237/5","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"mDCF: (доцетаксел 40 + кальция фолинат 400 + фторурацил 1000 + цисплатин 40, 46-часовая инфузия)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":932,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1004,"subscribed":null,"table_field_MKB_CODE":"C15.0; C15.1; C15.2; C15.3; C15.4; C15.5; C15.8; C15.9; C16.0","table_field_CLINICAL_RECOMMENDATIONS":"Рак пищевода и кардии, 2021, КР237/5","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Капецитабин: (капецитабин 1600)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":933,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1005,"subscribed":null,"table_field_MKB_CODE":"C25.0; C25.1; C25.2; C25.3; C25.4; C25.7; C25.8; C25.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак поджелудочной железы, 2021, КР335/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Гемцитабин: (гемцитабин 300)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":934,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1006,"subscribed":null,"table_field_MKB_CODE":"C25.0; C25.1; C25.2; C25.3; C25.4; C25.7; C25.8; C25.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак поджелудочной железы, 2021, КР335/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Мегэстрол: (мегэстрол 320-480)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":935,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1007,"subscribed":null,"table_field_MKB_CODE":"C25.0; C25.1; C25.2; C25.3; C25.4; C25.7; C25.8; C25.9","table_field_CLINICAL_RECOMMENDATIONS":"Рак поджелудочной железы, 2021, КР335/4","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"AI: (доксорубицин 60-75 + ифосфамид 1500-2500 + месна 750-1000 + филграстим 5)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":936,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1008,"subscribed":null,"table_field_MKB_CODE":"C48.0","table_field_CLINICAL_RECOMMENDATIONS":"Забрюшинные неорганные саркомы, 2020, КР618/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Доксорубицин: (доксорубицин 25)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":937,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1009,"subscribed":null,"table_field_MKB_CODE":"C48.0","table_field_CLINICAL_RECOMMENDATIONS":"Забрюшинные неорганные саркомы, 2020, КР618/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Ифосфамид + месна: (ифосфамид 3000 + месна 600-1500)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":938,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1010,"subscribed":null,"table_field_MKB_CODE":"C48.0","table_field_CLINICAL_RECOMMENDATIONS":"Забрюшинные неорганные саркомы, 2020, КР618/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"HD I: (ифосфамид 2000 + месна 2000-2400 + филграстим 5)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":939,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1011,"subscribed":null,"table_field_MKB_CODE":"C48.0","table_field_CLINICAL_RECOMMENDATIONS":"Забрюшинные неорганные саркомы, 2020, КР618/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Палбоциклиб: (палбоциклиб 200)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":940,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1012,"subscribed":null,"table_field_MKB_CODE":"C48.0","table_field_CLINICAL_RECOMMENDATIONS":"Забрюшинные неорганные саркомы, 2020, КР618/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Даназол","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":941,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1013,"subscribed":null,"table_field_MKB_CODE":"N60.0; N60.1; N60.2; N60.3; N60.4; N60.8; N60.9; N63; N64.4","table_field_CLINICAL_RECOMMENDATIONS":"Доброкачественная дисплазия молочной железы, 2020, КР598/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Тамоксифен: (тамоксифен 10-20)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":942,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1014,"subscribed":null,"table_field_MKB_CODE":"N60.0; N60.1; N60.2; N60.3; N60.4; N60.8; N60.9; N63; N64.4","table_field_CLINICAL_RECOMMENDATIONS":"Доброкачественная дисплазия молочной железы, 2020, КР598/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Прогестерон: (прогестерон 25)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":943,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1015,"subscribed":null,"table_field_MKB_CODE":"N60.0; N60.1; N60.2; N60.3; N60.4; N60.8; N60.9; N63; N64.4","table_field_CLINICAL_RECOMMENDATIONS":"Доброкачественная дисплазия молочной железы, 2020, КР598/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"42"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"42 (Гормонотерапия)","table_field_NAME_REGIMEN":"Прогестерон: (прогестерон 200-400)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":944,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1016,"subscribed":null,"table_field_MKB_CODE":"N60.0; N60.1; N60.2; N60.3; N60.4; N60.8; N60.9; N63; N64.4","table_field_CLINICAL_RECOMMENDATIONS":"Доброкачественная дисплазия молочной железы, 2020, КР598/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"BEP: (блеомицин 30 + цисплатин 20 + этопозид 100, дни приема блеомицина 1,3,5)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":945,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1017,"subscribed":null,"table_field_MKB_CODE":"C76.0; C76.1; C76.2; C76.3; C76.4; C76.5; C76.7; C76.8; C77.0; C77.1; C77.2; C77.3; C77.4; C77.5; C77.8; C77.9; C78.0; C78.1; C78.2; C78.3; C78.4; C78.5; C78.6; C78.7; C78.8; C79.0; C79.1; C79.2; C79.3; C79.4; C79.5; C79.6; C79.7; C79.8; C79.9; C80.0; C80.9","table_field_CLINICAL_RECOMMENDATIONS":"Опухоли невыявленной первичной локализации, 2021, КР504/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"XELOX (CAPOX, CapeOx): (капецитабин 850-1000 + оксалиплатин 130)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":946,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1018,"subscribed":null,"table_field_MKB_CODE":"C76.0; C76.1; C76.2; C76.3; C76.4; C76.5; C76.7; C76.8; C77.0; C77.1; C77.2; C77.3; C77.4; C77.5; C77.8; C77.9; C78.0; C78.1; C78.2; C78.3; C78.4; C78.5; C78.6; C78.7; C78.8; C79.0; C79.1; C79.2; C79.3; C79.4; C79.5; C79.6; C79.7; C79.8; C79.9; C80.0; C80.9","table_field_CLINICAL_RECOMMENDATIONS":"Опухоли невыявленной первичной локализации, 2021, КР504/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"GD, GemTax: (гемцитабин 1000 + доцетаксел 75)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":947,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1019,"subscribed":null,"table_field_MKB_CODE":"C76.0; C76.1; C76.2; C76.3; C76.4; C76.5; C76.7; C76.8; C77.0; C77.1; C77.2; C77.3; C77.4; C77.5; C77.8; C77.9; C78.0; C78.1; C78.2; C78.3; C78.4; C78.5; C78.6; C78.7; C78.8; C79.0; C79.1; C79.2; C79.3; C79.4; C79.5; C79.6; C79.7; C79.8; C79.9; C80.0; C80.9","table_field_CLINICAL_RECOMMENDATIONS":"Опухоли невыявленной первичной локализации, 2021, КР504/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"FOLFIRI: (иринотекан 180 + кальция фолинат 200 + фторурацил 400 + фторурацил 1200, 46-48-часовая инфузия)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":948,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1020,"subscribed":null,"table_field_MKB_CODE":"C76.0; C76.1; C76.2; C76.3; C76.4; C76.5; C76.7; C76.8; C77.0; C77.1; C77.2; C77.3; C77.4; C77.5; C77.8; C77.9; C78.0; C78.1; C78.2; C78.3; C78.4; C78.5; C78.6; C78.7; C78.8; C79.0; C79.1; C79.2; C79.3; C79.4; C79.5; C79.6; C79.7; C79.8; C79.9; C80.0; C80.9","table_field_CLINICAL_RECOMMENDATIONS":"Опухоли невыявленной первичной локализации, 2021, КР504/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Капецитабин: (капецитабин 850-1250)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":993,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1021,"subscribed":null,"table_field_MKB_CODE":"C76.0; C76.1; C76.2; C76.3; C76.4; C76.5; C76.7; C76.8; C77.0; C77.1; C77.2; C77.3; C77.4; C77.5; C77.8; C77.9; C78.0; C78.1; C78.2; C78.3; C78.4; C78.5; C78.6; C78.7; C78.8; C79.0; C79.1; C79.2; C79.3; C79.4; C79.5; C79.6; C79.7; C79.8; C79.9; C80.0; C80.9; C02.0; C02.1; C02.2; C02.3; C02.8; C02.9; C03.0; C03.1; C03.9; C04.0; C04.1; C04.8; C04.9; C05.0; C06.0; C06.1; C06.2; C06.8; C06.9","table_field_CLINICAL_RECOMMENDATIONS":"Опухоли невыявленной первичной локализации, 2021, КР504/2; Злокачественные новообразования полости рта, 2020, КР164/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Капецитабин: (капецитабин 625-825)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":949,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1022,"subscribed":null,"table_field_MKB_CODE":"C76.0; C76.1; C76.2; C76.3; C76.4; C76.5; C76.7; C76.8; C77.0; C77.1; C77.2; C77.3; C77.4; C77.5; C77.8; C77.9; C78.0; C78.1; C78.2; C78.3; C78.4; C78.5; C78.6; C78.7; C78.8; C79.0; C79.1; C79.2; C79.3; C79.4; C79.5; C79.6; C79.7; C79.8; C79.9; C80.0; C80.9","table_field_CLINICAL_RECOMMENDATIONS":"Опухоли невыявленной первичной локализации, 2021, КР504/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CF, PF: (фторурацил 750 + цисплатин 75)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":950,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1023,"subscribed":null,"table_field_MKB_CODE":"C76.0; C76.1; C76.2; C76.3; C76.4; C76.5; C76.7; C76.8; C77.0; C77.1; C77.2; C77.3; C77.4; C77.5; C77.8; C77.9; C78.0; C78.1; C78.2; C78.3; C78.4; C78.5; C78.6; C78.7; C78.8; C79.0; C79.1; C79.2; C79.3; C79.4; C79.5; C79.6; C79.7; C79.8; C79.9; C80.0; C80.9","table_field_CLINICAL_RECOMMENDATIONS":"Опухоли невыявленной первичной локализации, 2021, КР504/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"PCF: (паклитаксел 175 + фторурацил 500 + цисплатин 100, 24-часовая инфузия)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":951,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1024,"subscribed":null,"table_field_MKB_CODE":"C76.0; C76.1; C76.2; C76.3; C76.4; C76.5; C76.7; C76.8; C77.0; C77.1; C77.2; C77.3; C77.4; C77.5; C77.8; C77.9; C78.0; C78.1; C78.2; C78.3; C78.4; C78.5; C78.6; C78.7; C78.8; C79.0; C79.1; C79.2; C79.3; C79.4; C79.5; C79.6; C79.7; C79.8; C79.9; C80.0; C80.9","table_field_CLINICAL_RECOMMENDATIONS":"Опухоли невыявленной первичной локализации, 2021, КР504/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Карбоплатин + фторурацил: (карбоплатин 5-6 + фторурацил 1000)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":994,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1025,"subscribed":null,"table_field_MKB_CODE":"C02.0; C02.1; C02.2; C02.3; C02.8; C02.9; C03.0; C03.1; C03.9; C04.0; C04.1; C04.8; C04.9; C05.0; C06.0; C06.1; C06.2; C06.8; C06.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественные новообразования полости рта, 2020, КР164/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"mDCF: (доцетаксел 75 + фторурацил 1000 + цисплатин 75)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":995,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1026,"subscribed":null,"table_field_MKB_CODE":"C02.0; C02.1; C02.2; C02.3; C02.8; C02.9; C03.0; C03.1; C03.9; C04.0; C04.1; C04.8; C04.9; C05.0; C06.0; C06.1; C06.2; C06.8; C06.9","table_field_CLINICAL_RECOMMENDATIONS":"Злокачественные новообразования полости рта, 2020, КР164/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Капецитабин: (капецитабин 500)","table_field_COMMENTS":"Кодирование нейроэндокринных опухолей по МКБ-10 происходит в соответствии с органной принадлежностью опухоли","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":996,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1027,"subscribed":null,"table_field_MKB_CODE":"C15.0; C15.1; C15.2; C15.3; C15.4; C15.5; C15.8; C15.9; C16.0; C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9; C17.0; C17.1; C17.2; C17.3; C17.8; C17.9; C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19.9; C20.9; C21.0; C21.1; C21.2; C21.8; C23.9; C24.0; C24.1; C24.8; C24.9; C25.0; C25.1; C25.2; C25.3; C25.4; C25.7; C25.8; C25.9; C26.0; C26.8; C26.9; C34.0; C34.1; C34.2; C34.3; C34.8; C34.9; C37.9; C73.9; C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; C44.0; C44.1; C44.2; C44.3; C44.4; C44.5; C44.6; C44.7; C44.8; C44.9; C51.0; C51.1; C51.2; C51.8; C51.9; C52.9; C53.0; C53.1; C53.8; C53.9; C54.0; C54.1; C54.2; C54.3; C54.8; C54.9; C55.9; C56.9; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9; C61.9; C64.9; C65.9; C66.9; C67.0; C67.1; C67.2; C67.3; C67.4; C67.5; C67.6; C67.7; C67.8; C67.9; C68.0; C68.1; C68.8; C68.9; C74.3","table_field_CLINICAL_RECOMMENDATIONS":"Нейроэндокринные опухоли, 2020, КР610/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Темозоломид: (темозоломид 75)","table_field_COMMENTS":"Кодирование нейроэндокринных опухолей по МКБ-10 происходит в соответствии с органной принадлежностью опухоли","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":997,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1028,"subscribed":null,"table_field_MKB_CODE":"C15.0; C15.1; C15.2; C15.3; C15.4; C15.5; C15.8; C15.9; C16.0; C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9; C17.0; C17.1; C17.2; C17.3; C17.8; C17.9; C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19.9; C20.9; C21.0; C21.1; C21.2; C21.8; C23.9; C24.0; C24.1; C24.8; C24.9; C25.0; C25.1; C25.2; C25.3; C25.4; C25.7; C25.8; C25.9; C26.0; C26.8; C26.9; C34.0; C34.1; C34.2; C34.3; C34.8; C34.9; C37.9; C73.9; C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; C44.0; C44.1; C44.2; C44.3; C44.4; C44.5; C44.6; C44.7; C44.8; C44.9; C51.0; C51.1; C51.2; C51.8; C51.9; C52.9; C53.0; C53.1; C53.8; C53.9; C54.0; C54.1; C54.2; C54.3; C54.8; C54.9; C55.9; C56.9; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9; C61.9; C64.9; C65.9; C66.9; C67.0; C67.1; C67.2; C67.3; C67.4; C67.5; C67.6; C67.7; C67.8; C67.9; C68.0; C68.1; C68.8; C68.9; C74.3","table_field_CLINICAL_RECOMMENDATIONS":"Нейроэндокринные опухоли, 2020, КР610/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Темозоломид: (темозоломид 100, приём каждый день)","table_field_COMMENTS":"Кодирование нейроэндокринных опухолей по МКБ-10 происходит в соответствии с органной принадлежностью опухоли","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":998,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1029,"subscribed":null,"table_field_MKB_CODE":"C15.0; C15.1; C15.2; C15.3; C15.4; C15.5; C15.8; C15.9; C16.0; C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9; C17.0; C17.1; C17.2; C17.3; C17.8; C17.9; C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19.9; C20.9; C21.0; C21.1; C21.2; C21.8; C23.9; C24.0; C24.1; C24.8; C24.9; C25.0; C25.1; C25.2; C25.3; C25.4; C25.7; C25.8; C25.9; C26.0; C26.8; C26.9; C34.0; C34.1; C34.2; C34.3; C34.8; C34.9; C37.9; C73.9; C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; C44.0; C44.1; C44.2; C44.3; C44.4; C44.5; C44.6; C44.7; C44.8; C44.9; C51.0; C51.1; C51.2; C51.8; C51.9; C52.9; C53.0; C53.1; C53.8; C53.9; C54.0; C54.1; C54.2; C54.3; C54.8; C54.9; C55.9; C56.9; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9; C61.9; C64.9; C65.9; C66.9; C67.0; C67.1; C67.2; C67.3; C67.4; C67.5; C67.6; C67.7; C67.8; C67.9; C68.0; C68.1; C68.8; C68.9; C74.3","table_field_CLINICAL_RECOMMENDATIONS":"Нейроэндокринные опухоли, 2020, КР610/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CVD: (винкристин 1,4 + дакарбазин 600 + циклофосфамид 750)","table_field_COMMENTS":"Кодирование нейроэндокринных опухолей по МКБ-10 происходит в соответствии с органной принадлежностью опухоли","table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":999,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1030,"subscribed":null,"table_field_MKB_CODE":"C15.0; C15.1; C15.2; C15.3; C15.4; C15.5; C15.8; C15.9; C16.0; C16.1; C16.2; C16.3; C16.4; C16.5; C16.6; C16.8; C16.9; C17.0; C17.1; C17.2; C17.3; C17.8; C17.9; C18.0; C18.1; C18.2; C18.3; C18.4; C18.5; C18.6; C18.7; C18.8; C18.9; C19.9; C20.9; C21.0; C21.1; C21.2; C21.8; C23.9; C24.0; C24.1; C24.8; C24.9; C25.0; C25.1; C25.2; C25.3; C25.4; C25.7; C25.8; C25.9; C26.0; C26.8; C26.9; C34.0; C34.1; C34.2; C34.3; C34.8; C34.9; C37.9; C73.9; C50.0; C50.1; C50.2; C50.3; C50.4; C50.5; C50.6; C50.8; C50.9; C44.0; C44.1; C44.2; C44.3; C44.4; C44.5; C44.6; C44.7; C44.8; C44.9; C51.0; C51.1; C51.2; C51.8; C51.9; C52.9; C53.0; C53.1; C53.8; C53.9; C54.0; C54.1; C54.2; C54.3; C54.8; C54.9; C55.9; C56.9; C57.0; C57.1; C57.2; C57.3; C57.4; C57.7; C57.8; C57.9; C61.9; C64.9; C65.9; C66.9; C67.0; C67.1; C67.2; C67.3; C67.4; C67.5; C67.6; C67.7; C67.8; C67.9; C68.0; C68.1; C68.8; C68.9; C74.3","table_field_CLINICAL_RECOMMENDATIONS":"Нейроэндокринные опухоли, 2020, КР610/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Вемурафениб: (вемурафениб 240-960)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1000,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1031,"subscribed":null,"table_field_MKB_CODE":"C91.4","table_field_CLINICAL_RECOMMENDATIONS":"Волосатоклеточный лейкоз, 2020, КР130/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"BR, RB: (бендамустин 70 + ритуксимаб 375)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1001,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1032,"subscribed":null,"table_field_MKB_CODE":"C91.4","table_field_CLINICAL_RECOMMENDATIONS":"Волосатоклеточный лейкоз, 2020, КР130/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Меркаптопурин + метотрексат + третиноин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1002,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1033,"subscribed":null,"table_field_MKB_CODE":"C92.4","table_field_CLINICAL_RECOMMENDATIONS":"Острый промиелоцитарный лейкоз, 2020, КР132/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Мышьяка триоксид + третиноин","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1003,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1034,"subscribed":null,"table_field_MKB_CODE":"C92.4","table_field_CLINICAL_RECOMMENDATIONS":"Острый промиелоцитарный лейкоз, 2020, КР132/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Иматиниб: (иматиниб 300-400, 2 раза в день)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1004,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1035,"subscribed":null,"table_field_MKB_CODE":"C92.1","table_field_CLINICAL_RECOMMENDATIONS":"Хронический миелолейкоз, 2020, КР142/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Нилотиниб: (нилотиниб 300-400)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1005,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1036,"subscribed":null,"table_field_MKB_CODE":"C92.1","table_field_CLINICAL_RECOMMENDATIONS":"Хронический миелолейкоз, 2020, КР142/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Дазатиниб: (дазатиниб 50-140)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1006,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1037,"subscribed":null,"table_field_MKB_CODE":"C92.1","table_field_CLINICAL_RECOMMENDATIONS":"Хронический миелолейкоз, 2020, КР142/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бозутиниб","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1007,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1038,"subscribed":null,"table_field_MKB_CODE":"C92.1","table_field_CLINICAL_RECOMMENDATIONS":"Хронический миелолейкоз, 2020, КР142/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Гидроксикарбамид: (гидроксикарбамид 10-40)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1008,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1039,"subscribed":null,"table_field_MKB_CODE":"C92.1","table_field_CLINICAL_RECOMMENDATIONS":"Хронический миелолейкоз, 2020, КР142/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"ABVD: (доксорубицин 25 + блеомицин 10 + винбластин 6 + дакарбазин 375)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1019,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1040,"subscribed":null,"table_field_MKB_CODE":"C81.0; C81.1; C81.2; C81.3; C81.4; C81.7; C81.9","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома Ходжкина, 2020, КР139/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"BEACOPP-эскалированный: (блеомицин 10 + винкристин 1,4 + доксорубицин 35 + преднизолон 40 + прокарбазин 100 + циклофосфамид 1250 + этопозид 200)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1020,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1041,"subscribed":null,"table_field_MKB_CODE":"C81.0; C81.1; C81.2; C81.3; C81.4; C81.7; C81.9","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома Ходжкина, 2020, КР139/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"BEACOPP-эскалированный: (блеомицин 10 + винкристин 1,4 + дакарбазин 375 + доксорубицин 35 + преднизолон 40 + циклофосфамид 1250 + этопозид 200)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1021,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1042,"subscribed":null,"table_field_MKB_CODE":"C81.0; C81.1; C81.2; C81.3; C81.4; C81.7; C81.9","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома Ходжкина, 2020, КР139/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"EACOPP-14: (винкристин 1,4 + доксорубицин 50 + преднизолон 40 + прокарбазин 100 + циклофосфамид 650 + этопозид 200)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1022,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1043,"subscribed":null,"table_field_MKB_CODE":"C81.0; C81.1; C81.2; C81.3; C81.4; C81.7; C81.9","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома Ходжкина, 2020, КР139/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"EACOPP-14: (винкристин 1,4 + дакарбазин 375 + доксорубицин 50 + преднизолон 40 + циклофосфамид 650 + этопозид 200)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1023,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1044,"subscribed":null,"table_field_MKB_CODE":"C81.0; C81.1; C81.2; C81.3; C81.4; C81.7; C81.9","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома Ходжкина, 2020, КР139/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"R-CHOEP: (винкристин 1,4 + доксорубицин 50 + преднизолон 100 + ритуксимаб 375 + циклофосфамид 750 + этопозид 100)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1024,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1045,"subscribed":null,"table_field_MKB_CODE":"С83.3; С83.7; С85.2; С91.8","table_field_CLINICAL_RECOMMENDATIONS":"Агрессивные нефолликулярные лимфомы – диффузная крупноклеточная В-клеточная лимфома, первичная медиастинальная В-клеточная лимфома, лимфома Беркитта, 2020, КР129/2","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CHOEP: (винкристин 2 + доксорубицин 50 + преднизолон 100 + циклофосфамид 750 + этопозид 100, цикл 21 день)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4765,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1046,"subscribed":null,"table_field_MKB_CODE":"C84.5; C84.6; C84.7; C84.9; C86.0; C86.5","table_field_CLINICAL_RECOMMENDATIONS":"Нодальные Т-клеточные лимфомы, 2020, КР138/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CHOEP: (винкристин 2 + доксорубицин 50 + преднизолон 100 + циклофосфамид 750 + этопозид 100, цикл 14 день)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4766,"table_field_ID_FFOMS":" ","table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1047,"subscribed":null,"table_field_MKB_CODE":"C84.5; C84.6; C84.7; C84.9; C86.0; C86.5","table_field_CLINICAL_RECOMMENDATIONS":"Нодальные Т-клеточные лимфомы, 2020, КР138/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"R-BAC: (бендамустин 70 + ритуксимаб 375 + цитарабин 500)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1025,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1048,"subscribed":null,"table_field_MKB_CODE":"C83.1","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома из клеток мантии, 2020, КР136/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"RiBVD, Ri-BVD: (бендамустин 90 + бортезомиб 1,3 + дексаметазон 40 + ритуксимаб 375)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1026,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1049,"subscribed":null,"table_field_MKB_CODE":"C83.1","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома из клеток мантии, 2020, КР136/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"VR-CAP: (бортезомиб 1,3 + доксорубицин 50 + преднизолон 100 + ритуксимаб 375 + циклофосфамид 750)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4767,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1050,"subscribed":null,"table_field_MKB_CODE":"C83.1","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома из клеток мантии, 2020, КР136/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"DeVic: (дексаметазон 40 + ифосфамид 1000 + карбоплатин 200 + этопозид 67)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1027,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1051,"subscribed":null,"table_field_MKB_CODE":"C84.5; C84.6; C84.7; C84.9; C86.0; C86.5","table_field_CLINICAL_RECOMMENDATIONS":"Нодальные Т-клеточные лимфомы, 2020, КР138/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"R-CHOEP: (винкристин 1,4 + доксорубицин 50 + преднизолон 40 + ритуксимаб 375 + циклофосфамид 750 + этопозид 75)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1028,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1052,"subscribed":null,"table_field_MKB_CODE":"C83.1","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома из клеток мантии, 2020, КР136/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"R-DHAP: (дексаметазон 40 + ритуксимаб 375 + цисплатин 100 + цитарабин 2000)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1029,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1053,"subscribed":null,"table_field_MKB_CODE":"C83.1","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома из клеток мантии, 2020, КР136/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"R-DHAP: (дексаметазон 40 + оксалиплатин 120 + ритуксимаб 375 + цитарабин 2000)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1030,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1054,"subscribed":null,"table_field_MKB_CODE":"C83.1","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома из клеток мантии, 2020, КР136/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"R-MaxiCHOP: (винкристин 2 + доксорубицин 75 + преднизолон 100 + ритуксимаб 375 + циклофосфамид 1200)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1031,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1055,"subscribed":null,"table_field_MKB_CODE":"C83.1","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома из клеток мантии, 2020, КР136/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"R-HAD: (дексаметазон 40 + ритуксимаб 375 + цитарабин 3000)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1032,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1056,"subscribed":null,"table_field_MKB_CODE":"C83.1","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома из клеток мантии, 2020, КР136/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"EACOPP-14: (винкристин 1,4 + дексаметазон 20 + доксорубицин 50 + прокарбазин 100 + циклофосфамид 650 + этопозид 200)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1033,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1057,"subscribed":null,"table_field_MKB_CODE":"C81.0; C81.1; C81.2; C81.3; C81.4; C81.7; C81.9","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома Ходжкина, 2020, КР139/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"EACOPP-14: (винкристин 1,4 + дакарбазин 375 + дексаметазон 20 + доксорубицин 50 + циклофосфамид 650 + этопозид 200)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1034,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1058,"subscribed":null,"table_field_MKB_CODE":"C81.0; C81.1; C81.2; C81.3; C81.4; C81.7; C81.9","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома Ходжкина, 2020, КР139/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"BEACOPP-14: (блеомицин 10 + винкристин 1,4 + доксорубицин 25 + преднизолон 40 + прокарбазин 100 + циклофосфамид 650 + этопозид 100)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1035,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1059,"subscribed":null,"table_field_MKB_CODE":"C81.0; C81.1; C81.2; C81.3; C81.4; C81.7; C81.9","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома Ходжкина, 2020, КР139/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"BEACOPP-14: (блеомицин 10 + винкристин 1,4 + дексаметазон 20 + доксорубицин 25 + прокарбазин 100 + циклофосфамид 650 + этопозид 100)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1036,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1060,"subscribed":null,"table_field_MKB_CODE":"C81.0; C81.1; C81.2; C81.3; C81.4; C81.7; C81.9","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома Ходжкина, 2020, КР139/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"OEPA: (винкристин 1,5 + доксорубицин 40 + преднизолон 60 + этопозид 125)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1037,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1061,"subscribed":null,"table_field_MKB_CODE":"C81.0; C81.1; C81.2; C81.3; C81.4; C81.7; C81.9","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома Ходжкина, 2020, КР139/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"BV-AVD: (брентуксимаб ведотин 1,2 + винбластин 6 + дакарбазин 375 + доксорубицин 25)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4768,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1062,"subscribed":null,"table_field_MKB_CODE":"C81.0; C81.1; C81.2; C81.3; C81.4; C81.7; C81.9","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома Ходжкина, 2020, КР139/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"COPDAC: (винкристин 1,5 + дакарбазин 250 + преднизолон 40 + циклофосфамид 500)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1038,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1063,"subscribed":null,"table_field_MKB_CODE":"C81.0; C81.1; C81.2; C81.3; C81.4; C81.7; C81.9","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома Ходжкина, 2020, КР139/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"ChlVPP: (винбластин 6 + преднизолон 40 + прокарбазин 100 + хлорамбуцил 6)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1039,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1064,"subscribed":null,"table_field_MKB_CODE":"C81.0; C81.1; C81.2; C81.3; C81.4; C81.7; C81.9","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома Ходжкина, 2020, КР139/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CVPP: (винбластин 6 + преднизолон 40 + прокарбазин 100 + циклофосфамид 600)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1040,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1065,"subscribed":null,"table_field_MKB_CODE":"C81.0; C81.1; C81.2; C81.3; C81.4; C81.7; C81.9","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома Ходжкина, 2020, КР139/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"COPP: (винкристин 1,4 + преднизолон 40 + прокарбазин 100 + циклофосфамид 600)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1041,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1066,"subscribed":null,"table_field_MKB_CODE":"C81.0; C81.1; C81.2; C81.3; C81.4; C81.7; C81.9","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома Ходжкина, 2020, КР139/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"IVDG: (винбластин 5 + гемцитабин 800 + дакарбазин 375 + идарубицин 5)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1042,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1067,"subscribed":null,"table_field_MKB_CODE":"C81.0; C81.1; C81.2; C81.3; C81.4; C81.7; C81.9","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома Ходжкина, 2020, КР139/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"VEPEMB: (блеомицин 10 + винбластин 6 + митоксантрон 6 + преднизолон 30 + прокарбазин 100 + циклофосфамид 500 + этопозид 60)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1043,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1068,"subscribed":null,"table_field_MKB_CODE":"C81.0; C81.1; C81.2; C81.3; C81.4; C81.7; C81.9","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома Ходжкина, 2020, КР139/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CVP: (винбластин 6 + преднизолон 692 + циклофосфамид 1000)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":1044,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1069,"subscribed":null,"table_field_MKB_CODE":"C81.0; C81.1; C81.2; C81.3; C81.4; C81.7; C81.9","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома Ходжкина, 2020, КР139/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"R-BAC: (бендамустин 70 + ритуксимаб 375 + цитарабин 800)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4769,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1070,"subscribed":null,"table_field_MKB_CODE":"C83.1","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома из клеток мантии, 2020, КР136/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"R-BAC: (бендамустин 70 + ритуксимаб 375→1400 + цитарабин 800)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4770,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1071,"subscribed":null,"table_field_MKB_CODE":"C83.1","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома из клеток мантии, 2020, КР136/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"VR-CAP: (бортезомиб 1,3 + доксорубицин 50 + преднизолон 100 + ритуксимаб 375→1400 + циклофосфамид 750)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4771,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1072,"subscribed":null,"table_field_MKB_CODE":"C83.1","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома из клеток мантии, 2020, КР136/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"R-DHAP: (дексаметазон 40 + ритуксимаб 1400 + цисплатин 100 + цитарабин 2000)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4772,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1073,"subscribed":null,"table_field_MKB_CODE":"C83.1","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома из клеток мантии, 2020, КР136/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"R-DHAP: (дексаметазон 40 + оксалиплатин 120 + ритуксимаб 1400 + цитарабин 2000)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4773,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1074,"subscribed":null,"table_field_MKB_CODE":"C83.1","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома из клеток мантии, 2020, КР136/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"R-MaxiCHOP: (винкристин 2 + доксорубицин 75 + преднизолон 100 + ритуксимаб 375→1400 + циклофосфамид 1200)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4774,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1075,"subscribed":null,"table_field_MKB_CODE":"C83.1","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома из клеток мантии, 2020, КР136/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"R-HAD: (дексаметазон 40 + ритуксимаб 1400 + цитарабин 3000)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4775,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1076,"subscribed":null,"table_field_MKB_CODE":"C83.1","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома из клеток мантии, 2020, КР136/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"R-CHOEP: (винкристин 1,4 + доксорубицин 50 + преднизолон 40 + ритуксимаб 375→1400 + циклофосфамид 750 + этопозид 75)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4776,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1077,"subscribed":null,"table_field_MKB_CODE":"C83.1","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома из клеток мантии, 2020, КР136/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"R-HAD + B: (бортезомиб 1,5 + дексаметазон 40 + ритуксимаб 375 + цитарабин 2000)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4777,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1078,"subscribed":null,"table_field_MKB_CODE":"C83.1","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома из клеток мантии, 2020, КР136/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"R-HAD + B: (бортезомиб 1,5 + дексаметазон 40 + ритуксимаб 375→1400 + цитарабин 2000)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4778,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1079,"subscribed":null,"table_field_MKB_CODE":"C83.1","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома из клеток мантии, 2020, КР136/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"PEPC: (преднизолон 20 + прокарбазин 50 + циклофосфамид 50 + этопозид 50)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4779,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1080,"subscribed":null,"table_field_MKB_CODE":"C83.1","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома из клеток мантии, 2020, КР136/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Ибрутиниб: (ибрутиниб 560)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4780,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1081,"subscribed":null,"table_field_MKB_CODE":"C83.1","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома из клеток мантии, 2020, КР136/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Ибрутиниб + ритуксимаб: (ибрутиниб 560 + ритуксимаб 375)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4781,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1082,"subscribed":null,"table_field_MKB_CODE":"C83.1","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома из клеток мантии, 2020, КР136/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Ибрутиниб + ритуксимаб: (ибрутиниб 560 + ритуксимаб 375→1400)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4782,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1083,"subscribed":null,"table_field_MKB_CODE":"C83.1","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома из клеток мантии, 2020, КР136/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"43"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"43 (Иммунотерапия)","table_field_NAME_REGIMEN":"Леналидомид: (леналидомид 25)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4783,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1084,"subscribed":null,"table_field_MKB_CODE":"C83.1","table_field_CLINICAL_RECOMMENDATIONS":"Лимфома из клеток мантии, 2020, КР136/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"43"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"43 (Иммунотерапия)","table_field_NAME_REGIMEN":"Интерферон альфа-2b: (интерферон альфа-2b 3-10 млн, еженедельно)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4784,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1085,"subscribed":null,"table_field_MKB_CODE":"C84.0","table_field_CLINICAL_RECOMMENDATIONS":"Грибовидный микоз, 2020, КР223/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"43"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"43 (Иммунотерапия)","table_field_NAME_REGIMEN":"Интерферон альфа-2b: (интерферон альфа-2b 3-10 млн, 3 раза в неделю)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4785,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1086,"subscribed":null,"table_field_MKB_CODE":"C84.0","table_field_CLINICAL_RECOMMENDATIONS":"Грибовидный микоз, 2020, КР223/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"Винбластин: (винбластин 6)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4786,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1087,"subscribed":null,"table_field_MKB_CODE":"C84.5; C84.6; C84.7; C84.9; C86.0; C86.5","table_field_CLINICAL_RECOMMENDATIONS":"Нодальные Т-клеточные лимфомы, 2020, КР138/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CHOP: (винкристин 2 + доксорубицин 50 + преднизолон 100 + циклофосфамид 750)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4787,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1088,"subscribed":null,"table_field_MKB_CODE":"C84.5; C84.6; C84.7; C84.9; C86.0; C86.5","table_field_CLINICAL_RECOMMENDATIONS":"Нодальные Т-клеточные лимфомы, 2020, КР138/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CHOP: (винкристин 1,4 + доксорубицин 50 + преднизолон 100 + циклофосфамид 750)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4788,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1089,"subscribed":null,"table_field_MKB_CODE":"C84.0","table_field_CLINICAL_RECOMMENDATIONS":"Грибовидный микоз, 2020, КР223/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"DA-EPOCH: (винкристин 0,4 + доксорубицин 10 + преднизолон 60 + циклофосфамид 750 + этопозид 50)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4789,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1090,"subscribed":null,"table_field_MKB_CODE":"C84.5; C84.6; C84.7; C84.9; C86.0; C86.5","table_field_CLINICAL_RECOMMENDATIONS":"Нодальные Т-клеточные лимфомы, 2020, КР138/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"DHAP: (дексаметазон 40 + цисплатин 100 + цитарабин 2000)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4790,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1091,"subscribed":null,"table_field_MKB_CODE":"C84.5; C84.6; C84.7; C84.9; C86.0; C86.5","table_field_CLINICAL_RECOMMENDATIONS":"Нодальные Т-клеточные лимфомы, 2020, КР138/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"DHAP + брентуксимаб ведотин: (брентуксимаб ведотин 1,2 + дексаметазон 40 + цисплатин 70 + цитарабин 2000)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4791,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1092,"subscribed":null,"table_field_MKB_CODE":"C84.5; C84.6; C84.7; C84.9; C86.0; C86.5","table_field_CLINICAL_RECOMMENDATIONS":"Нодальные Т-клеточные лимфомы, 2020, КР138/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"ESHAP: (метилпреднизолон 500 + цисплатин 25 + цитарабин 2000 + этопозид 40, цикл 21 день)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4792,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1093,"subscribed":null,"table_field_MKB_CODE":"C84.5; C84.6; C84.7; C84.9; C86.0; C86.5","table_field_CLINICAL_RECOMMENDATIONS":"Нодальные Т-клеточные лимфомы, 2020, КР138/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"ESHAP: (метилпреднизолон 500 + цисплатин 25 + цитарабин 2000 + этопозид 40, цикл 28 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4793,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1094,"subscribed":null,"table_field_MKB_CODE":"C84.5; C84.6; C84.7; C84.9; C86.0; C86.5","table_field_CLINICAL_RECOMMENDATIONS":"Нодальные Т-клеточные лимфомы, 2020, КР138/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"ICE: (ифосфамид 1700 + ифосфамид 1600 + карбоплатин 5 + этопозид 100)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4794,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1095,"subscribed":null,"table_field_MKB_CODE":"C84.5; C84.6; C84.7; C84.9; C86.0; C86.5","table_field_CLINICAL_RECOMMENDATIONS":"Нодальные Т-клеточные лимфомы, 2020, КР138/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"GDP: (гемцитабин 1000 + дексаметазон 40 + цисплатин 70)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4795,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1096,"subscribed":null,"table_field_MKB_CODE":"C84.5; C84.6; C84.7; C84.9; C86.0; C86.5","table_field_CLINICAL_RECOMMENDATIONS":"Нодальные Т-клеточные лимфомы, 2020, КР138/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"VIPD: (дексаметазон 40 + ифосфамид 1200 + цисплатин 33 + этопозид 100)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4796,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1097,"subscribed":null,"table_field_MKB_CODE":"C84.5; C84.6; C84.7; C84.9; C86.0; C86.5","table_field_CLINICAL_RECOMMENDATIONS":"Нодальные Т-клеточные лимфомы, 2020, КР138/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"AspMetDex: (аспарагиназа 6000 + дексаметазон 40 + метотрексат 3000)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4797,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1098,"subscribed":null,"table_field_MKB_CODE":"C84.5; C84.6; C84.7; C84.9; C86.0; C86.5","table_field_CLINICAL_RECOMMENDATIONS":"Нодальные Т-клеточные лимфомы, 2020, КР138/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"VMP: (бортезомиб 1,3 + мелфалан 9 + преднизолон 60, дни приема бортезомиба 1, 4, 8, 11, 22, 25, 29, 32)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4798,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1099,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"VMP: (бортезомиб 1,3 + мелфалан 9 + преднизолон 60, дни приема бортезомиба 1, 8, 22, 29)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4799,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1100,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"VMP: (бортезомиб 1,3 + мелфалан 9 + преднизолон 60, дни приема бортезомиба 1, 8, 15, 22)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4800,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1101,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"VD: (бортезомиб 1,3 + дексаметазон 40)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4801,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1102,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"VD: (бортезомиб 1,3 + дексаметазон 20)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4802,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1103,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"VCP: (бортезомиб 1,3 + преднизолон 30 + циклофосфамид 50)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4803,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1104,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"43"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"43 (Иммунотерапия)","table_field_NAME_REGIMEN":"Rd: (дексаметазон 40 + леналидомид 25, дни приема дексаметазона 1,8,15,22)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4804,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1105,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"43"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"43 (Иммунотерапия)","table_field_NAME_REGIMEN":"MPR: (леналидомид 10 + мелфалан 0,18 + преднизолон 2)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4805,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1106,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"43"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"43 (Иммунотерапия)","table_field_NAME_REGIMEN":"Леналидомид: (леналидомид 10)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4806,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1107,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"MP: (мелфалан 8-10 + преднизолон 60)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4807,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1108,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"MP: (мелфалан 9 + преднизолон 100)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4808,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1109,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CP: (преднизолон 40-60 + циклофосфамид 200, цикл 21 день)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4809,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1110,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CP: (преднизолон 40-60 + циклофосфамид 200, цикл 28 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4810,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1111,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"BP: (бендамустин 100-150 + преднизолон 60)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4811,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1112,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"PAD: (бортезомиб 1,3 + дексаметазон 40 + доксорубицин 9)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4812,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1113,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"CVD, VCD: (бортезомиб 1,3 + дексаметазон 40 + циклофосфамид 400)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4813,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1114,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"CVD, VCD: (бортезомиб 1,3 + дексаметазон 40 + циклофосфамид 200)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4814,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1115,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"CVD, VCD: (бортезомиб 1,3 + дексаметазон 40 + циклофосфамид 50)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4815,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1116,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"CVD, VCD: (бортезомиб 1,3 + дексаметазон 20 + циклофосфамид 400)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4816,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1117,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"CVD, VCD: (бортезомиб 1,3 + дексаметазон 20 + циклофосфамид 200)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4817,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1118,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"CVD, VCD: (бортезомиб 1,3 + дексаметазон 20 + циклофосфамид 50, цикл 21 день, прием циклофосфамида в 1-14 дни)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4818,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1119,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бортезомиб: (бортезомиб 1,3, цикл 21 день)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4819,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1120,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Бортезомиб: (бортезомиб 1,3, цикл 35 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4820,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1121,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Vel + PLD: (бортезомиб 1,3 + доксорубицин)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4821,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1122,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"CVD, VCD: (бортезомиб 1,3 + дексаметазон 20 + циклофосфамид 50, цикл 21 день, прием циклофосфамида в 1-21 дни)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4822,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1123,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"CVD, VCD: (бортезомиб 1,3 + дексаметазон 20 + циклофосфамид 50, цикл 35 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4823,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1124,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"CVD, VCD: (бортезомиб 1,3 + дексаметазон 20 + циклофосфамид 500)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4824,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1125,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"43"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"43 (Иммунотерапия)","table_field_NAME_REGIMEN":"Rd: (дексаметазон 40 + леналидомид 25, дни приема дексаметазона 1-4)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4825,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1126,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"43"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"43 (Иммунотерапия)","table_field_NAME_REGIMEN":"Rd: (дексаметазон 40 + леналидомид 25, дни приема дексаметазона 1-4, 15-18)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4826,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1127,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"43"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"43 (Иммунотерапия)","table_field_NAME_REGIMEN":"Rd: (дексаметазон 40 + леналидомид 25, дни приема дексаметазона 1-4, 9-12, 17-20)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4827,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1128,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"VRD: (бортезомиб 1,3 + дексаметазон 40 + леналидомид 25)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4828,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1129,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"43"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"43 (Иммунотерапия)","table_field_NAME_REGIMEN":"RAD: (дексаметазон 40 + доксорубицин 9 + леналидомид 25)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4829,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1130,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"43"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"43 (Иммунотерапия)","table_field_NAME_REGIMEN":"RCD: (дексаметазон 20 + леналидомид 25 + циклофосфамид 500)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4830,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1131,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"43"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"43 (Иммунотерапия)","table_field_NAME_REGIMEN":"RCP: (леналидомид 25 + преднизолон 100 + циклофосфамид 300)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4831,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1132,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"BP: (бендамустин 100 + преднизолон 1)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4832,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1133,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"BBD: (бендамустин 70 + бортезомиб 1,3 + дексаметазон 20)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4833,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1134,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"43"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"43 (Иммунотерапия)","table_field_NAME_REGIMEN":"BRD: (бендамустин 75 + дексаметазон 40 + леналидомид 10)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4834,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1135,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"43"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"43 (Иммунотерапия)","table_field_NAME_REGIMEN":"Pom + dex: (дексаметазон 40 + помалидомид 4)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4835,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1136,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Карфилзомиб: (карфилзомиб 20)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4836,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1137,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Карфилзомиб: (карфилзомиб 27)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4837,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1138,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Kd: (дексаметазон 20 + карфилзомиб 56)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4838,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1139,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Kd: (дексаметазон 20 + карфилзомиб 20)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4839,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1140,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"KRd: (дексаметазон 40 + карфилзомиб 27 + леналидомид 25, дни приема карфилзомиба 1,2,8,9,15,16)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4840,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1141,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"KRd: (дексаметазон 40 + карфилзомиб 27 + леналидомид 25, дни приема карфилзомиба 1,2,15,16)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4841,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1142,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"IxaRd: (дексаметазон 40 + иксазомиб 4 + леналидомид 25)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4842,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1143,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"EloRd: (дексаметазон 40 + леналидомид 25 + элотузумаб 10)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4843,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1144,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Даратумумаб: (даратумумаб 16, цикл 7 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4844,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1145,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Даратумумаб: (даратумумаб 16, цикл 14 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4845,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1146,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Даратумумаб: (даратумумаб 16, цикл 28 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4846,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1147,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Dara-VD: (бортезомиб 1,3 + даратузумаб 16 + дексаметазон 20, цикл даратузумаба 7 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4847,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1148,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Dara-VD: (бортезомиб 1,3 + даратузумаб 16 + дексаметазон 20, цикл даратузумаба 21 день)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4848,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1149,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Dara-Rd: (бортезомиб 1,3 + даратумумаб 16 + леналидомид 25, цикл дратумумаба 7 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4849,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1150,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Dara-Rd: (бортезомиб 1,3 + даратумумаб 16 + леналидомид 25, цикл дратумумаба 14 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4850,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1151,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"44"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"44 (Таргетная терапия)","table_field_NAME_REGIMEN":"Dara-Rd: (бортезомиб 1,3 + даратумумаб 16 + леналидомид 25, цикл дратумумаба 28 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4851,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1152,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"VMCP: (винкристин 1 + мелфалан 6 + преднизолон 60 + циклофосфамид 125, цикл 21 день)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4852,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1153,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"VMCP: (винкристин 1 + мелфалан 6 + преднизолон 60 + циклофосфамид 125, цикл 28 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4853,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1154,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"VBAP: (винкристин 1 + доксорубицин 30 + кармустин 30 + преднизолон 60, цикл 21 день)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4854,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1155,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"VBAP: (винкристин 1 + доксорубицин 30 + кармустин 30 + преднизолон 60, цикл 28 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4855,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1156,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"VBAP: (винкристин 1 + доксорубицин 30 + ломустин 80 + преднизолон 60, цикл 21 день)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4856,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1157,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"VBAP: (винкристин 1 + доксорубицин 30 + ломустин 80 + преднизолон 60, цикл 28 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4857,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1158,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"VBMCP, M2: (винкристин 1,2 + кармустин 30 + мелфалан 8 + преднизолон 40 + циклофосфамид 400, цикл 35 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4858,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1159,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"VBMCP, M2: (винкристин 1,2 + кармустин 30 + мелфалан 8 + преднизолон 40 + циклофосфамид 400, цикл 42 дня)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4859,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1160,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"VBMCP, M2: (винкристин 1,2 + ломустин 80 + мелфалан 8 + преднизолон 40 + циклофосфамид 400, цикл 35 дней)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4860,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1161,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"VBMCP, M2: (винкристин 1,2 + ломустин 80 + мелфалан 8 + преднизолон 40 + циклофосфамид 400, цикл 42 дня)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4861,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1162,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}
{"searchInput":null,"table_field_ID_TYPE_ref":{"value":"41"},"table_field_dictionaryId":null,"table_field_ID_TYPE":"41 (Химиотерапия)","table_field_NAME_REGIMEN":"CD: (дексаметазон 40 + циклофосфамид 600)","table_field_COMMENTS":null,"table_field_RELEVANCE_RUSSIA":"Актуальный","SYS_RECORDID":4862,"table_field_ID_FFOMS":null,"table_field_RELEVANCE__INTERNATIONAL":null,"table_field_ID":1163,"subscribed":null,"table_field_MKB_CODE":"C90.0","table_field_CLINICAL_RECOMMENDATIONS":"Множественная миелома, 2020, КР144/1","table_field_NAME_INTERNATIONAL_PROTOCOL":null,"version":{"id":14373}}